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ABBREVIATIONS 
(Boc)2O  di-tert-butyl dicarbonate 
Å   Ångström 
abs.   absolute 
AIBN   2,2azobisisobutyronitrile 
Ala   alanine 
Arg   arginine 
ATP   adenosine triphosphate 
Boc   tert-butyloxycarbonyl 
CDCl3   deuterochloroform 
CH2Cl2  dichloromethane 
CHCl3   chloroform 
COSY   correlation spectroscopy 
Cyt b   cytochrome b 
Cyt c   cytochrome c 
DBH2   reduced decylubiquinone 
DCPIP   2,6-dichlorophenolindophenol 
de   diastereomeric excess 
DIBAL  diisobutylaluminium hydride 
DIPEA  N,N-diisopropylethylamine (Hünig's base) 
DMAP   4-dimethylaminopyridine 
DMSO  dimethyl sulfoxide 
dr   diastereoisomeric ratio 
E   entgegen 
EDC·HCl  N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
ee   enantiomeric excess 
eq.   equivalent 
Et2O   diethyl ether 
Et3N   triethylamine 
EtOH   ethanol 
FRAC   Fungicide Resistance Action Committee 
HETCOR  heteronuclear correlation spectroscopy 
His   histidine 
HMBC  heteronuclear multiple bond correlation 
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HMDS  bis(trimethylsilyl)amine 
HMPA  hexamethylphosphoramide 
HOBt   1-hydroxybenzotriazole 
HSQC   heteronuclear single quantum correlation 
IC50   half maximal inhibitory concentration 
Ile   isoleucine 
Leu   leucine 
MA   malt extract agar 
MeOH   methanol 
Met   methionine 
min.   minute 
mp   melting point 
MS   molecular sieves 
MTPA   α-methoxy-α-trifluoromethylphenylacetic acid 
MTPACl  α-methoxy-α-trifluoromethyl-phenylacetyl chloride 
NADH  nicotinamide adenine dinucleotide 
NBS   N-bromosuccinimide 
nBuLi   n-butyllithium 
NMR   nuclear magnetic resonance 
NOE   nuclear Overhauser effect 
NOESY  nuclear Overhauser effect spectroscopy 
Phe   phenylalanine 
PPTS   pyridinium p-toluenesulfonate 
Pro   proline 
Q   quinone ‘outer’ binding site 
R   Rectus 
rt   room temperature 
S   Sinister 
SDH   succinate dehydrogenase 
SDHA   succinate dehydrogenase complex flavoprotein subunit A 
SDHB   succinate dehydrogenase complex iron sulfur subunit B 
SDHC   succinate dehydrogenase complex subunit C 
SDHD   succinate dehydrogenase complex subunit D 
SDHI   succinate dehydrogenase inhibitor 
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TBAI   tetrabutylammonium iodide 
THF   tetrahydrofuran 
TPAP   tetrapropylammonium perruthenate 
Trp   tryptophan 
Tyr   tyrosine 
Val   valine 
X   undefined halide 
Z   zussamen 
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ABSTRACT 
Currently, the increase of food demand of a steadily growing human population is not 
balanced by a global agricultural supply. As a consequence, crop protection plays a crucial 
role in maximising crop productivity and preventing losses caused by biological and not 
biological agents. Biological agents, collectively named as pests, are responsible for 
quantitative losses ranging from 20 % to 40 %, and qualitative losses, thus reducing the value 
of crops. For these reasons, new methods to control pests must be developed.The discovery of 
new agrochemicals is necessary to face the problem of the emergence of resistances and the 
increasing of stringent regulatory standards, which are leading to the ban of many products no 
longer considered acceptable. All these factors are changing the research of new pesticides 
that is becoming a more expensive and time-consuming process. Thus, new methods to 
improve and speed up the discovery of new agrochemicals must be developed. In this context, 
the aim of this Ph.D. thesis was to explore new approaches to the synthesis of agrochemicals. 
Our attention was focused on the naturally derived compound-based molecules, due to the 
proved value of these compounds in development of agrochemicals and more in general of 
biologically active compounds. 
The first part of this Ph.D. thesis is focused on the development of dual-target fungicides 
obtained by combination of the naturally derived strobilurin fungicides with succinate 
dehydrogenase inhibitors. The development of dual-target molecules is a well-known 
approach in pharmaceutic research, while it is still underexplored in the field of 
agrochemicals. The research work was organized following a cycle of design, synthesis, in 
vitro tests, and evaluation of the mechanism of action. The dual-target compounds were 
designed on the basis of the reported structure-activity relationship for both the classes of 
fungicides. The designed compounds were synthetized, and the antifungal activity was 
screened in vitro by measurement of the mycelium growth inhibition. Finally, the mechanism 
of action was evaluated in silico by docking studies and in vitro in a cell free system. 
The second part of this dissertation was focused on the development of versatile synthetic 
approaches in the synthesis of biologically active natural compounds. SmI2 chemistry was 
employed in light of the remarkable synthetic power of this reagent. First, a SmI2-mediated 
Reformatsky reaction was developed as a complementary approach to Evans aldol reaction 
for the synthesis of precursors of cembranoids. Then, a SmI2-mediated pinacol coupling was 
investigated as a key step for the synthesis of the natural herbicide auscalitoxin aglycone. 
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RIASSUNTO 
La domanda di cibo della popolazione umana in costanta crescita non è attualmente 
soddisfatta dalla produzione agricola globale. Come conseguenza la protezione delle colture 
gioca un ruolo di vitale importanza nel massimizzare le rese produttive e nel prevenire le 
perdite provocate da fattori sia abiotici che biotici. Gli agenti biologici sono causa di perdite 
quantitative, comprese tra il 20 % e il 40 %, ma possono provocare anche perdite qualitative 
riducendo il valore dei raccolti. Per questi motivi è importante lo sviluppo di nuovi metodi di 
controllo, tra cui anche nuovi agrofarmaci. Lo sviluppo di nuovi agrofarmaci è indispensabile 
anche per affrontare il problema dell’insorgenza di resistenze e per compensare la messa al 
bando di prodotti in uso a causa dell’aumentata pressione regolatoria in termini di salute 
umana e ambientale. Questi ultimi fattori hanno come conseguenza l’aumento dei tempi e dei 
costi di ricerca e sviluppo di nuovi prodotti e, di conseguenza, diventa importante trovare 
nuovi metodi per accelerare e aumentare l’efficienza dei processi di ricercar e sviluppo. 
In questo contesto lo scopo di questa tesi di dottorato è l’esplorazione di nuovi potenziali 
approcci alla ricerca di nuovi agrofarmaci. La nostra attenzione è stata focalizzata in 
particolare verso molecule naturali o derivate da composti naturali per via della loro 
riconosciuta importanza nei processi di ricercar e sviluppo di nuovi agrofarmaci e, più in 
generale di nuove molecule biologicamente attive. 
La prima parte di questa tesi tratta lo sviluppo di fungicidi dual-target ottenuti combinando le 
strutture delle strobilurine con gli inibitori della succinato deidrogenasi, in quanto nonostante 
lo sviluppo di composti dual-target sia un approccio ben conosciuto in ambito farmaceutico 
nel campo degli agrofarmaci è quasi sconosciuto. Il lavoro di ricercar è stato organizzato 
secondo un ciclo di design, sintesi, test in vitro e valutazione dell’attività. I composti 
progettati sulla base delle relazioni struttura-attività di entrambe le classis ono stati sintetizzati 
e poi testati in vitro per la loro capacità di inibire la crescita del micelio. Infine, la loro attività 
è stata valutata in silico tramiti studi di docking e in vitro su frazioni mitocondriali isolate. 
La seconda parte della tesi tratta lo sviluppo di approcci sintetici alternativi nella sintesi di 
composti naturali. In particolare, l’attenzione è stata posta nei confronti della chimica del 
SmI2 per la dimostrata utilità e versatilità sintetica di questo reagente. Per prima è stata 
sviluppata una metodologia per la sintesi di precursori dei cembranoidi basata sull’utilizzo 
della reazione di Reformatsky mediate da SmI2. In seguito, è stato studiate un coupling 
pinacolico mediato da SmI2 come passaggio chiave per la sintesi dell’aglicone 
dell’auscalitossina. 
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1 INTRODUCTION 
 
Despite the world growth rates is declining, the human population is steadily growing, and it 
is estimated to reach 9.73 billion by 2050 and 11.2 billion by 2100. The growth of population 
is generally accompanied by increasing urbanization and this will lead to changes in dietary 
habits, that will eventually have a strong influence on the agriculture and the food systems.
1
 
Nowadays, the increase of food demand of a growing human population is not balanced by 
the increase of the global agricultural supply. This situation has dramatically worsened in the 
recent decades culminating in the 2007-8 and 2010-12 world food prices crisis.
2,3
 Crop 
protection has a pivotal role in meeting this increasing food demand. Animals, weeds and 
plant pathologies are altogether responsible for crop losses ranging from 20 % to 40 %. Food 
security can be divided into different components including food availability (production, 
import, storing), physical and economic access to food, and food utilisation (e.g. nutritional 
value, safety). Crop losses directly affect the first component of food security, but they can 
also affect directly or indirectly the others. Crop losses are not only related to yield reductions 
but also to post harvest quality losses and accumulation of toxins. The scope of crop 
protection is to maximise crop productivity preventing losses caused by biological and no 
biological agents. Currently, this is a still challenging problems, but new levels of complexity 
have arisen because of the reduction of natural resources (e.g. arable land, water, fertilizers, 
biodiversity) available for the agriculture.
4
 
 
1.1 Crop losses and pest control 
Crop losses can be caused by abiotic as well as by biotic factors. Abiotic factors include 
inadequate temperature, irradiation, water and nutrients supply, and, except for nutrient 
supply, only a limited control can be done. Biotic factors comprise animal organisms (insects, 
mites and other arthropods, nematodes, rodents, slugs and snails, birds), plant pathogens 
(fungi, bacteria, viruses) and weeds. All of these are collectively named as pests.  
Pests can cause crop losses in different ways and classified in different categories: stand 
reducers (damping-off pathogens), photosynthetic rate reducers (fungi, bacteria, viruses), leaf 
senescence accelerators (pathogens), light stealers (weeds, some pathogens), assimilate 
sappers (nematodes, pathogens, sucking arthropods), and tissue consumers (chewing animals, 
necrotrophic pathogens). Crop losses can be quantitative and/or qualitative: quantitative losses 
are the direct result of reduced productivity, conversely, qualitative losses are linked to the 
reduction of the value of crop related to a reduced content of valuable ingredients, reduced 
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market quality, reduced storage characteristics, or to the contamination of the harvested 
product with toxic products (e.g. mycotoxins).
5
 
Crop protection against pest can be obtained by applying physical and agronomical methods 
(e.g. weeding, crop rotation, improving growing conditions etc.), biological methods (e.g. 
resistant varieties, biological agents etc.) and/or the action of chemicals (pesticides). 
 
1.2 Pesticides 
In the Manual on development and use of FAO and WHO specifications for pesticides defines 
pesticides as: “Any substance or mixture of substances intended for preventing, destroying or 
controlling any pest, including vectors of human or animal disease, unwanted species of 
plants or animals causing harm during or otherwise interfering with the production, 
processing, storage, transport or marketing of food, agricultural commodities, wood and wood 
products or animal feedstuffs, or substances which may be administered to animals for the 
control of insects, arachnids or other pests in or on their bodies. The term includes substances 
intended for use as a plant growth regulator, defoliant, desiccant or agent for thinning fruit or 
preventing the premature fall of fruit. It is also used for substances applied to crops either 
before or after harvest to protect the commodity from deterioration during storage and 
transport.”6  
Pesticides are characterized by different structures with different physical and chemical 
properties; thus, different system of classification are adopted depending on the needs. The 
three most popular methods of classification currently in use were proposed by Drum.
7
 The 
three pesticides classification methods are based on the mode of entry, on the pesticide 
function and the pest organism they kill, and on the chemical composition. Classification 
based on the mode of entry considers the pathways used by pesticides to enter in contact or 
enter in the target pest organism. Thus, this method distinguishes systemic, non-systemic 
(contact), stomach poisonings and stomach toxicant, fumigant, and repellent pesticides. The 
second method considers the kind of pest controlled. The name of a group of pesticide 
usually, but not necessarily, derives from the name of the target pest with the suffix -cide (e.g. 
insecticides, fungicides, herbicides etc.). 
Classification based on the chemical composition is the most common method used. This 
method provides the largest number of information on the physicochemical properties, which 
are useful in determining the rates, modes, risks of application. Classification based on the 
chemical nature is complex. Pesticides are generally organic compounds, both synthetic or of 
natural origin, however also inorganic compounds are currently in use. 
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Other less used classification methods exist which are based on mode of action, sources of 
origin, on range of target (broad spectrum and selective pesticides) and on the type of 
formulation. 
The World Health Organization (WHO) classification method is based on the toxicity and the 
risk related with pesticides. Considering the oral and dermal median lethal dose (LD50) on rat, 
pesticides are classified in different categories with increasing toxicity.
8
 (Table 1.1). 
 
Table 1.1 WHO classifications of pesticides
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WHO Class  
LD50 for the rat 
(mg/kg body weight) 
  Oral Dermal 
Ia Extremely hazardous <5 <50 
Ib Highly hazardous 5-50 50-200 
II Moderately hazardous 50-2000 200-2000 
III Slightly hazardous Over 2000 Over 2000 
U Unlikely to present acute hazard 5000 or higher 
 
1.2.1 Development of new pesticides 
In the past, pesticides had a key role in the green revolution providing increasing crop yields. 
Nowadays, they still have a key role in controlling a wide array of pests, thus providing the 
desired crop yields. The agronomical systems are characterized by an extreme dynamicity due 
to the onset of resistance in pest populations, appearance of new pests, changes in in the 
cropping systems, introduction of genetically modified crops and increasing regulatory 
pressure in terms of health and environmental safety. To face all these changes, it is necessary 
to develop new methods for control of pests and this includes the discovery and development 
of new agrochemicals.  
Today, worldwide emergence of resistance in pest population represents a serious problem in 
crop protection. The situation is particularly critical for insecticides with about 15000 unique 
cases of resistances observed. Resistance in weeds and plant pathogens seem to be less critical 
but an increasing number of unique cases of resistance, now close to 500 each, has been 
reported. Thus, the overcoming of resistance is an important driving force to the development 
of new pesticides along with an increased attention to resistance management. Particularly 
valuable is the discovery of agents with different mechanism of action, e.g. compounds able 
to interact in different ways with a known molecular target in the pest organism or able to 
10 
 
bind new or underexploited molecular targets. New mechanisms of action are important in 
resistance control since they facilitate the management schemes, in particular those based on 
the rotation of compounds with different mechanisms of action. 
Regulatory standards are in continuous evolution and move towards a more favourable 
toxicological and ecological profile. Considering the increase of regulatory pressure, the use 
of many old products has been banned since they no longer meet the standards. The more 
stringent regulatory standards have the effect to make the discovery of new pesticides more 
challenging and time-consuming. Furthermore, the need to fully characterize the new 
pesticides and to complete all the required regulatory studies contribute to the increase of the 
costs of the development.
10
 
 
1.2.2 Evolution of modern discovery process of pesticides 
The emergence of resistance and the increasing of stringent regulatory standards with 
consequent increased costs of research and development represent the main challenges faced 
by companies in development of new agrochemicals. These challenges are forcing the 
agrochemical companies in finding new ways to improve and speed up the process of 
discovery and development of new pesticides. 
Modern agrochemicals and pharmaceuticals share several features. Both agrochemicals and 
pharmaceuticals act by interaction with the target (generally and enzyme or receptor) with the 
same molecular mechanisms. Bioavailability, with some variation, is another important aspect 
for both the classes of molecules. Thus, the process of discovery and development of 
pesticides is evolving from a “chemistry first” approach to a process incorporating elements 
and techniques derived from the pharmaceutical industry. 
In the development process several chemical sources (e.g. natural compounds, intermediates 
form other projects, competitor-inspired chemicals, combinatorial chemistry libraries etc.) can 
be used to obtain lead candidates for the development. Then, the selected compounds are 
subjected to different steps of design-synthesis-test-analysis cycle (Figure 1.1). 
11 
 
 
Figure 1.1 Development process of agrochemicals
12
 
 
Structure-based design is a well-known approach to the development of active substances in 
pharmaceutical companies. Conversely, this is relatively new in agrochemical industries. 
However, in recent years, this approach demonstrated its usefulness. The development of 
scytalone dehydratase inhibitors as fungicide represent on the most detailed examples of 
application of structure-based design in crop protection.
11
 Other techniques like fragment-
based design, virtual screening and gene sequencing developed in pharmaceutical industry 
could be exploited also by agrochemical industry to improve and to speed up the process of 
discovery of new lead candidates.
12
 
 
1.2.3 Natural compounds in development of pesticides 
Natural products have been, and still are, valuable tools either in pharmaceutical and 
agrochemical research and development. In particular, their importance is related to their role 
as model compounds in the discovery of new active molecules. A good example of the 
importance of natural compounds in agrochemicals discovery is represented by the 
development of strobilurin fungicides from natural products produced by fungi. 
13
 
The value of natural compounds in the agrochemicals discovery arises from the combination 
of useful properties. These compounds are the result of a coevolution of the producing 
organism with the biotic component of its environment. Thus, this continuous adaptation has 
led to products with physico-chemical properties particularly suitable to perform in vivo, 
although the environmental half life of natural compounds is generally shorter than half life of 
synthetic compounds and this might reduce the environmental impact. Furthermore, natural 
12 
 
compounds are often featured by structural diversity and complexity greater than the 
structures generated by chemists, allowing a greater exploration of the chemical space and 
increasing the possibility to obtain lead structure.
14
  
Whereas the chemical complexity represents a useful source of chemical diversity, on the 
other hand, it represents a limitation to a natural products-based discovery and development 
process. Indeed, the chemical structure of natural products is generally complex, often with 
multiple stereogenic centres, which make their synthesis particularly challenging. This 
complexity reduces the “druggability” of natural-derived compounds, complicating the 
conversion of many compounds in products suitable for the use as pesticides. 
Many natural compounds possess a short environmental half-life. Despite the advantages 
linked to a reduction of environmental impact, this also represents an important limitation to 
the direct use as pesticides. Furthermore, many natural products often do not have the right 
physicochemical, stability, activity, and toxicity properties, and present issues related to the 
production. For these reasons, natural compounds are generally used as models and subjected 
to several steps of chemical modifications to obtain compounds with optimized structures, 
activities, and properties.
13
 
Quite often, the amount of easily available natural compounds is very low, and this is an 
important limitation both for their use as such and for the discovery and development studies. 
Thus, the development of appropriate synthetic protocols is pivotal to fully exploit the 
potential of natural products. 
 
1.2.4 Dual-target pesticides 
Traditionally, drug discovery was oriented on the design of agents targeting a single 
biological structure with high selectivity to avoid unwanted effect arising by binding with 
other biological entities. However, the complexity of diseases like cancer, metabolic disorder 
and central nervous system pathologies demonstrated that a single agent treatment is 
inadequate to obtain significant therapeutic effects. This has led the concept of dual(multi)-
target drugs, first enunciated at the beginning of 2000, to become a well-known strategy to the 
development of new active substances. Simultaneous intervention on two or more targets has 
demonstrated to improve the therapeutic efficacy. Dual-target drugs can modulate two 
receptors, inhibit two enzymes, act on an enzyme and a receptor, or affect an ion channel and 
a transporter. 
Multi-target compounds can be designed by combination of different structures into a new 
chemical entity. Thus, multi-target compounds derive by the linkage of pharmacophores of 
13 
 
distinct molecules. Pharmacophores with similar structure could be fused or merged 
depending on the overlapping degree. Conversely, pharmacophores with great structural 
diversity could be conjugates with a cleavable or non-cleavable linker, although this strategy 
often leads to compounds with poor drug-likeness properties. The essential requirement of 
multi-target compound is the retain of the ability to interact with the different targets. Thus, it 
is pivotal to take into account the structure-activity relationship that underpin the interactions 
of the parent compounds with their specific target.
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The concept of dual(multi)-target agents could be exploited for the discovery and 
development of new pesticides. A dual(multi)-target agrochemical might express a synergistic 
activity then an increased efficacy and consequent reduction of the rates of application can be 
envisaged. Furthermore, activity on two or more target might reduce the risk of resistance. 
Despite of the possible advantage, this approach is almost unexploited in the field of 
agrochemicals. Indeed, up to now only one synthetic study directed to the synthesis of a dual-
target insecticides is reported in scientific literature.
16
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2 AIM OF THE THESIS 
 
The aim of the present Ph.D. thesis was the discovery and development of new 
agrochemicals. In particular, the research activity was focused on natural and natural derived 
molecules because of the demonstrated importance of natural compounds as starting material 
in the process of research and development of agrochemicals and other bioactive molecules. 
The research project has been divided into two part, as described below. 
 
Part I 
The first part of this study was focused on the development of dual-target fungicides obtained 
combining the natural-derived fungicides of the class of strobilurins with compounds of the 
class of succinate dehydrogenase inhibitors. With this work we intend to demonstrate that the 
design of dual-target active compounds is a valuable approach to the discovery and 
development of new agrochemicals. In this context, five different activities were scheduled: 
I. Design of hybrid compounds based on the reported structure-activity relationship of 
both classes of fungicides; 
II. Development of a synthetic strategy for the preparation of the designed compounds; 
III. Evaluation of the in vitro antifungal activity of the synthetized compounds; 
IV. Investigation of the mechanism of action in silico and in cell-free in vitro systems; 
V. Modification of the structure, according to the results of points III and IV, to improve 
the activity and subsequent assessment of the activity of the newly synthetized 
compounds. 
 
Part II 
In the second part different application of samarium (II) iodide were studied in order to 
develop novel alternatives for the synthesis of bioactive compounds. In this context, two 
different activities were scheduled: 
I. Development of a Sm(II) iodide-mediated Reformatsky reaction of Evans’s N-acyl-
oxazolidinones with terpene aldehydes as key step for the synthesis of cembranoids 
II. Development of a synthetic approach towards the total synthesis of the natural 
herbicide auscalitoxin aglycone involving a Sm(II) iodide-mediated asymmetric 
pinacol coupling. 
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The first of these activities was carried out under the supervision of professor Sabine Laschat 
at the Institut für Organische Chemie, Universität Stuttgart (Stuttgart, Germany).  
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PART I: SYNTHESIS OF DUAL-TARGET AGROCHEMICALS 
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3 DESIGN AND DEVELOPMENT OF SDHI-STROBILURIN AS DUAL 
TARGET FUGICIDES 
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3.1 Introduction 
As discussed in Chapter 1, the design of hybrid bifunctional compounds could represent a 
promising alternative for the discovery and the development of new agrochemicals. 
In this Chapter are reported the results of our efforts to develop hybrid fungicides combining 
the pharmacophoric features of strobilurins and those of SDH inhibitors. The main reason 
behind the choice of these two classes of fungicides is related to their mechanism of action. 
Indeed, both classes act at the level of mitochondria, and in particular by inhibition of 
enzymes involved in the mitochondrial electron transport chain. More importantly, both the 
classes interfere with the reduction or the oxidation of ubiquinone. Thus, the design of this 
hybrid compound should be easier since the two classes share the same sub-cellular site of 
action and act as competitive antagonists for the same substrate. 
 
3.1.1 Strobilurins 
Strobilurins are a class of natural substances with fungicidal activity, mainly isolated from 
saprophytic basidiomycete fungi such as Strobilurus tenacellus (Pers. ex Fr.) Singer and 
Oudemansiella mucida (Schrad. ex Fr.) Hohn. Strobilurin A 3.1 was the first isolated 
compound of this class. All compounds contain a methyl (E)-β-methoxyacrylate group, 
generally linked to a 5-phenylpenta-2,4-dienyl chain with different substitutions on the phenyl 
ring at the positions 3 and 4.
1,2
 These molecules show a very high photolability, due to the 
extended double bonds conjugation, which strongly limits their application as fungicides. In 
order to solve this problem, the first research was focused on the replacement of the dienyl 
system. The modification of the double bond proximal to the methyl β-methoxyacrylate group 
led to the active stilbene derivative 3.2. Replacement of the other double bond of 3.2 led to 
the active naphthalene derivative 3.3. The distal double bond can be replaced as well, leading 
to the antifungal diphenyl 3.4. 
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Figure 3.1 Modification of strobilurin A by double bond replacement 
 
Since also the stilbene derivative 3.2 has been found to be not photostable, further 
optimization of the structure was made to replace the styryl group with different aryl ethers 
side chains. The result of these efforts was the discovery of azoxystrobin 3.5, that became first 
strobilurin fungicide launsched on the market. Further studies demonstrated that strobilurin 
fungicides tolerate a great variety of different side chain and the most common used in the 
commercial compounds are aryl ethers, aryl alkyl ethers and oxime ethers.  
Many efforts in the optimization works were made in finding moieties that could replace the 
methyl β-methoxyacrylate group. It was found that the conversion into methoxyiminoacetate 
(as in 3.6 and 3.7) by bioisosteric replacement of the β CH with a nitrogen atom is compatible 
with the activity. Further replacement of the methyl β-methoxyacrylate group with other 
moieties such as methoxyiminoacetamide, and methoxycarbamate pharmacophores has also 
been uncovered. It was demonstrated that the side chain should be linked at the ortho position 
of the phenyl ring bearing the methyl β-methoxyacrylate group as the presence of the side 
chain in meta or para position generally leads to the loss of activity.
3
 The ortho-substitution 
pattern seems to be essential for twisting the pharmacophoric group outside the plane of the 
phenyl ring due to steric hindrance, as demonstrated by X-ray crystallographic mesauremets.
4
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Figure 3.2 Examples of commercially available strobilurin fungicides 
 
Strobilurins, pyribencarb, and the commercially fungicides famoxadone and fenamidone are 
classified in the same resistance group (FRAC group 11) by the Fungicide Resistance Action 
Committee (FRAC).
5
 Despite the structural differences between the strobilurins and the other 
compounds, all of them are able to bind the quinone outer (Qo) binding site of cytochrome bc1 
complex (complex III) in the inner mitochondrial membrane. Strobilurins and the other 
fungicides of this group bind the ubiquinol oxidation site of cytochrome b located on the outer 
part of the mitochondrial inner membrane. The occupation of the Qo site does not hamper the 
binding of the ubiquinol but prevents the oxidation of the quinol and the transfer of the 
electrons to the cytochrome c1. The block of the electron transfer leads to the block of the 
oxidative phosphorylation and the production of ATP.  
Strobilurins are broad-spectrum fungicides with protectant activity against several plant 
pathogenic fungi and oomycetes. Some of strobilurins possess systemic, translaminar and 
protectant activity.
6
 
Unfortunately, strobilurins and the other Qo inhibitors are prone to the onset of resistance. 
The main mechanism of resistance to these fungicides involves the mutation of the target. The 
most common mutations observed are the substitution from glycine to alanine at position 143 
(G143A), from phenylalanine to leucine at position 129 (F129L), and from glycine to arginine 
at position 137 (G137R). It is noteworthy that expression of G143A mutated protein is 
correlated to total expression of resistance. Other mechanisms of resistance to strobilurins, 
such as expression of alternative respiration or expression of efflux transporters, were 
observed.
2
 
 
3.1.2 SDH Inhibitors 
The class of succinate dehydrogenase (SDH) inhibitors includes compounds originally called 
carboxamides since the presence of an amide moiety is pivotal for the activity. The first 
compound of this class, carboxin 3.8, was launched on the market in 1966 and was 
characterized by a narrow-spectrum of activity and limited applications, mainly as seed 
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treatment. Further developments have led to compounds such as flutolanil 3.9 and mepronil 
3.10 with slightly broader-spectrum of action, but it was boscalid 3.11, launched in 2003, the 
first compound of this class with a true broad-spectrum of action. More recently, the research 
trends were focused on the development of pyrazole-4carboxamides. In particular, 
compounds such as fluxapyroxad 3.12, containing a difluoromethyl group in position 3 of the 
pyrazole ring, have gained a considerable attention for their broad-spectrum of activity.
7
 
Fluopyram 3.13 is the only SDH inhibitor belonging to the subclass of the pyridinyl-ethyl 
benzamides. With the discovery of this compound it was demonstrated that the rigid anilide 
moiety is not essential for the activity. Notwithstanding the lack of activity against Oomycetes 
and Basidiomycetes, it shows an outstanding activity against a great number of Ascomycetes 
species with lower application rates than other SDH inhibitors.
8
 
 
Figure 3.3 Examples of commercially available SDH inhibitors 
 
Despite the chemical diversity exhibited, all SDH inhibitors share a similar chemical 
structure, characterized by the presence of the central amide group. As highlighted in Figure 
3.4, a five- or six-membered ring is usually linked to the carbonyl side of the amide group. 
This system is essential for the binding to the target and for in vivo potency. On the amino 
side of the amide group, it is possible to distinguish two portions: the linker and the 
hydrophobic rest. The linker is often represented by an ortho-substituted phenyl ring, but the 
replacement with an heteroaromatic ring or an ethyl bridge is possible. The main function of 
the linker is to maintain the right geometry between the amide group and the hydrophobic 
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rest, that is partially exposed at the surface of the enzyme, having an important role in order to 
determine the potency of action and the spectrum of activity.
9
 
 
 
Figure 3.4 Schematic overview of chemical structures of SDH inhibitors
9
 
 
SDH enzyme, also called complex II, represent the contact point between the Krebs cycle and 
the mitochondrial respiration as it couples the oxidation of succinate to fumarate with the 
reduction of ubiquinone derived from the pool of the respiratory chain.
10
 All compounds 
belonging to the class if SDHI bind the ubiquinone-binding site hampering the access of 
ubiquinone. The presence of the inhibitor does not permit to ubiquinone to act as electron 
acceptor preventing further oxidation of the succinate. The binding mode of the SDH 
inhibitors is depicted in Figure 3.5. H-bond mediated interactions between the amide group 
and the strictly conserved Trp124 and Tyr130 characterize the binding of most of SDH 
inhibitors.
9
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Figure 3.5 Schematic view of binding mode and intermolecular interaction of SDH inhibitors inside 
Mycosphaerella graminicola ubiquinonebinding site
9
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3.2 Results and discussion 
3.2.1 Design of hybrids 
The dual target fungicides were designed taking into account the structure activity 
relationships discussed above for both classes of fungicides. The strobilurin trifloxystrobin 
3.7 and the SDH inhibitor fluopyram 3.13, as highlighted in Figure 3.6, were chosen as 
model compounds for the design of the hybrids. The methyl β-methoxyacrylate moiety of 
strobilurins was incorporated into a substituted benzamide, which is considered the 
pharmacophore of SDHI. The phenyl ring directly connected to the methyl β-methoxy 
acrylate to exert the desired activity tolerates only one substitution in ortho position. This 
substituent acts as a linker group, and we perceived it as a flexibility element to obtain a better 
adaptation in binding both the enzymes. Since the identification of the outdistancing between 
the two pharmacophores is a crucial step in the design, initially we chose a spacer group of 
four atoms (including the carboxamide group) between the aromatic ring of SDH inhibitors 
and the phenyl ring bearing the β-methoxy acrylate. In this way, the distance between the 
aromatic rings are comparable to the distance of the aromatic rings in the two model 
compounds. 
 
 
Figure 3.6 Design of hybrid compounds 
 
The oxygen atom in the linker group of strobilurins was maintained and incorporated into the 
spacer group of the hybrids. Consequently, the hybrid compounds were characterized by the 
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presence of an ortho substituted arylhydroxamate moiety linked by a methylene group to an 
aromatic ring bearing the methyl β-methoxy acrylate. 
SDH inhibitors show a great variability in terms of aromatic and heteroaromatic rings directly 
linked to the carboxamide moiety. Thus, the design was limited to the development of three 
hybrids compound incorporating the aromatic rings of the commercial fungicides mepronil 
3.10, boscalid 3.11, and fluopyram 3.13. 
 
3.2.2 Synthesis of hybrids 3.18 and 3.19a-c 
Our synthetic strategy for the preparation of compounds was thought to be a divergent 
pathway, starting from the pharmacophore of the strobilurins and introducing the variable 
aromatic rings of SDH inhibitors in the end. 
The pharmacophoric moiety of strobilurins was prepared starting from the commercially 
available methyl β-methoxy acrylate 3.14, which was converted in good yield into the α-iodo-
β-methoxy acrylate 3.15 following the procedure reported by Coleman and Lua in 2006.11 
Then, the methyl β-methoxy acrylate group was linked to the ortho-methyl phenyl ring by a 
Suzuki-Miyaura cross-coupling with the commercially available 2-methyl-1-phenylboronic 
acid 3.20, in presence of 4 mol% of Pd(PPh3)4 and K3PO4 as base.
12
 Despite the good yields 
obtained, the amount of catalyst used made this protocol non-suitable for the scale up of the 
reaction on gram scale. The reaction was repeated using 250 mg of compound 3.15 with 
decreasing amounts of catalysts to test if a further optimization of the reaction condition was 
possible. We observed that the catalyst can be reduced up to 0.5 mol% without significant 
variation in yield and reaction time. Further reduction of the loading of catalyst led to 
prolonged reaction time and incomplete conversion of the starting materials. With these 
results in hand, the optimized conditions were successfully applied for the scale up of the 
reaction. The benzyl bromide 3.17 was prepared by radical bromination starting from 
compound 3.16 in presence of NBS and AIBN.
13
 N-Hydroxyphthalimide was used as 
hydroxylamine equivalent for the synthesis of the hydroxamate moiety of the hybrid 
compound. The nucleophilic substitution of benzyl bromide 3.17 with N-hydroxyphthalimide 
was achieved in presence of K2CO3 as a base.
14,15
 Compound 3.18 was obtained in 
unsatisfactory yield (40 %), thus a screening of different bases was performed to increase the 
yield of the reaction. Organic bases, like triethylamine and Hünig’s base, performed similarly 
to K2CO3 affording compound 3.18 in 38 % and 35 % yield, respectively. The use of sodium 
and potassium hydroxides has led to poor yield because of the competing hydrolysis of the 
methyl ester on the methoxy acrylate. The replacement of K2CO3 with Na2CO3 or Cs2CO3 has 
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not led to significant changes in the reaction outcome. Furthermore, no changes were 
observed after addition of potassium iodide or TBAI in catalytic amount (0.1 eq.). 
The phthalimido-derivative 3.18 was deprotected by hydrazinolysis and the unstable O-benzyl 
hydroxylamine was used in the acylation reactions without purification. The reactions of 
acylation were performed in presence of pyridine with the acyl chlorides 3.21a-c.
15
 The three 
acyl chlorides 3.21a-c were previously prepared from the respective acids following reported 
procedures.
16
 The three hybrid compounds 3.19a-c were obtained in 26 %, 32 % and 24 % 
yield, respectively. The yields of the last three reaction were poor because of the instability of 
the O-benzyl hydroxylamine. Indeed, the main products of the reactions was the cyclic 
hydroxamate derived by nucleophilic acyl substitution on the ester of β-methoxy acrylate. 
Figure 3.7 Synthesis of compounds 3.18 and 3.19a-c. (a) i. NIS, AcOH, DCM, rt; ii. Et3N, CH2Cl2, rt, 
70 %; (b) 2-methyl-1-phenylboronic acid (3.20), Pd(PPh3)4, K3PO4, dioxane/H2O, 90 °C, 83 %; (c) 
NBS, AIBN, CCl4, 78 %; (d) N-hydroxyphthalimide, NaOH, DMF, rt, 40 %; (e) NH2NH2·H2O, EtOH, rt; 
(f) 3.21a-c, py, CH2Cl2, 0 °C to rt, 24-39 %. 
 
3.2.3 In vitro screening of antifungal activity of 3.18 and 3.19a-c 
The antifungal activity of compounds 3.19a-c was evaluated in vitro by inhibition of 
mycelium growth. Their direct precursor 3.18 could be considered a conformationally blocked 
analogue, because of the presence of the phthalimido moiety, and was included in the test.  
The tested compounds were dissolved in acetone (concentration of the stock solution was 
2500 ppm) due to their poor solubility in water.
17
 Therefore, malt agar (MA) medium 
supplement with 1 % acetone was included as control together with untreated MA medium 
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control. The radial growth of the mycelium was evaluated daily up to seven days after 
inoculum (dai), except the fast-growing fungus Sclerotinia sclerotiorum, whose growth was 
evaluated only for two days. Results are highlighted in Figure 3.8 
 
 
Figure 3.8 Mycelium growth of six fungal species on control media (NTC – non-treated control, ACT – 
1 % acetone) and media supplemented with commercial fungicides (KM – kresoxim-methyl 3.6, FLP – 
fluopyram 3.13 at concentrations 25 mg/L) and compounds 3.18 and 3.19a-c, at concentrations 25 
mg/L. The measurements were done at 7 dai. The error bars represent standard error (N = 3). 
 
Compound 3.18 showed the highest inhibitory activity, while compound 3.19a-c showed no 
or very low activity. In particular, the growth of Pyricularia oryzae was inhibited by 
compound 3.18 by ca. 35 %, and its activity was comparable to the commercial fungicide 
kresoxim-methyl 3.6. Moreover, 3.18 inhibited S. sclerotiorum and Curvularia sp. to the same 
extent of kresoxim-methyl 3.6, but less than fluopyram 3.13. 
The rice blast fungus P. oryzae is the causal agent of one of the most serious disease of 
cultivated rice.
18
 Each year rice blast is responsible for 10-30 % yield loss of rice at harvest, 
the equivalent of feeding 60 million people. Furthermore, the fungus is part of the species 
complex that cause disease on a wide range of economically important crops including barley, 
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oats, rye grass, millets and, most recently, wheat.
18,19
 Thus, the activity of compound 3.18 
against this fungus was further investigated using three different concentrations against four 
strains of P. oryzae. The activity of four commercial fungicides, two strobilurins 
(azoxystrobin 3.5 and kresoxim-methyl 3.6) and two SDH inhibitors (fluxapyroxad 3.12 and 
fluopyram 3.13) was also investigated at two concentrations, 2.5 and 25 mg/mL, respectively. 
Azoxystrobin 3.5 showed the highest inhibitory activity, while the activity of compound 3.18 
at 25 mg/L was better than fluopyram 3.13 and comparable to fluxapyroxad 3.12 at 2.5 mg/L. 
Results are highlighted in Figure 3.9. 
 
 
Figure 3.9 Mycelium growth of four P. oryzae strains on control media (NTC – non-treated control, 
ACT – 1 % acetone) and media supplemented with commercial fungicides (AZX – azoxystrobin, KM – 
kresoxim-methyl, FLP – fluopyram, FXP – fluxapyroxad, at concentrations 2.5 or 25 mg/L) and 
compound 3.18, at concentrations 2.5, 12.5 or 25 mg/L. The mycelium growth was measured at 4 and 
7 days after inoculation (dai). The error bars represent standard error (N = 8). The mean values with 
the same letter at each dai measurement are not significantly different (P = 0.05) according to Tukey 
post-hoc test. 
 
3.2.4 Docking studies 
Docking simulations were performed to understand the mechanism of action of compound 
3.18, to explain the lack of activity of compounds 3.19a-c, and to explore the binding mode of 
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the new synthesized molecules to both Cyt b subunit and succinate dehydrogenase. For both 
the enzymes the models were built by homology modelling techniques and the docking results 
were analysed by comparison with known ligands. Considering the importance of P. oryzae in 
crop protection and the promising results obtained with compound 3.18 in the in vitro 
screening for the antifungal activity, a study of the binding mode to Cyt b was planned. The 
available sequence for Cyt b of P. oryzae is unsuitable to model the binding pocket of the 
enzyme. Indeed, the sequence comprises a fragment with only 170 residues. The available 
sequence and the Cyt b of P. grisea are substantially identical in the common region, 
suggesting a high identity degree. Therefore, the homology model was based on the primary 
sequence of the Cyt b of P. grisea (Uniprot code Q85KP9). The three-dimensional structure 
of Cyt b of P. grisea was modelled using as a template the resolved structure of the complex 
of Cyt b with the inhibitor stigmatellin A from S. cerevisiae (PDB Id: 3CX5). In the docking 
studies, all simulated compounds 3.18 and 3.19a-c showed a binding mode and an interaction 
pattern similar to that observed for azoxystrobin 3.5, which was included in the simulation for 
comparison. 
Figure 3.10 compares the poses as computed for 3.18 and azoxystrobin 3.5 and reveals that 
both complexes are almost exclusively stabilized by hydrophobic contacts. In detail, the (E)-
methyl β-methoxyacrylate moiety of both molecules is inserted within a highly hydrophobic 
subpocket, where it interacts with Phe75, Val92, Leu96, Pro218, Leu222, Tyr226, and 
Leu229 side chains. The phenyl ring elicits π-π stacking with Phe225 and S/π interactions 
with Met242. The phthalimido ring of 3.18 and the aromatic side chain of azoxystrobin 3.5 
are similarly accommodated inside an apolar subpocket and interact with Met71, Ala72, 
Phe75, Leu76, Ile93, and Phe243. In good agreement with what observed for the resolved 
complex with stigmatellin A, the computed complexes are completely devoid of polar 
interactions. On these grounds, the difference in bioactivity seen for the tested hybrids 
compounds can be mostly ascribed to the capacity of the variable portion to stabilize π-π 
contacts with aromatic residues. Therefore, the marked activity of 3.18 can be explained by 
considering the enriched stacking interactions mediated by the phthalimido moiety with 
Phe243.
20
 In the same way, the reduced activity of 3.19b could be explained by the hampering 
of the arrangement of Phe75 caused by the steric hindrance of trifluoromethyl group. 
Furthermore, for compound 3.19c the loss of activity could be explained by the less 
effectiveness of pyridine ring in stabilizing T-shaped π-π stacking with Phe75 and to minor 
extent with Phe125. 
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Figure 3.10 Comparison of the putative poses as computed for 3.18 and azoxystrobin 3.5 (colored in 
light green) within the Cyt b binding site 
 
The SDH enzyme is a tetrameric complex composed of four subunit which must be modelled 
together since the ubiquinone-binding site is located at the interface between the subunits 
SDHB, SDHC, and SDHD.
21
 Since the primary sequence of SDHD from P. oryzae was 
unavailable, the model was based on the primary sequences of SDHA, SDHB, and SDHC 
from P. oryzae (SDHA: G4NE44; SDHB: L7JQS7; SDHC: G4NP5), while the primary 
sequence of SDHD was obtained from P. grisea (Q5G5B2). The three-dimensional structure 
of the protein was modelled using as template the resolved structure the porcine enzyme in 
complex with N-[(4-tert-butylphenyl)-methyl]-2-(trifluoromethyl)-benzamide (E23). 
Figure 3.11 compares the poses as computed for 3.18 and for mepronil 3.10 and reveals a 
different binding mode for the two molecules. In both cases a charge transfer interaction was 
observed between a phenyl ring and Arg83, and the presence of the phthalimido ring should 
reinforce this interaction in the case of compound 3.18. The other aromatic ring is inserted in 
a lateral subpocket, and, in the case of mepronil 3.10, it elicits Trp201 and Trp202 π-π 
stacking interaction. Conversely, for compound 3.18 the steric hindrance due to the presence 
of (E)-methyl β-methoxyacrylate group determines a significative shift of the phenyl ring to a 
more lateral position, where it contacts Tyr71 and elicits hydrophobic interactions with Leu76 
and Val80. The substituents on the phenyl ring stabilize different interactions because of the 
different arrangement of the phenyl ring itself. In the case of the mepronil 3.10, the 
isopropyloxy group stabilizes a H-bond with His65 while the (E)-methyl β-methoxyacrylate 
group is moved to a more lateral position, where it can interact with Tyr123 and Trp202. 
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Figure 3.11 Comparison of the putative poses as computed for 3.18 and mepronil 3.10 (colored in 
light green) within the SDH binding site 
 
The main and most important difference between the two molecules can be seen for the 
contacts stabilized by the central link. Indeed, the carbonyl function of the amido group of 
mepronil 3.10 stabilizes two H-bonds with the highly conserved Tyr123 and Trp202, and 
these interactions characterize the binding mode of most SDHI. Conversely, in the case of 
compound 3.18, Tyr123 and Trp202 are shielded by (E)-methyl β-methoxyacrylate moiety 
and cannot conveniently approach the central link. Notably and regardless of the specific 
arrangement of the phenyl ring bearing the (E)-methyl β-methoxyacrylate moiety, the poor 
contacts stabilized by the central link are observed in all proposed ligands. 
 
3.2.5 Enzymatic inhibition assessment in vitro cell-free system of 3.18 and 3.19a-c 
Compound 3.18 was tested for the ability to affect the NADH-driven respiration. For this test, 
the consumption rate of NADH mediated by the submitochondrial fraction of P. oryzae 
A2.5.2 was measured. The NADH-consumption rate in presence of compound 3.18 (200 μM) 
was 67.2 ± 7.2 % lower than that measured in the control, containing DMSO (used as 
cosolvent) without the tested compound. A weaker reduction of the NADH-consumption rate 
(33.3 ± 6.0 %) for compound 3.18 was still observable reducing the concentration to 20 μM. 
Azoxystrobin 3.5, used as positive control, (20 μM) and in the same assay conditions showed 
a higher inhibition of the NADH-consumption rate (80.7 ± 5.4 %) than compound 3.18. The 
ability of compound 3.18 to inhibit the NADH-driven respiration in a cell-free system 
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supports the hypothesis that the target of this compound is located in the mitochondrial 
respiratory chain. Results are highlighted in Figure 3.12. 
 
 
Figure 3.12 Inhibition of the P. oryzae A2.5.2 mitochondrial NADH-mediated respiration. Rate of 
NADH-consumption mediated by the submitochondrial fraction was measured at 30°C (λ = 340 nm) in 
the presence of AZX – azoxystrobin (20 µM), FXP – fluxapyroxad (200 µM), or 3.18 (20 and 200 µM). 
 
Two specific sets of experiments were designed to assess the expression of the strobilurin-like 
activity and the ability to inhibit the SDH enzyme of compound 3.18. The same in vitro cell-
free system was used for both tests. 
The assessment of the DBH2-Cyt c oxidoreductase activity (i.e. the cytochrome bc1 complex 
activity) was used to evaluate the strobilurin-like activity of compounds 3.18. For this test the 
reduction rate of Cyt c mediated by the submitochondrial fraction of P. oryzae A2.5.2 was 
measured. The Cyt c-reduction rate in presence of compound 3.18 (20 μM) was 68.2 ± 13.4 % 
lower than that measured in the control, containing DMSO without the tested compound. 
Compound 3.18 at 100 μM tend to reah saturation of the inhibition (83.1 ± 10.9 %). 
Azoxystrobin 3.5, used as positive control, (20 μM) and in the same assay conditions showed 
an inhibition of the Cyt c-reduction rate (76.7 ± 11.2 %) similar to that of compound 3.18. 
Fluxapyroxad 3.12, used as negative control, (20 μM) and in the same assay conditions 
showed an almost not detectable inhibition of the Cyt c-reduction rate (6.7 ± 15 %). The 
obtained results for compound 3.18 support the hypothesis that this compound is able to 
express a strobilurin-like activity. Results are highlighted in Figure 3.13. 
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Figure 3.13 Inhibition of the P. oryzae A2.5.2 mitochondrial DBH2-Cyt c oxidoreductase activity. Rate 
of Cyt c-reduction mediated by the submitochondrial fraction was measured at 30°C (λ = 550 nm) in 
the presence of AZX – azoxystrobin (20 µM), FXP – fluxapyroxad (20 µM), or 3.18 (20 µM). 
 
Compound 3.18 was tested for the ability to inhibit the SDH activity. For this test, the 
reduction rate of 2,6-dichlorophenolindophenol (DCPIP) mediated by the submitochondrial 
fraction of P. oryzae A2.5.2 was measured by means of a colorimetric method. Inhibition of 
SDH activity (65.7 ± 17.4 %) was observed for fluxapyroxad 3.12 (20 μM). Conversely, no 
inhibition was observed for compound 3.18 and azoxystrobin 3.5. Results are highlighted in 
Figure 3.14. 
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Figure 3.14 Inhibition of the P. oryzae A2.5.2 mitochondrial DBH2-Cyt c oxidoreductase activity. Rate 
of DCPIP-reduction mediated by the submitochondrial fraction was measured at 30°C (λ = 595 nm) in 
the presence of AZX – azoxystrobin (20 µM), FXP – fluxapyroxad (20 µM), or 3.18 (20 µM). 
 
3.2.6 Optimization of the activity 
As resulted from the in vitro cell-free enzymatic assay, compound 3.18 seems to exhibit only 
a strobilurin-like activity. Since the scope of this work was the design and synthesis of dual-
target fungicides, the structure of compound 3.18 was modified in an effort to improve the 
affinity and the activity on SDH enzyme.  
The design of the new molecules was based on the information obtained from the docking 
studies. As discussed above, the binding mode of compound 3.18 to the SDH enzyme differs 
significantly from that of mepronil 3.10. The sterically demanding methyl β-methoxyacrylate 
group seems to interfere with the binding, hindering the hydrogen bonding between the 
carbonyl of the amide (or the phthalimide ring) with Tyr123 and Trp202. 
Initially, we planned to increase the distance between the two pharmacophores to reduce the 
steric hindrance. Thus, the hydroxamate group was replaced and a phenylene group was 
inserted between the nitrogen and the oxygen both in compound 3.18 and in compounds 
3.19a-c, as highlighted in Figure 3.15. 
We observed that most strobilurins, i.e. azoxystrobin 3.5 and kresoxim-methyl 3.6, possess an 
aromatic ring linked by a short spacer to the phenyl ring bearing the methyl β-
methoxyacrylate. In trifloxystrobin 3.7, this aromatic ring is replaced by a linker containing a 
methyleneaminoxy methyl moiety. It was reported that the methyleneaminoxy methyl moiety 
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could be used as bioisoster of aryl and other aromatic groups.
22
 Compound 3.19a-c were 
designed using the structure of trifloxystrobin 3.7 as model, however replacing the 
methyleneaminoxy methyl moiety with a hydroxamate moiety, and this could be the reason 
for the loss of the strobilurin-like activity. The insertion of a phenylene group could be useful 
to solve this problem. The resulting compounds 3.23a-c, as highlighted in Figure 3.13, would 
assume a three rings-based structure similar to that of azoxystrobin 3.5. In order to select the 
most promising structures, the new proposed compounds were evaluated in a docking 
experiment. Compound 3.23d was designed as flexible analogue of 3.22 where the ortho-
substituted aromatic ring was replaced by an unsubstituted phenyl ring to exclude every 
possible interference and limit the differences between the two structure to the change of 
conformational mobility. No SDH inhibitors with unsubstituted phenyl ring have been 
launched in the market; it is likely that small substituent linked to the ortho position are useful 
to stabilize the best conformation for the activity. For this reason, compound 3.23d was not 
synthetized. Compounds 3.22 and 3.23d were evaluated in a docking experiments using the 
computational model of the SDH enzyme model discussed above. 
 
 
Figure 3.15 Design of hybrid compounds 
 
The structures of compounds 3.23a-c provided a better score of docking than compound 3.22. 
Compounds 3.23a-c reveal a π-cation interaction between the phenyl ring and Arg83, and its 
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central link is stabilized by hydrogen bonds with Tyr123 and Trp202. Furthermore, the 
aromatic ring connected with the (E)-β-methoxyacrylate moiety is able to establish π-π 
interactions with Tyr123, thanks to the addition of the central phenyl ring which acts as a 
spacer which decreases the (E)-β-methoxyacrylate steric hindrance. 
In contrast, 3.22 shows only the hydrogen bonds involving the central link as mentioned 
above and lacks the interaction of the aromatic rings with Arg83 and Tyr123. These 
differences are probably due to the lower flexibility of 3.22, which prevents the right fitting 
within the pocket. The results of docking were reported in Figure 3.16. 
 
 
Figure 3.16 Comparison of the putative poses as computed for 3.22 (colored in grey)and for 3.23d 
(colored in light green) within the SDH binding site 
 
3.2.7 Synthesis of hybrids 3.23a-c 
For the synthesis of compounds 3.23a-c we followed a divergent strategy similar to that used 
for compound 3.19a-c. The synthetic strategy is highlighted in Figure 3.17. 
38 
 
 
Figure 3.17Synthesis of compounds 3.23a-c. (a) (Boc)2O, NaI, CH2Cl2, rt; 90 %; (b) 3.17, K2CO3, 
acetone, reflux, 65 %; (c) 10 % v/v trifluoroacetic acid, CH2Cl2, 0 °C, 90 %; (d) 3.28a-c, EDC·HCl, 
HOBt, DIPEA, CH2Cl2, 0 °C to rt, 65-86 %. 
 
Protection of the commercially available 3-aminophenol 3.24 was performed with (Boc)2O 
following a reported procedure. Protected aminophenol 3.25 was obtained in 90 % yield. As 
described in the literature, the presence of NaI resulted in a dramatic reduction of the reaction 
time; indeed, complete conversion was obtained after only one hour.
23
 Then, the N-Boc 
protected aminophenol 3.25 was alkylated with the benzyl bromide 3.17 in presence of K2CO3 
as a base, affording compound 3.26 in 65 % yield. Boc deprotection was easily performed 
with 10 % v/v trifluoroacetic acid in anhydrous dichloromethane. The reaction afforded the 
trifluoroacetic salt that was converted to the free amine 3.27 during the work up by treatment 
with NaHCO3 saturated solution. Finally, the amine 3.27 was coupled with the three acids 
3.28a-c providing the desired compounds 3.23a-c. The coupling was performed with 
EDC·HCl and HOBt as coupling reagents and Hünig’s base. The reaction required an excess 
of both acid and of coupling reagents to reah completion, affording the three compounds 
3.23a-c in good yields. 
 
3.2.8 In vitro screening of antifungal activity of 3.23a-c 
Antifungal activity of compounds 3.23a-c were evaluated in vitro following the same protocol 
used for compound 3.18 and 3.19a-c. The tested compounds were dissolved in acetone 
because of their poor solubility in water. Therefore, MA medium supplement with 1 % 
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acetone and untreated MA medium were included as controls. Commercially fungicides 
azoxystrobin 3.5 and fluxapyroxad 3.12 were included together with kresoxim-methyl 3.6 and 
fluopyram 3.13 as positive controls. The radial growth of the mycelium was evaluated daily 
up to seven days, except the fast-growing fungus Sclerotinia sclerotiorum, whose growing 
was evaluated after three days. Results are highlighted in Figure 3.18. 
 
 
Figure 3.18 Mycelium growth of seven fungal species on control media (NTC – non-treated control, 
ACT – 1 % acetone) and media supplemented with commercial fungicides (AZX – azoxystrobin, KM – 
kresoxim-methyl, FLP – fluopyram, FXP – fluxapyroxad, at concentrations 25 mg/L) and compounds 
3.23a-c, at concentrations 25 mg/L. The measurements were done at 7 dai, except for S. sclerotiorum, 
which were done at 3 dai. The error bars represent standard error (N = 3). 
 
Moderate inhibitory activity was observed for 3.23a-c against Curvularia sp., P. ultimum, and 
R. solani, while poor activity was observed for F. fujikuroi and B. cinerea. Conversely, good 
inhibitory activity was observed for all compounds 3.23a-c against P. oryzae and S. 
sclerotiorum. In particular, 3.23a-c exhibited inhibitory activities against P. oryzae for 3.23a-
c in a range of ca. 60-70 % and their activity was better than that of kresoxim-methyl 3.6 and 
fluopyram 3.13 and comparable to that of fluxapyroxad 3.12. Azoxystrobin 3.5 exhibited the 
best inhibitory activity against P. oryzae.  
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Compounds 3.23a-c showed inhibitory activities against S. sclerotiorum in a range of ca. 70-
80 %. The activities were comparable to that of azoxystrobin 3.5, but inferior to that of 
fluxapyroxad 3.12 and fluopyram 3.13. 
In all the cases compounds 3.23a-c showed comparable inhibitory activity. 
 
3.2.9 Enzymatic inhibition assessment in cell-free in vitro system of 3.23a-c 
The assessment of the DBH2-Cyt c oxidoreductase activity was used to evaluate the 
strobilurin-like activity of compounds 3.23a-c. The test was performed as described for 
compound 3.18. Inhibition of Cyt c reduction was observed with the three target compounds. 
Compounds 3.23a,b (20 μM) showed a complete inhibition, while for compound 3.23c lower 
activity (54.6 ± 13.7 %) was measured. Azoxystrobin 3.5, used as positive control, (20 μM) 
and under the same experimental conditions showed an inhibition of the Cyt c-reduction rate 
(76.7 ± 11.2 %), whereas fluxapyroxad 3.12, used as negative control, (20 μM) showed no 
inhibition of the Cyt c-consumption rate (6.7 ± 15.0 %; inhibition is not distinguishable from 
zero with this value of error). The ability of compounds 3.23a,b and, even if in minor extend, 
of compound 3.23c to inhibit the DBH2-Cyt c oxidoreductase activity in a cell-free system 
supports the hypothesis that these compounds are able to express a strobilurin-like activity. 
Results are highlighted in Figure 3.19. 
 
 
Figure 3.19 Inhibition of the P. oryzae A2.5.2 mitochondrial DBH2-Cyt c oxidoreductase activity. Rate 
of Cyt c-reduction mediated by the submitochondrial fraction was measured at 30°C (λ = 550 nm) in 
the presence of AZX – azoxystrobin (20 µM), FXP – fluxapyroxad (20 µM), or 3.23a,c (20 µM). 
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Compounds 3.23a,c were tested for the ability to inhibit the SDH activity. The test was 
performed as described for compound 3.18. Inhibition of the SDH activity was observed for 
all the tested compounds at 80 μM concentration. Out of three tested compounds, 3.23b 
showed the highest inhibitory activity (47.6 ± 16.6), followed by 3.23a (34.7 ± 14.2) and 
3.23c (19.0 ± 8.6). For all three tested compounds the inhibition was minor than that of 3.12 
50 μM and in the same assay conditions (65.7 ± 17.4). No inhibition was observed for 
azoxystrobin 3.5. These results suggest support the hypothesis that compound 3.23a-c are 
able to inhibit SDH activity. Results are highlighted in Figure 3.20. 
 
 
Figure 3.20 Inhibition of the P. oryzae A2.5.2 mitochondrial DBH2-Cyt c oxidoreductase activity. Rate 
of DCPIP-reduction mediated by the submitochondrial fraction was measured at 30°C (λ = 340 nm) in 
the presence of AZX – azoxystrobin (50 µM), FXP – fluxapyroxad (50 µM), or 3.23a-c (80 µM). 
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3.3 Summary 
In this Chapter the results of the design and development of dual-target fungicides are 
reported. The efforts were focussed on the development of hybrid molecules obtained by the 
combination of the SDH inhibitors with the strobilurin fungicides. 
Compounds 3.18 and 3.19a-c were designed taking into account the known SAR of both the 
classes of fungicides. The phenyl ring bearing the methyl (E)-β-methoxy acrylate of 
strobilurins was incorporate in the structure of a substituted benzamide, which is considered 
the pharmacophore of SDH inhibitors. The substituent linked in ortho position of phenyl ring 
was exploited as linker group. A four atoms spacer group (including the carboxamide group) 
was used to link the aromatic ring of SDH inhibitors and the phenyl ring bearing the β-
methoxy acrylate. The oxygen atom in the linker group of strobilurins was maintained and 
incorporated into the spacer group. Thus, the amide group was converted into a hydroxamate 
group. 
A synthetic strategy for the preparation of compounds 3.18 and 3.19a-c was developed. 
Optimization of the reaction conditions for the Suzuki-Miyaura reaction used to synthetize 
compound 3.16 was successful. In particular, it was demonstrated that the reduction of the 
amount of catalyst up to 0.5 mol% is possible without effect on the yields and on reaction 
time. Compound 3.18 was obtained in low yield and no improvements seemed to be possible. 
Compounds 3.19a-c were obtained with poor yields because of the instability of their direct 
precursor formed during the deprotection of 3.18. 
The antifungal activity of compounds 3.18 and 3.19a-c was tested in vitro by evaluation of 
the inhibition of the mycelium growth. Compounds 3.19a-c showed poor or no activity 
against all the tested fungal species, while compound 3.18 expressed an inhibitory activity 
against P. oryzae that was comparable to that of the commercial fungicide kresoxim-methyl 
3.6. 
The binding mode of 3.18 to both the target enzymes was investigated in silico through 
docking studies. The computational models of SDH enzyme and Cyt b were built by 
homology. The docking of compound 3.18 with the computational model of Cyt b showed a 
binding mode similar to that of the commercial fungicide azoxystrobin 3.5. Conversely, a 
binding mode different from the commercial fungicide mepronil 3.10 was observed for 3.18 
in the active site of SDH enzyme. The observed differences were attributed to the steric 
hindrance of the (E)-β-methoxy acrylate group. 
The results of docking studies were confirmed by assessment of the enzymatic inhibition in a 
in vitro cell-free system. Tests were performed on isolated submitochondrial fractions of P. 
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oryzae A2.5.2. Compound 3.18 was tested to assess the ability to inhibit the mitochondrial 
NADH-mediated respiration, the activity of the DBH2-Cyt c oxidoreductase cytochrome bc1 
complex-mediated, and the activity of SDH enzyme. Inhibition was observed for the NADH-
mediated respiration and for the Cyt c reduction, while no inhibitory activity was observed on 
SDH enzyme. These results support the hypothesis that compound 3.18 is able to express only 
a strobilurin-like activity. 
Thus, a second series of compounds with increased distance between the two pharmacophoric 
moieties was designed. The results of docking studies were taken in account for the design of 
compounds 3.23a-c. A synthetic strategy was successfully developed and compounds 3.23a-c 
were obtained in good yields. 
The antifungal activity of 3.23a-c was assessed in vitro by evaluation of the mycelium growth 
inhibition. All the tested compounds resulted to be active. In particular, good activities were 
expressed against P. oryzae and S. sclerotiorum. 
Enzymatic inhibition was evaluated in the same in vitro cell-free system used for 3.18. 
Inhibition of the reduction of Cyt c was observed for all the tested compounds. A complete 
inhibition was observed for compounds 3.23a,b, while 3.23c expressed a lower activity. More 
importantly, a moderate to weak inhibitory activity of SDH enzyme was observed for all the 
tested compounds. These results support the hypothesis that compounds 3.23a-c can act as 
dual target fungicides expressing the activity of SDH inhibitors and strobilurins. 
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3.4 Experimental part 
Methyl (Z)-2-Iodo-3-methoxypropenoate (3.15) 
 
 
 
To a solution of methyl (E)-3-methoxypropenoate 3.14 (3.48 g, 30.0 mmol) in CH2Cl2 (60 
mL), N-iodosuccinimide (8.10 g, 36.0 mmol) and glacial acetic acid (4.5 mL, 60 mmol) were 
added at room temperature and the resulting solution was stirred at the same temperature for 
24 h. Et3N (12.6 mL, 90.0 mmol) was added, and the solution was stirred for 12 h at room 
temperature. Water (90 mL) was added, the layers were separated, and the aqueous layers was 
further extracted with Et2O (3×60 mL). The combined organic extracts were washed with a 
saturated solution of Na2S2O3 (3×60 mL), saturated solution of NaHCO3 (3×60 mL), and 
water (3×60 mL). The organic layer was dried with Na2SO4 and the solvent was removed at 
reduced pressure. The oily residue was purified by flash chromatography (SiO2, 5:1 petroleum 
ether/ethyl acetate) to afford 3.15 (5.09 g, 70 %) as a white solid: mp 50-52 °C. 
 
1
H NMR (300 MHz, CDCl3): δ = 7.68 (s, 1H,), 4.01 (s, 3H), 3.81 (s, 3H,) ppm. 
 
Spectroscopic data were in accordance with the literature.
11
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Methyl (E)-2-(2-methylphenyl)-3-methoxyacrylate (3.16) 
 
 
 
To a solution of methyl (Z)-2-Iodo-3-methoxypropenoate 3.15 (2.50 g, 10.3 mmol) in a 5:1 
dioxane/water mixture (52 mL), 2-methyl-1-phenylboronic acid 3.20 (1.68 g, 12.4 mmol,) and 
K3PO4 (6.58 g, 31.0 mmol) were added at room temperature and the resulting mixture was 
degassed by bubbling nitrogen through the solution for 20 min. Then Pd(PPh3)4 (59.7 mg, 0.5 
mol%) was added, and the reaction mixture was stirred in the dark at 90 °C for 6 h. After 
cooling to room temperature, the mixture was diluted with ethyl acetate (50 mL) and the 
organic layer was washed with water (1×50 mL) and with a saturated solution of NaCl (1×50 
mL). The organic layer was dried with Na2SO4 and the solvent was removed at reduced 
pressure. The dark oily residue was purified by flash chromatography (SiO2, 7:1 petroleum 
ether/ethyl acetate) to afford 3.16 (1.76 g, 83%) as colourless oil 
 
1
H NMR (300 MHz, CDCl3): δ = 7.52 (s, 1H), 7.39-6.97 (m, 4H), 3.79 (s, 3H), 3.68 (s, 3H), 
2.24 (s, 3H) ppm. 
 
Spectroscopic data were in accordance with the literature.
12
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Methyl (E)-2-(2-(bromomethyl) phenyl)-3-methoxyacrylate (3.17) 
 
 
 
To a solution of methyl (E)-2-(2-methylphenyl)-3-methoxyacrylate 3.16 (2.09 g, 10.1 mmol) 
in abs. carbon tetrachloride (50 mL), N-bromosuccinimide (1.98 g, 11.1 mmol) and 2,2'-azo-
bisisobutyronitrile (332.2 mg, 2.02 mmol) were added and the resulting suspension was 
stirred at reflux in the dark for 6 h. After cooling to room temperature, the mixture was 
filtered to remove the insoluble succinimide and the solid residue was washed with a small 
volume of carbon tetrachloride. The filtrated was concentrated at reduced pressure and the 
oily residue was purified by flash chromatography (SiO2, 8:1 petroleum ether/ethyl acetate) to 
afford 3.17 (2.25 g, 78%) as a white solid: mp 64-65 °C. 
 
1
H NMR (300 MHz, CDCl3): δ = 7.65 (s, 1H), 7.10-7.64 (m, 4H), 4.40 (s, 2H), 3.69 (s, 3H), 
3.38 (s, 3H) ppm. 
 
Spectroscopic data were in accordance with the literature.
13
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Methyl (E)-2-[2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yloxymethyl)-phenyl]-3-methoxy-
acrylate (3.18) 
 
 
 
To a solution of N-hydroxyphthalimide (630 mg, 3.86 mmol) in abs. N,N-dimethylformamide 
(35 mL), K2CO3 (728 mg, 5.26 mmol) was added and the resulting red suspension was stirred 
at room temperature for 20 min. After that, methyl (E)-2-(2-(bromomethyl) phenyl)-3-
methoxyacrylate 3.17 (1000 mg, 3.50 mmol) was added and the reaction mixture was stirred 
at 40 °C overnight. The reaction mixture was poured in cold water and stirred for 1 h. The 
obtained solid was collected by in vacuo filtration and washed with water. The solid was 
dissolved in CH2Cl2 (20 mL) and washed with water (1×20 mL). The organic layer was dried 
with Na2SO4 and the solvent was removed under reduced pressure. The residue was 
recrystallized from 1:4 CH2Cl2/hexane to afford 3.18 (568 mg, 40%) as a white solid: mp 
161-163 °C. 
 
1
H NMR (300 MHz, CDCl3): δ = 7.88-7.67 (m, 5H), 7.63 (s, 1H), 7.47-7.31 (m, 2H), 7.20-
7.09 (m, 1H), 5.12 (s, 2H), 3.75 (s, 3H), 3.61 (s, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 167.9, 163.5, 160.7, 134.4, 133.3, 133.2, 131.1, 130.6, 
129.2, 129.0, 128.1, 123.4, 77.5, 62.0, 51.7 ppm. 
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General procedure for the synthesis of 3.19a-c. 
 
To a solution of compound 3.18 (100 mg, 0.27mmol) in methanol (2 mL), hydrazine hydrate 
(15 μL, 0.30 mmol) was added dropwise and the resulting solution was stirred at room 
temperature for 4 h. The solution was then cooled to 0 °C and the white solid was removed by 
vacuum filtration. The methanolic solution was evaporated to dryness and the residue was 
suspended with a small volume of Et2O. The white solid was removed by vacuum filtration, 
the ethereal solution was dried with anhydrous CaCl2 and used for the next reaction without 
further purification. The ethereal solution was dried until dryness with a stream of nitrogen in 
a two necked round bottom flask. The residue was dissolved in abs. CH2Cl2 (2 mL) and the 
resulting solution was cooled to 0 °C. A solution of the suitable acyl chloride 3.21a-c (0.32 
mmol) in abs. CH2Cl2 (2 mL) and abs. pyridine (66 μL, 0.81 mmol) were added dropwise at 
the same temperature and the resulting solution was stirred at room temperature overnight. 
The three acyl chlorides 3.21a-c were previously prepared from the respective acids following 
reported procedures.
16
 The reaction mixture was diluted with CH2Cl2 (6 mL), washed with a 
saturated solution NaHCO3 (10 mL×1) and with a saturated solution of NaCl (10 mL×1). The 
organic phase was dried with Na2SO4, the solvent was removed at reduced pressure, and the 
raw material was purified by flash chromatography. 
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Methyl (E)-2-[2-(2-methyl-benzoylaminooxymethyl)-phenyl]-3-methoxy-acrylate (3.19a) 
 
 
 
Obtained according to the general procedure from 3.18 and 3.21a after flash chromatography 
(SiO2, 2:1 hexane/ethyl acetate) (29 mg, 30%) as white waxy solid. 
 
1
H NMR (CDCl3, 300 MHz) δ = 8.46 (s, 1H), 7.54 (s, 1H), 7.49-7.42 (m, 1H), 7.42-7.30 (m, 
2H), 7.30-7.11 (m, 9H), 5.00 (s, 2H), 3.77 (s, 3H), 3.66 (s, 3H), 2.38 (s, 3H) ppm. 
 
13
C NMR (CDCl3, 75 MHz) δ = 171.6, 168.5, 159.7, 137.0, 136.9, 134.8, 134.1, 133.5, 133.1, 
130.7, 130.4, 129.0, 128.8, 128.3, 127.3, 126.0, 125.9, 125.7, 110.8, 76.4, 62.0, 51.8, 19.0 
ppm. 
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Methyl (E)-2-[2-(2-trifluoromethyl-benzoylaminooxymethyl)-phenyl]-3-methoxy-
acrylate (3.19b) 
 
 
 
Obtained according to the general procedure from 3.18 and 3.21b after flash chromatography 
(SiO2, 2:1 hexane/ethyl acetate) (44 mg, 39 %) as white waxy solid. 
 
1
H NMR (CDCl3, 300 MHz) δ = 8.63 (s, 1H), 7.73-7.59 (m, 1H), 7.54 (s, 1H), 7.54-7.41 (m, 
4H), 7.41-7.30 (m, 4H), 7.30-7.23 (m, 2H), 7.19-7.12 (m, 1H) 4.99 (s, 2H), 3.79 (s, 3H), 3.67 
(s, 3H) ppm. 
 
13
C NMR (CDCl3, 75 MHz) δ = 168.8, 164.9, 159.8, 134.6, 133.5, 132.5, 132.0, 131.4, 130.7, 
130.4, 129.1, 129.0, 128.2, 126.6, 110.6, 76.6, 62.1, 51.8 ppm. 
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Methyl (E)-2-{2-[(2-Chloro-pyridine-3-carbonyl)-aminooxymethyl]-phenyl}-3-methoxy-
acrylate (3.19c) 
 
 
 
Obtained according to the general procedure from 3.18 and 3.21c after flash chromatography 
(SiO2, 1:1 hexane/ethyl acetate) (10.2 mg, 24 %) as yellow waxy solid. 
 
1
H NMR (CDCl3, 300 MHz) δ = 9.12 (s, 1H), 8.45-8.36 (m, 1H), 7.81-7.71 (m, 1H), 7.55 (s, 
1H), 7.49-7.41 (m, 2H), 7.42-7.29 (m, 4H), 7.26-7.20 (m, 2H), 7.19-7.12 (m, 1H), 5.01 (s, 
2H), 3.80 (s, 3H), 3.68 (s, 3H) ppm. 
 
13
C NMR (CDCl3, 75 MHz) δ = 168.7, 159.9, 151.2, 150.1, 139.3, 137.0, 134.4, 133.6, 131.6, 
130.8, 129.2, 128.3, 122.8, 122.5, 110.6, 76.6, 62.1, 51.9 ppm. 
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1,1-Dimethylethyl N-(3-hydroxyphenyl)carbamate (3.25) 
 
 
 
To a solution of 3-aminophenol 3.24 (500 mg, 4.58 mmol) and NaI (686.7 mg, 4.58 mmol) in 
abs. THF (10 mL), (Boc)2O (1.26 mL, 5.50 mmol) was added dropwise at 0 °C and the 
reaction mixture was stirred at room temperature for 1 h. The reaction mixture was diluted 
with ethyl acetate (20 mL), washed with a saturated solution of Na2S2O3 (1×20 mL) and with 
a saturated solution of NaHCO3 (1×20 mL). The organic layer was dried with Na2SO4 and the 
solvent was removed under reduced pressure. The oily residue was crystallized by scraping 
the oil in the presence of a mixture of 10 % ethyl acetate in hexane recovering 3.25 (862 mg, 
90 %) as a white solid: mp 130-132 °C. 
 
1
H NMR (300 MHz, CDCl3): δ = 7.19-7.04 (m, 2H), 6.71 (ddd, 1 H, J = 8.1, 2.0, 0.9 Hz), 
6.53 (ddd, 1H, J = 8.1, 2.4, 0.9 Hz), 6.50 (bs, 1H), 5.51 (s, 1H), 1.51 (s, 9H) ppm. 
 
Spectroscopic data were in accordance with the literature.
20
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Methyl (E)-2-[2-(3-tert-butoxycarbonylamino-phenoxymethyl)-phenyl-3-methoxy-
acrylate (3.26) 
 
 
 
Solid 3.25 (388 mg, 1.85 mmol) was added at room temperature to a suspension of anhydrous 
K2CO3 (308 mg, 2.23 mmol) in abs. acetone (11.6 mL) and the resulting mixture was stirred 
at reflux for 1 h. After that, solid benzyl bromide 3.17 (480 mg, 1.68 mmol) was added and 
the reaction mixture was stirred at reflux for 9 h. The suspended K2CO3 was removed by 
vacuum filtration and the filtrate was removed under reduced pressure. The residue was 
purified by flash chromatography (SiO2, 3:1 petroleum ether/ethyl acetate) to obtain 
compound 3.26 (452 mg, 65 %) as white waxy solid. 
 
1
H NMR (300 MHz, CDCl3): δ = 7.59 (s, 1H), 7.57-7.50 (m, 1H), 7.37-7.27 (m, 2H), 7.20-
7.08 (m, 2H), 7.00-6.94 (m, 1H), 6.94-6.90 (m, 1H), 6.57 (ddd, 1H, J = 8.2, 2.5, 0.9 Hz), 6.50 
(bs, 1H), 4.94 (s, 2H), 3.83 (s, 3H), 3.72 (s, 3H), 1.50 (s, 9H) ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 168.1, 160.3, 159.6, 152.7, 139.7, 136.3, 131.3, 131.1, 
129.8, 128.2, 127.7, 127.6, 111.0, 110.2, 109.7, 105.3, 80.5, 68.1, 62.1, 51.8, 28.5 ppm. 
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Methyl (E)-2-[2-(3-amino-phenoxymethyl)-phenyl]-3-methoxy-acrylate (3.27) 
 
 
 
To a solution of 3.26 (202 mg, 0.49 mmol) in abs. CH2Cl2 (4.9 mL), trifluoroacetic acid (0.49 
mL) was added dropwise at 0 °C. The reaction mixture was stirred at the same temperature 
for 3 h. The solvent was removed under reduced pressure, stripping with toluene (2×2 mL) 
and Et2O (2×2 mL) to remove the excess of trifluoroacetic acid. The residue was dissolved in 
CH2Cl2 (15 mL) and washed with saturated solution of NaHCO3 (1×15 mL), the layers were 
separated and the aqueous layer was extracted with ethyl acetate (2×15 mL). The combined 
organic layers were dried with Na2SO4 and the solvent was removed in vacuo. Compound 
3.27 (139,0 mg, 90 %) was obtained as white waxy solid and used for the next synthetic steps 
without further purification 
 
1
H NMR (300 MHz, CDCl3): δ = 7.59 (s, 1H), 7.57-7.52 (m, 1H), 7.38-7.27 (m, 2H), 7.19-
7.13 (m, 1H), 7.05-6.98 (m, 1H), 6.36-6.22 (m, 3H), 4.91 (s, 2H), 3.82 (s, 3H), 3.71 (s, 3H) 
ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 167.8, 159.6, 150.2, 147.7, 138.6, 133.7, 133.6, 130.3, 
130.0, 126.7, 126.6, 109.4, 107.4, 104.1, 100.7, 71.7, 60.1, 50.8 ppm. 
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General procedure for the synthesis of compound 3.23a-c 
 
To a solution of the suitable arylic acid 3.28a-c (0.18 mmol) in abs. CH2Cl2 (1 mL) at 0 °C 
under N2 atmosphere, EDC·HCl (0.19 mmol) and HOBt (0.19 mmol) were added. The 
reaction mixture was stirred at 0 °C for 1 h. After that, a solution of compound 3.27 (0.16 
mmol) in abs. CH2Cl2 (0.7 mL) was added dropwise at 0 °C. Then, DIPEA (0.32 mmol, 56 μl) 
was added dropwise at the same temperature and the reaction mixture was stirred at room 
temperature for 8 h. The arylic acid (0.18 mmol), EDC·HCl (0.19 mmol), HOBt (0.19 mmol), 
and DIPEA (0.32 mmol, 56 μl) were again added at 0 °C after 24 and 48 h of stirring, then the 
reaction mixture was stirred for further 24 h. The reaction mixture was diluted with ethyl 
acetate (15 mL) and washed with a saturated solution of NH4Cl (3×20 mL), saturated solution 
of NaHCO3 (1×20 mL) and saturated solution of NaCl (1×20 mL). The organic layer was 
dried with Na2SO4 and the solvent was removed in vacuo The residue was purified by flash 
chromatography to give the corresponding compound 3.23a-c. 
  
56 
 
Methyl (E)-2-{2-[3-(2-methyl-benzoylamino)-phenoxymethyl]-phenyl}-3-methoxy-
acrylate (3.23a) 
 
 
 
Prepared according to general procedure from 3.27 and 3.28a after flash chromatography 
(SiO2, 5:1 hexane/acetone) (59.4 mg, 86 %) as a white waxy solid. 
 
1
H NMR (300 MHz, CDCl3): δ = 7.59 (s, 1H), 7.58-7.54 (m, 2H), 7.52-7.45 (m, 1H), 7.39-
7.30 (m, 3H), 7.30-7.20 (m, 4H), 7.20-7.13 (m, 2H), 6.73-6.66 (m, 1H), 4.98 (s, 2H), 3.83 (s, 
3H), 3.64 (s, 3H), 2.49 (s, 3H) ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 168.2, 168.1, 160.4, 159.5, 139.4, 136.7, 136.6, 136.2, 
131.3, 131.1, 130.3, 129.9, 128.3, 127.7, 126.8, 126.0, 112.3, 111.5, 110.2, 106.5, 68.1, 62.2, 
51.8 ppm. 
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Methyl (E)-2-{2-[3-(2-trifluoromethyl-benzoylamino)-phenoxymethyl]-phenyl}-3-
methoxy-acrylate (3.23b) 
 
 
 
Prepared according to general procedure from 3.27 and 3.28b after flash chromatography 
(SiO2, 3:1 hexane/ethyl acetate) (62.2 mg, 80 %) as a white waxy solid. 
 
1H NMR (300 MHz, CDCl3): δ = 7.78-7.71 (m, 1H), 7.68-7.52 (m, 4H), 7.58 (s, 1H), 7.38-
7.28 (m, 2H), 7.25-7.19 (m, 2H), 7.19-7.13 (m, 2H), 6.76-6.68 (m, 1H), 4.98 (s, 2H), 3.82 (s, 
3H), 3.64 (s, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 168.2, 165.7, 160.4, 159.5, 138.8, 163.1, 132.3, 131.4, 
131.1, 130.2, 129.9, 128.7, 128.3, 127.8, 126.6, 125.5, 121.9, 112.5, 111.8, 110.1, 106.8, 68.2, 
62.2, 51.7 ppm. 
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Methyl (E)-2-(2-{3-[(2-chloro-pyridine-3-carbonyl)-amino]-phenoxymethyl}-phenyl)-3-
methoxy-acrylate (3.23c) 
 
 
 
Prepared according to general procedure from 3.27 and 3.28c after flash chromatography 
(SiO2, 1:1 hexane/acetone) (47.3 mg, 65 %) as a white waxy solid. 
 
1
H NMR (300 MHz, CDCl3): δ = 8.50 (dd, J = 4.8, 1.9 Hz, 1H), 8.22-8.16 (m, 1H), 8.12 (dd, 
J = 7.6, 1.9 Hz, 1H), 7.59 (s, 1H), 7.58-7.52 (m, 2H), 7.42-7.30 (m, 2H), 7.30-7.20 (m, 2H), 
7.20-7.13 (m, 1H), 6.77-6.70 (m, 1H), 4.99 (s, 1H), 3.84 (s, 3H), 3.67 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ = 168.2, 165.2, 162.2, 154.8, 148.9, 147.2, 140.3, 139.2, 
138.6, 133.7, 130.3, 129.7, 127.9, 128.0, 127.3, 127.2, 112.7, 110.0, 109.7, 105.9, 72.3, 54.0, 
51.2 ppm. 
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PART II: SAMARIUM CHEMISTRY IN SYNTHESIS OF NATURAL PRODUCTS 
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4 SmI2-MEDIATED REFORMATSKY REACTION OF α-HALO N-ACYL-
OXAZOLIDINONE WITH TERPENE ALDEHYDES 
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4.1 Introduction 
Samarium(II) iodide (SmI2, Kagan’s reagent) is a single-electron transfer reagent that can 
mediate both radical and ionic processes; it was first introduced in organic synthesis in 1977 
by Kagan who described the SmI2-mediated reduction of alkyl halides in refluxing THF.
1,2
 
Since its discovery, the number of applications in organic synthesis of SmI2 has been greatly 
expanded and SmI2 turned out to be one of the most important reducing agents available. This 
success comes from a valuable combination of high versatility, high power and a remarkable 
chemoselectivity. SmI2 can mediate many reactions including reduction, reductive coupling, 
and cascade reactions, with high tolerance for functional groups. SmI2 is an oxophilic reagent, 
and the ability to coordinate oxygenated centres can be exploited to perform reactions with 
high degree of stereoselectivity. Furthermore, its reactivity and selectivity can be manipulated 
and finely tuned by adding various additives and cosolvents (Lewis bases, proton donors, and 
inorganic additives) leading to control of reaction rate and chemo- and stereoselectivity of the 
reaction.
3
  
Despite their large varieties, SmI2-mediated reactions can be mainly classified in two large 
classes: (i) functional groups reductions and (ii) carbon-carbon bond-forming reactions.  
Many SmI2-mediated reductions of functional groups have been described in literature and the 
main conversions are listed in Table 4.1.
4
 
 
Table 4.1 Functional groups reduced by SmI2 
Entry Functional group Product 
Condition 
(SmI2 + additives) 
1 
 
 
 
2 
   
3 
  
 
4 
 
  
5    
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6 
  
 
7 
  
 
8 
 
 
 
9 
 
  
10 
 
  
EG = ethylene glycol; EWG = electron-withdrawing group 
 
The high versatility in functional groups reduction can be explained by coordination and 
complexation of SmI2 and Sm(III) salts by-products. SmI2 Lewis acid nature allows the 
coordination with functional groups making easier the electron transfer. Furthermore, Sm(III) 
salts can form complexes with functional groups enhancing the leaving ability of such 
groups.
3
 As mentioned above, the use of additives and cosolvents permits a fine tuning of 
SmI2 reactivity and selectivity. Particularly, this can be exploited in many cases to perform 
selective reductions in presence of different reducible groups.
5-7 
The SmI2-mediated reduction of functional groups underlies carbon-carbon bonds formation 
by reductive coupling. Radicals and organo-samarium species formed by reductions can be 
quenched with a proton source to obtain the reduced products or can be exploited to perform 
carbon-carbon bond-forming reactions. Reduction of alkyl halides generates both radicals, 
useful for cyclization reactions with alkenes,
8,9
 and organo-samarium intermediates that can 
be used for both intramolecular and intermolecular Barbier and Grignard reactions.
10
 
Reduction of carbonyl compounds generates ketyl radical anion intermediates used in pinacol 
coupling reactions
11
 and in carbonyl-alkene coupling reactions.
 12-14
  
Reduction of α-heteroatom-substituted carbonyl compounds is one of the most common use 
of SmI2.
15
 As reported by Molander in 1986, α-oxygenated, α-halo, α-sulfanyl, α-sulfinyl and 
α-sulfonyl ketones can be easily reduced with SmI2.
16
 Reduction of α-heteroatom-substituted 
carbonyl compounds is not limited to ketones, as it was also described on α-oxygenated esters 
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and α-heteroatom-substituted amides.17,18 SmI2-reduction of α-heteroatom-substituted 
carbonyl compounds proceeds through the formation of intermediate Sm(III) enolates that are 
usually quenched with a proton source to obtain the parent carbonyl compounds.
16
 
Furthermore, Sm(III) enolates that can be used for the formation of new carbon-carbon bonds 
in aldol reactions with aldehydes and ketones.
3
 
 
4.1.2 SmI2-promoted Reformatsky reactions 
As mentioned above, Sm(III) enolate can be prepared starting from a variety of α-heteroatom-
substituted carbonyl compounds. When the starting material is an α-halo carbonyl compound 
the reaction is generally indicated as SmI2-promoted Reformatsky reaction. This Reformatsky 
reaction occurs under mild, homogeneous, cryogenic conditions and in the absence of 
additives, allowing the presence of functional groups susceptible of SmI2-mediated reduction 
in other conditions.
4
 
The first example of SmI2-Reformatsky was described by Kagan in 1980. In this work the 
authors describe the reaction of methyl α-bromopropionate 4.1 with cyclohexanone 4.2 in 
presence of SmI2 to obtain the corresponding coupling products 4.3 in high yields as 
diastereomeric mixture (Figure 4.1).
19
 
 
 
Figure 4.1 SmI2-mediated Reformatsky reaction of methyl 2-bromopropionate with cyclohexanone 
 
Since this first results, the scope of the reaction was greatly expanded and several examples of 
intramolecular and intermolecular SmI2-Reformatsky reactions were reported in scientific 
literature. The largest number of applications of SmI2-Reformatsky is in its intramolecular 
version; this reaction has proven to be successful on a large number of substrates that can be 
classified into four large classes: α-halo esters, α-halo amides, α-halo ketones, and α-halo 
nitriles. Conversely, the application of the intermolecular version of this reaction has proven 
to be more challenging because of competition with side reactions, such as carbonyl 
reduction, pinacol coupling, self-condensation of α-halo carbonyls, and Evans-Tishchenko-
type reaction. Despite these problems, several examples of intermolecular SmI2-Reformatsky 
with various classes of substrates have been reported in literature in the past decades.
4 
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One of the most interesting advancement in SmI2-promoted Reformatsky reaction is the 
development of the asymmetric version with the use of chiral auxiliaries. The first examples 
were reported by Fukuzawa in 2000 (Figure 4.2). It was demonstrated that chiral α-bromo N-
acetyl-oxazolidinones 4.4a can react with aliphatic and aromatic aldehydes in SmI2-
Reformatsky reaction. The reaction occurs with good to excellent yields and high 
diastereomeric excess, particularly in case of aldehydes with hindered side chain. As 
suggested by the authors, samarium(III) ions seem to play a pivotal role in the transition state, 
and the stereochemistry of the reaction is determined by chelation control and coordination of 
the incoming aldehydes.
20
 
 
 
Figure 4.2 Asymmetric SmI2-mediated Reformatsky reaction of α-bromo N-acetyl-oxazolidinones with 
2,2-dimethylpropanal. 
 
An interesting application of asymmetric SmI2-Reformatsky reaction was described by Burke 
in 2012. In this work, the authors describe the reaction of samarium(III) enolates derived from 
α-chloro N-acetyl Evans’ oxazolidinone 4.4b with chiral α-amino aldehydes 4.6, providing β-
hydroxy-γ-amino acids with good yields and high diastereoselectivity (Figure 4.3).21 
 
 
Figure 4.3 Asymmetric SmI2-mediated Reformatsky reaction of α-chloro N-acetyl oxazolidinone 4.4b 
with chiral α-amino aldehydes 4.6 
 
Despite the good results obtained and the promising application, the use of chiral SmI2-
Reformatsky is still an underexplored area. In the examples previously discussed, the 
applications were limited to alkyl and aromatic aldehydes and no evidences are reported in the 
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use of enals and terpene-derived aldehydes, that can be exploited as precursors in the 
synthesis of natural products like cembranoids.
22
 
 
4.1.3 Cembranoids 
Cembranoids are a class of 14-membered macrocyclic diterpenoids derived mainly from 
marine organism.
23
 This class of secondary metabolites exhibits a wide range of biological 
activities, thus cembranoids are potentially candidates as lead compounds for pharmaceutical 
development.
24-26
 Some examples of cembranoids are shown in Figure 4.5. 
 
 
Figure 4.5 Asperdiol (4.8a), its analogue knightol (4.9a), their acetates4.8b, 4.9b and knightal (4.10) 
 
Asperdiol 4.8a and its acetate 4.8b are two members of this class which have been isolated 
from soft corals Eunicea asperula and E. tourneforti by Weinheimer in 1977.
24
 Asperdiol and 
its closely related analogues knightol 4.9a, knightol acetate 4.9b, and knightal 4.10, which 
were isolated from Eunicea knighti,
25
 have received increasing interest due to their promising 
cytotoxic and antimicrobial activity. 
The main source of cembranoids is still the extraction from natural sources, but this is not an 
ecologically sustainable strategy because of the large amount of biomass requested to extract 
small amounts of compound.
27
 Thus, a synthetic approach for the preparation of cembranoids 
was investigated. 
Five total syntheses of asperdiol have been reported by Still,
28
 Marshall,
29
 and Tius
30
 utilizing 
a Nozaki-Hiyami-Kishi reaction,
28
 sulfone alkylation,
29b
 [2,3]-Witting rearrangements
29a
 or 
Horner-Wadsworth-Emmons olefinations
30
 as key steps for the ring closure.  
In 2014, Kriening proposed the use of asymmetric aldol reaction of N-acyloxazolidinones 
with terpene-derived enals as key step for the synthesis of asperdiol precursor. Despite the 
high diastereoselectivity, the synthesis turned out to be syn-selective, leading to a product 
with opposite stereochemistry at alcohol moiety (Figure 4.6). The stereochemistry of alcohol 
could not be inverted and any attempts to obtain anti-aldol reactions was unsuccessfully.
22
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Figure 4.6 Asymmetric aldol reactions of N-acyloxazolidinones 4.11 with neral 4.13b 
 
In this Chapter is described the development of a SmI2-mediated Reformatsky reaction of 
Evans’ N-acyloxazolidinones with terpene-derived aldehydes as key step for the synthesis of 
asperdiol precursor. We intend to develop a complementar method to the Evans aldol 
reaction-based approach to asperdiol precursors. 
The investigation was based on the results previously reported by Fukuzawa
20
 and then by 
Burke.
21
 As shown in Figure 4.7, the reactions of readily accessible N-acyloxazolidinones 
4.4a-d with simple terpene-derived aldehydes 4.13a,b were performed as a simplified model 
to investigate which factors influence the outcome of the reaction in terms of yield and 
diastereoselectivity. As highlighted in Figure 4.7, the project was focused on the 
investigation of the effect E-Z configuration of the double bond of the aldehyde, the role of 
the halide on the N-acyloxazolidinones, the effect of the temperature, and the presence and the 
configuration of stereocenters on the N-acyloxazolidinones. 
 
 
Figure 4.7 SmI2-mediated Reformatsky reaction N-acyloxazolidinones 4.4a-d with enals 4.13a,b 
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4.2 Results and discussion 
4.2.1 Synthesis of precursors Evans’ N-acyloxazolidinones 4.4a-d 
N-Acetyloxazolidinones 4.4a and 4.4b were prepared starting from Evans’ oxazolidinone 4.18 
and obtained after chromatographic separation in 74 % and 85 % yield, respectively (Figure 
4.8).
31
 
 
 
Figure 4.8 Synthesis of N-Acetyloxazolidinones 4.4a,b 
 
α-Bromo N-propionyloxazolidinones 4.4c,d were prepared with the same procedure used for 
compound 4.4a,b starting from Evans’ oxazolidinone 4.18 and freshly distilled racemic 
bromopropionyl bromide (Figure 4.9). The products 4.4c,d were obtained in 53 % yield as 
approximately 1:2 mixture of diastereomers.
32
 Separation of the two diastereomers has been 
accomplished by flash cromatography, but any attempts to assign the absolute configuration 
was unsuccessful because of the rapid epimerization of the single diastereomers. Complete 
epimerization was observed in samples stored at -22 °C in less than a week. 
 
 
Figure 4.9 Synthesis of α-Bromo N-propionyloxazolidinones 4.4c,d 
 
4.2.2 Synthesis of precursors terpene aldehydes 4.13a,b 
Firstly, geranial 4.13a and neral 4.13b were prepared by oxidation of geraniol 4.19a and nerol 
4.19b with Dess-Martin periodinane (Figure 4.10, method A).
33
 The oxidation with Dess-
Martin periodinane has proved to be a good strategy for small scale oxidation of terpene 
alcohols providing the desired terpene aldehydes in good yield with user-friendly and 
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operationally simple reaction conditions. Conversely, this strategy turned out to be not 
suitable for scale-up because of the high cost of the reagent and its poor atom economy. 
Ley-Griffith oxidantion
34
 was chosen as alternative strategy for terpene alcohols oxidation 
(Figure 4.10, method B). Therefore, the starting terpene alcohol 4.19a or 4.19b was 
dissolved in a stirred suspension of grinded 4 Å molecular sieves and N-methylmorpholine-N-
oxide before the Ley-Griffith reagent (tetrapropylammonium perruthenate, TPAP) was added 
in catalityc amount. The desired terpene aldehydes 4.13a and 4.13b were obtained in 81 % 
and 78 % yield, respectively. It should be noted that complete removal of any residues of the 
catalyst turned out to be crucial to avoid isomerization of the double bound. 
 
 
Figure 4.10 Synthesis of terpene aldehydes 4.13a,b 
 
4.2.3 SmI2-mediate Reformatsky reaction 
Initially α-bromo N-acetyloxazolidinone 4.15a was coupled with geranial 4.13a and neral 
4.13b in SmI2-mediated Reformatsky reaction following the procedure reported in ref 
18
 
(Figure 4.11). A solution of SmI2 (0.1 M in THF) was cooled to -78 °C before simultaneous 
addition of α-bromo N-acetyloxazolidinone 4.15a and aldehyde 4.13a or 4.13b dissolved in 
THF. In these conditions reaction proceeded sluggish and the consumption of starting α-
bromo N-acetyloxazolidinone 4.15a was incomplete, affording compounds 4.14b [(E)-
derivative] and 4.15b [(Z)-derivative] in only 32 % and 23 % yield, respectively. Moreover, 
the formation of a large number of side products was observed thus the isolation of the pure 
minor diastereomers was hampered. 
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Figure 4.11 SmI2-mediated Reformatsky reaction of 4.15a with 4.13a,b 
 
The ability of SmI2 to carry out the reduction of carbonyl compounds and to promote 
carbonyl-alkene coupling is well known.
2
 In agreement with this evidence, reduction of 
terpene aldehydes could compete with the SmI2-mediate Reformatsky reaction leading to 
consumption of SmI2 and formation of side products. Hence, a solution of SmI2 0.1 M in THF 
was cooled to -78 °C before addition of a solution of α-bromo N-acetyloxazolidinone 4.15a in 
THF. The reaction mixture was stirred in the dark for 5 minutes to permit the formation of 
Sm(III) enolate. After that, a solution of geranial 4.13a was added dropwise at -78 °C and the 
reaction mixture was stirred at the same temperature in the dark. In these conditions the 
reaction was complete after 0.5 h, affording diastereomers 4.14a and 4.14b with a ratio 
4.14b/4.14a 92:8 (Table 4.1; entry 1). The reaction was carried out in the same condition 
using neral 4.13b, affording after chromatographic separation diastereomers 4.15a and 4.15b 
after chromatographic separation with a ratio 4.15b/4.15a 91:9 (Table 4.1; entry 2). 
 
4.2.4 Role of the halide and effect of the temperature 
To investigate the role of the halide and the effect of the temperature on the SmI2-mediate 
Reformatsky reaction, a series of screening reactions were undertaken; the results are 
summarized in Table 4.2. All the reactions were carried with the optimized procedure 
described above. Reaction of α-bromo N-acetyloxazolidinone 4.4a with geranial 4.13a at -100 
°C provided products 4.14a and 4.14b in ratio 4.14b/4.14a 90:10 (Table 4.2; entry 3). The 
yield of the reaction is lower compared to the same reaction performed at -78 °C. Sm(III) 
enolate formed as intermediate is poorly soluble at -100 °C and this slows down the reaction 
with the terpene aldehyde, favouring the formation of side products. It should be noted that 
the lowering the temperature did not significantly influence the diastereomeric ratio. 
Analogous results were obtained from the same reaction with neral 4.13b (Table 4.2; entry 
4). 
Reactions of α-chloro N-acetyloxazolidinone 4.4b with geranial 4.13a at -78 °C provided 
products 4.14a and 4.14b with lower yield compared to α-bromo N-acetyloxazolidinone 4.4a. 
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Despite a slightly increase of the yields could be obtained lowering the temperature of the 
reaction to -100 °C, the yields of the reaction with α-chloro N-acetyloxazolidinone 4.4b were 
still lower compared to the reaction with α-bromo N-acetyloxazolidinone 4.4a at -78 °C.  
The diastereomeric ratios were not significantly different, suggesting that the 
diastereoselectivity of the reactions was mainly controlled by the chiral auxiliary in the 
samarium(III) enolate (Table 4.2; entries 5, 7). Analogous results were obtained from the 
same reactions with neral 4.13b (Table 4.2; entries 6, 8). 
 
Table 4.2 Determination of the effect of temperature and halide on yield and diastereoselectivity 
 
Entry Enal X T Products Yield (b) Ratio b/a 
1 4.13a Br -78 °C 4.14° 4.14b 73 % 92:8 
2 4.13b Br -78 °C 4.15° 4.15b 71 % 91:9 
3 4.13a Br -100 °C 4.14° 4.14b 59 % 90:10 
4 4.13b Br -100 °C 4.15° 4.15b 54 % 90:10 
5 4.13a Cl -78 °C 4.14° 4.14b 48 % 89:11 
6 4.13b Cl -78 °C 4.15° 4.15b 43 % 90:10 
7 4.13a Cl -100 °C 4.14° 4.14b 56 % 90:10 
8 4.13b Cl -100 °C 4.15° 4.15b 50 % 91:9 
1.2 equiv. of enal, 2.2 equiv. SmI2, stirring 30 min. in dark 
 
4.2.5 Role of stereocenters on the N-acyloxazolidinones 
To investigate the reactivity of secondary halides on the acyl chain and the effect of chirality 
on the reaction outcomes, a series of screening reactions on α-bromo N-
propionyloxazolidinones 4.4c and 4.4d were undertaken. Reactions were performed as 
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described above both on diastereomeric mixture and on single diastereomers. Because of the 
rapid epimerization of the α-bromo N-propionyloxazolidinones,32 the pure single 
diastereomers were obtained by chromatographic separation and immediately used for the 
reactions. Results are summarized in Table 4.3. The yields of reactions of the diastereomeric 
mixture with geranial 4.13a and neral 4.13b were good, suggesting that the reactivity of α-
bromo N-propionyloxazolidinones 4.4c and 4.4d doesn’t differ significantly from α-bromo N-
acetyloxazolidinone 4.4a. Diastereomers 4.16a-c and 4.17a-c were isolated after 
chromatographic separation. Reaction of single diastereomers 4.4c and 4.4d with geranial and 
neral 4.13a or 4.13b provided the diastereomers with no significant differences in terms of 
yields and diastereomeric ratios, suggesting that the configuration of the stereocenter on α-
bromo N-propionyl group had no influence on the outcome of the reaction. In agreement with 
the proposed mechanism,
1
 the first step of samarium(II) iodide-mediated Reformatsky 
reaction should involve the reduction of the α-bromopropionyl group to give the 
samarium(III) enolate with loss of chirality. Therefore, the configuration of the α-
bromopropionyl group should not influence the outcome of the reaction and the ratio of 
diastereomers. 
 
Table 4.3 Determination of the effect of the stereocenter on the acyl group 
 
Entry N-acyloxazolidinone Enal Products Yield (b) Ratio a/b/c 
1 
4.4c,d 
(1:2 mixture) 4.13a 4.16a-c 55 % 16:63:21 
2 
4.4c,d 
(1:2 mixture) 4.13b 4.17a-c 59 % 9:71:20 
4 4.4c 4.13a 4.16a-c 52 % 15:63:22 
5 4.4c 4.13b 4.17a-c 59 % 11:70:19 
7 4.4d 4.13a 4.16a-c 53 % 16:62:22 
8 4.4d 4.13b 4.17a-c 57 % 10:71:19 
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1.2 equiv. of enal, 2.2 equiv. SmI2, stirring 30 min. in dark 
 
4.2.6 Assigment of absolute configuration at C-2/C-3 
Mosher’s method35 was applied to determine the absolute configuration at C-3. Therefore, 
product 4.14b was esterified with Mosher acyl chloride (R)- and (S)-MTPA to obtain the 
corresponding (S)- and (R)-MTPA esters (S)-4.20 and (R)-4.20 in 85 and 84 % yield, 
respectively. The procedure was adapted from the procedure repoted in ref.
22
 (S)- and (R)-
MTPA esters (S)-4.21 and (R)-4.21 were prepared from 4.15b following the same procedure, 
in 70 % and 80 % yield, respectively.  
Analysis of the 
1
H NMR differences in the chemical shifts
35
 indicated the absolute 
configuration for both products 4.14b and 4.15b at C-3 as (R). (Table 4.4) 
 
Table 4.4 Determination of the configuration of 4.14b and 4.15b by Mosher's method 
 
  Compound 4.14b  Compound 4.15b 
  (S)-4.20 (R)-4.20 Δδ = δ(S)-δ(R)  (S)-4.21 (R)-4.21 Δδ = δ(S)-δ(R) 
Proton  δ = δ = (ppm)  δ = δ = (ppm) 
2-Ha  3.45 3.53 -0.08  3.47 3.54 -0.07 
2-Hb  3.16 3.03 +0.13  3.07 2.94 +0.13 
4-H  5.07 5.23 -0.16  5.08 5.25 -0.17 
1.3 equiv. (R/S)-MTPACl, 2.2 equiv. pyridine, 0.5 equiv. DMAP, 0 °C to RT, 12 h 
 
(S)- and (R)-MTPA esters (S)-4.22 and (R)-4.22 were prepared by the same procedures 
starting from products 4.16b, while esters (S)-4.23 and (R)-4.23 were prepared from 4.17b. 
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Analysis of the 
1
H NMR differences in the chemical shifts
35
 indicated the absolute 
configuration for both products 4.16b and 4.17b at C-3 as (2S). (Table 4.5) 
 
Table 4.5 Determination of the configuration of 4.16b and 4.17b by Mosher's method 
 
  Compound 4.16b  Compound 4.17b 
  (S)-4.22 (R)-4.23 Δδ = δ(S)-δ(R)  (S)-4.23 (R)-4.23 Δδ = δ(S)-δ(R) 
Proton  δ = δ = (ppm)  δ = Δ = (ppm) 
5-Me  1.23 1.08 +0.15  1.23 1.07 +0.16 
4-H  5.09 5.25 -0.16  5.08 5.27 -0.19 
1.3 equiv. (R/S)-MTPACl, 2.2 equiv. pyridine, 0.5 equiv. DMAP, 0 °C to RT, 12 h 
 
To assign the configuration at C-2, products 4.16b and 4.17b were converted into the 
conformational blocked cyclic acetal 4.26 and 4.27 (Figure 4.10). To remove the chiral 
auxiliary, 4.16b was treated a 0 °C with LiBH4 in abs. THF/abs. MeOH 100:1. Diol 4.24 was 
obtained in 64 %.
22
 Diol 4.25 was obtained following the same procedure in 60 % yield.  
To synthesize the cyclic acetal, diol 4.24 was treated with 2,2-dimethoxypropane and PPTS at 
room temperature. Acetal 4.26 was obtained in 90 % yield.
22
 Acetal 4.27 was obtained 
following the same procedure in 88 % yield. 
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Figure 4.12 Synthesis of conformationally blocked acetals 4.26 and 4.27 
 
NOESY correlations were used to assign the relative configuration at C-2/C-3.
22
 A strong 
NOE of H-2 with H-3 was observed for acetal 4.26, confirming a syn-configuration of the 
stereogenic centers C-2/C-3. Consequently, a (2S,3S)-configuration for acetal 4.26 and 
(2R,3S)-configuration for 4.16b were assumed (Figure 4.11). Analogous results were 
obtained for acetal 4.27, confirming a syn-configuration of the stereogenic centers C-2/C-3. 
Consequently, a (2S,3S)-configuration for acetal 4.27 and (2R,3S)-configuration for 4.17b 
were assumed (Figure 4.11) 
 
 
Figure 4.13 Observed NOE for 4.26 and 4.27 
 
Because of the very limited amount of products obtained, the procedure described above 
could not be used for minor diastereomers 4.16a-c and 4.17a-c. Hence, the absolute and 
relative configuration at C-2/C-3 for these products has been hypothesized considering the 
structure of the chelated transition state described in ref.
20
 and the possible presence of an 
equilibrium between (Z) and (E)-enolate. The formation of the three diastereomers may be the 
consequence of an equilibrium between the (Z) and the less sterically favoured (E)-enolate. 
As described by Fukuzawa,
20
 asymmetric samarium(II) iodide-promoted Reformatsky 
reactions should occur with the formation of a chelated intermediate state. Samarium 
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coordinates the oxygen of the incoming aldehyde favouring the re face attack because of the 
isopropyl group of the Evans’ oxazolidinone is oriented in a less sterically hindered 
environment. Thus, (Z)-enolate can lead to the formation of two syn-diastereomers deriving 
by favoured re face and disfavoured si face attack. (Figure 4.12)  
The stereochemistry of the adduct derived by re face attack is in agreement with the absolute 
and relative configuration determined experimentally for the main diastereomers 4.16b and 
4.17b. 
The less sterically favoured (E)-enolate may potentially lead to the formation of two 
diastereomers, but probably the presence of the pseudo-equatorial methyl group in the 
chelated transition state further disfavours the si face attack, leading to the formation of a 
single anti-diastereomer rather than two. (Figure 4.12) 
 
 
Figure 4.14 Speculation on the configurations at C-2/C-3 for 4.16a,c and 4.17a,c 
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4.3 Summary 
In this Chapter are reported the results for the investigation of the use of enals in samarium(II) 
iodide-promoted Reformatsky reaction. The efforts were focused on the use of terpene-
derived aldehydes geranial 4.13a and neral 4.13b, to investigate the potential of this reaction 
for the synthesis of cembranoids. 
Samarium(II) iodide-promoted Reformatsky reaction of α-halo N-acyl-oxazolidinones 4.4a-d 
with terpene-derived aldehydes 4.13a,b was successful. The reaction provided the coupling 
product 4.14b, 4.15b, 4.16b, and 4.17b with good yields and high diastereomer ratio.  
The role of the halide, the effect of the temperature, and influence of stereochemistry on the 
N-acyl group were investigated. Replacing the halogen atom on the N-acyl group and 
lowering the temperature of the reaction turned out to be detrimental for the yield of the 
reaction. Conversely, it was demonstrated that the temperature and the halide have little or no 
effect on the diastereoselectivity of the reaction. The stereochemistry on the N-acyl group 
turned out to have no effects on the outcome of the reaction and on the diastereomeric ratio. 
The absolute configuration at the C-3 for products 4.14b, 4.15b, 4.16b, and 4.17b was 
successful determined by application of the Mosher’s method. It was demostrated that the 
absolute configuration at C-3 is (R) for compounds 4.14b and 4.15b and (S) for compounds 
4.16b and 4.17b. 
The absolute configuration at the C-2 for products 4.16b and 4.17b was successful 
determined by conversion into the conformational blocked cyclic acetal 4.26 and 4.27 and 
analisy of NOESY correlation. It was demostrated a (2R,3S)-configuration for both the 
products 4.16b and 4.17b. 
Experimental determination of the absolute configuration at C-2/C-3 for products 4.16a,c and 
4.17a,c was not possible. A conjecture on the stereochemistry was made considering the 
chelated transition state of the reaction. 
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4.4 Experimental part 
(4S)-3-(bromoacetyl)-4-(1-methylethyl)-oxazolidin-2-one (4.4a) 
 
 
 
To a solution of (S)-4-(1-methylethyl)-oxazolidin-2-one 4.18 (1.0 g, 7.74 mmol) in abs. THF 
(30 mL) a solution of nBuLi (2.5 M in hexane, 3.4 mL, 8.52 mmol) was added dropwise at -
78 °C, and the reaction mixture was stirred at the same temperature. After 60 min. a solution 
of bromoacetyl bromide (810 μL, 9.29 mmol) in abs. THF (8 mL) was added dropwise at -78 
°C. The mixture was kept for 30 min. at -78 °C, then slowly warmed to room temperature and 
stirred overnight. A saturated solution of NaHCO3 (50 mL) was added and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3×50 mL), the combined 
organic layers were dried with MgSO4 and the solvent was removed in vacuo. The residue 
was purified by flash chromatography (SiO2, 5:1 petroleum ether/ethyl acetate) to 4.4a (1.45g, 
75 %) as a white solid: mp 54-56 °C. [α]20D = +83.0 (c 1.0; CHCl3). 
 
1
H NMR (400 MHz, CDCl3): δ = 4.61-4.25 (m, 5H), 2.47-2.36 (m, 1H), 0.94 (dd, J = 7.0 Hz, 
3H), 0.88 (dd, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 165.9, 153.5, 63.9, 58.6, 28.1, 17.7, 14.6 ppm. 
 
Spectroscopic data were in accordance with the literature.
32
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(4S)-3-(chloroacetyl)-4-(1-methylethyl)-oxazolidin-2-one (4.4b) 
 
 
 
Prepared as described for 4.4a from 4.18 (1.5 g, 11.61 mmol) and freshly distilled chloroacety 
chloride (1.11 mL, 13.93 mmol) to give 4.4b (2.03 g, 85 %) after flash chromatography (SiO2, 
5:1 petroleum ether/ethyl acetate) as a yellow oil. [α]20D = +97.9 (c 1.0; CHCl3) 
 
1
H NMR (400 MHz, CDCl3): δ = 4.81-4.63 (m, 2H), 4.50-4.41 (m, 1H), 4.39-4.31 (m, 1H), 
4.28 (dd, J = 9.1, 3.2 Hz, 1H), 2.50-2.34 (m, 1H), 0.94 (d, J = 7.0 Hz, 3H), 0.89 (d, J = 6.9 
Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 166.2, 153.9, 64.3, 58.9, 43.8, 28.3, 18.0, 14.7 ppm. 
 
Spectroscopic data were in accordance with the literature.
32 
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(4S)-3-(2-bromopropanoyl)-4-(1-methylethyl)-oxazolidin-2-one (4.4c,d) 
 
 
 
To a solution of (S)-4-(1-methylethyl)-oxazolidin-2-one 4.18 (1.0 g, 7.74 mmol) in abs. THF 
(30 mL) a solution of nBuLi (2.5 M in hexane, 3.72 mL, 9.29 mmol) was added dropwise at -
78 °C and the reaction mixture was stirred at the same temperature. After 60 min. a solution 
of (2RS)-bromopropanoyl bromide (1.05 mL, 10.06 mmol) in abs. THF (10 mL) was added 
dropwise at -78 °C. The mixture was kept for 60 min. at -78 °C, then slowly warmed to room 
temperature and stirred overnight. The reaction mixture was diluted with CH2Cl2 (40 mL) and 
washed with saturated solution of NaHCO3 (1×40 mL); afterwards the aqueous layer was 
extracted with ethyl acetate (3×40 mL). The combined organic layers were washed with brine 
(1×120 mL), dried with MgSO4 and the solvent was removed in vacuo. The residue was 
purified by flash chromatography (SiO2, 5:1 petroleum ether/ethyl acetate) to give products 
4.4c,d in 1:2 diastereomeric mixture (1.06g, 52 %) as a white waxy solid. 
 
4.4c 
 
Obtained as a white waxy solid (354 mg, 17 %). [α]20D = + 53.3 (c 1.0, CHCl3). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.75 (q, J = 6.8 Hz, 1H), 4.43 (ddd, J = 8.0, 3.7, 2.7 Hz, 
1H), 4.34 (t, J = 8.6 Hz, 1H), 4.25 (dd, J = 9.0, 2.5 Hz, 1H), 1.85 (d, J = 6.8 Hz, 3H), 0.91 
(dd, J = 19.8, 7.0 Hz, 6H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 165.9, 153.5, 63.9, 58.6, 28.1, 17.7, 14.6 ppm. 
 
4.4d 
 
Obtained as a white solid (708 mg, 35 %): mp 54-56 °C. [α]20D = +72.2 (c 1.0, CHCl3). 
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1
H NMR (400 MHz, CDCl3): δ = 5.75 (q, J = 6.8 Hz, 1H), 4.43 (ddd, J = 8.0, 3.7, 2.7 Hz, 
1H), 4.34 (t, J = 8.6 Hz, 1H), 4.25 (dd, J = 9.0, 2.5 Hz, 1H), 1.85 (d, J = 6.8 Hz, 3H), 0.91 
(dd, J = 19.8, 7.0 Hz, 6H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 165.9, 153.5, 63.9, 58.6, 28.1, 17.7, 14.6 ppm. 
 
Spectroscopic data were in accordance with the literature.
32
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General procedure for the synthesis of (E/Z)-3,7-dimethylocta-2,6-dienal) 4.13a and 
4.13b with Dess-Martin Periodinane (Method A) 
 
To a solution of the appropriate terpenic alcohol (300 mg, 1.94 mmol) in abs. CH2Cl2 (15 mL) 
Dess-Martin Periodinane (987.4 mg, 2.33 mmol) was added at room temperature. The 
reaction mixture was stirred at the same temperature for 2 h. Then a saturated solution of 
Na2S2O3 was added and the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3×15 mL). The combined organic layers were washed with brine (1×45 mL), dried 
with MgSO4 and the solvent was removed in vacuo. The residue was purified by flash 
chromatography (SiO2, 25:1 petroleum ether/ethyl acetate) to give the corresponding enal. 
 
General procedure for the synthesis of (E/Z)-3,7-dimethylocta-2,6-dienal) 4.13a and 
4.13b with Ley-Griffith Reagent (tetrapropylammonium perruthenate, TPAP) (Method 
B) 
 
In a Schlenk flask, grinded 4 Å molecular sieves (6.5 g) were activated by prolonged heating 
under vacuo. After cooling under N2 atmosphere, N-methylmorpholine-N-oxide (2,28 g) was 
added and the flask was three times evacuated and then filled with N2. The powder mixture 
was suspended with abs. CH2Cl2 (26 ml) and the appropriate terpenic alcohol (2,0 g) was 
added at room temperature under vigorous stirring. TPAP (44mg, 0.1 mol%) was quickly 
added and the reaction mixture was stirred overnight. The reaction mixture was filtered on a 
short plug of silica and concentrated in vacuo. The residue was purified by flash 
chromatography (SiO2, 25:1 petroleum ether/ethyl acetate) to give the corresponding enal. 
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(2E)-3,7-dimethylocta-2,6-dienal (4.13a, Geranial) 
 
 
 
Prepared according to method A (263 mg, 89 %) as a colourless oil. 
Prepared according to method B (1.64 g, 83 %) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 10.00 (d, J = 8.0 Hz, 1H), 5.90-5.87 (m, 1H), 5.09-5.05 (m, 
1H), 2.26-2.19 (m, 2H), 2.17 (s, 3H), 1.69 (s, 3H), 2.61 (s, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 191.4, 163.9, 133.1, 127.5, 122.7, 40.7, 25.9, 25.8, 17.8, 
17.7 ppm. 
 
Spectroscopic data are in good agreement with ref.
33
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(2Z)-3,7-dimethylocta-2,6-dienal (4.13b, Neral) 
 
 
 
Prepared according to method A (239 mg, 81 %) as a colourless oil. 
Prepared according to method B (1.54 g, 78 %) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 9.88 (d, J = 8.3 Hz, 1H), 5.89-5.87 (m, 1H), 5.10-5.06 (m, 
1H), 2.58-2.22 (m, 2H), 1.98 (s, 3H), 1.68 (s, 3H), 1.59 (s, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 190.9, 163.9, 133.8, 128.8, 122.4, 32.7, 27.2, 25.8, 25.2, 
17.9 ppm. 
 
Spectroscopic data are in agreement with ref.
33
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General Procedure for the Samarium(II) iodide mediated-Reformatsky Reaction of N-
Acyloxazolidinones (4.4a-d) with enals (4.13a, 4.13b) 
 
To a solution of samarium(II) iodide (0.1M in THF, 22 mL) a solution of N-
acyloxazolidinone (1.0 mmol) in abs. THF (3 mL) was added dropwise at -78 °C in the dark. 
The reaction mixture was stirred for 5 min. before a solution of the enal (1.2 mmol) in abs. 
THF (3 mL) was added dropwise. The reaction was stirred at -78 °C in the dark for 30 min. 
Then a saturated solution of NH4Cl (1×20 mL) was added at -78 °C, and the reaction mixture 
was warmed to room temperature. The layers were separated, and the aqueous fraction was 
extracted with ethyl acetate (3×15 mL). The combined organic layers were washed with a 
saturated solution Na2S2O3 (1×45, dried with MgSO4 and concentrated under vacuum. The 
residue was purified by flash chromatography (SiO2, 5:1→1:1 petroleum ether/ethyl acetate). 
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(S)-3-((S,E)-3-hydroxy-5,9-dimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.14a) 
 
 
 
Prepared according to general procedure from 4.4a and 4.13a after flash chromatography (20 
mg, 6 %) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 5.29-5.24 (m, 1H), 5.12-5.05 (m, 1H), 4.88-4.83 (m, 1H), 
4.48-4.44 (m, 1H), 4.31-4.21 (m, 2H), 3.22 (dd, J = 17.1, 9.1 Hz, 1H), 3.05 (dd, J = 17.1, 3.3 
Hz, 1H), 2.46-2.30 (m, 1H), 2.12-1.99 (m, 4H) 1.70 (s, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 0.94 
(d, J = 7.0 Hz, 3H), 0.88 (d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 176.8, 154.2, 141.1, 132.1, 125.4, 124.1, 70.9, 63.8, 58.8, 
44.7, 39.9, 28.9, 26.6, 18.2, 18.0, 17.1, 15.1, 14.9 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 346.1995, found 346.1983. 
 
FT-IR (ATR): ν = 3524 (w), 2963 (m), 2923 (m), 2855 (m), 1782 (vs), 1699 (s), 1486 (w), 
1448 (w), 1387 (s), 1374 (s), 1303 (m), 1205 (s), 1142 (w), 1120 (w), 1105 (w), 1061 (w), 
1021 (w), 973 (w).  
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(S)-3-((R,E)-3-hydroxy-5,9-dimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.14b) 
 
 
 
Prepared according to general procedure from 4.4a and 4.13a after flash chromatography (236 
mg, 73 %) as a colourless oil. [α]20D = +33.5 (c 1.2, CH2Cl2) 
 
1
H NMR (400 MHz, CDCl3): δ = 5.25 (dd, J = 8.5, 1.1 Hz, 1H), 5.11-5.04 (m, 1H), 4.91-4.85 
(m, 1H), 4.48-4.39 (m, 1H), 4.30-4.20 (m, 2H), 3.16-3.06 (m, 2H), 2.43-2.32 (m, 1H), 2.14-
1.95 (m, 4H) 1.71 (s, 3H), 1.67 (s, 3H), 1.59 (s, 3H), 0.92 (d, J = 7.0 Hz, 3H), 0.88 (d, J = 6.9 
Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 172.3, 154.1, 139.5, 131.9, 125.5, 124.0, 65.2, 63.8, 58.6, 
43.0, 39.6, 28.6, 26.5, 25.8, 18.1, 17.8, 16.8, 14.9 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 346.1995, found 346.1993. 
 
FT-IR (ATR): ν =3485 (w), 2964 (m), 2920 (m), 1777 (vs), 1696 (s), 1486 (w), 1441 (w), 
1372 (s), 1301 (m), 1202 (s), 1141 (m), 1120 (m), 1104 (m), 1058 (s), 1020 (s), 928 (w), 814 
(w), 774 (m), 753 (m), 713 (m), 640 (m), 590 (w), 526 (w). 
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(S)-3-((S,Z)-3-hydroxy-5,9-dimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.15a) 
 
 
 
Prepared according to the general procedure from 4.4a and 4.13b after flash chromatography 
(21 mg, 7 %) as a colourless oil.  
 
1
H NMR (400 MHz, CDCl3): δ = 5.28 (d, J = 8.9 Hz, 1H), 5.15-5.07 (m, 1H), 4.92-4.83 (m, 
1H), 4.48 -4.41 (m, 1H), 4.30-4.20 (m, 2H), 3.16-3.06 (m, 2H), 2.43-2.32 (m, 1H), 2.14-1.95 
(m, 4H) 1.71 (s, 3H), 1.67 (s, 3H), 1.59 (s, 3H), 0.93 (d, J = 7.0 Hz, 3H), 0.88 (d, J = 6.9 Hz, 
3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 172.3, 154.1, 139.5, 131.9, 125.5, 124.0, 65.2, 63.8, 58.6, 
43.0, 39.6, 28.6, 26.5, 25.8, 18.1, 17.8, 16.8, 14.9 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 346.1995, found 346.2004. 
 
FT-IR (ATR): ν =3495 (w), 2964 (w), 2925 (w), 2976 (w), 1778 (s), 16996 (m), 1447 (w), 
1386 (s), 1373 (s), 1302 (m), 1204 (s), 1179 (m), 1143 (w), 1120 (w), 1102 (w), 1058 (m), 
1020 (m), 972 (w), 845 (w), 775 (w), 754 (w), 713 (w), 640 (w), 587 (w), 527 (w), 454 (w). 
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(S)-3-((R,Z)-3-hydroxy-5,9-dimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.15b) 
 
 
 
Prepared according to the general procedure from 4.4a and 4.13b after flash chromatography 
(230 mg, 71 %) as a colourless oil. [α]20D = +38.7 (c 1.0, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.28 (d, J = 8.9 Hz, 1H), 5.15-5.08 (m, 1H), 4.90-4.85 (m, 
1H), 4.49-4.41 (m, 1H), 4.32-4.19 (m, 2H), 3.14-3.09 (m, 2H), 2.44-2.33 (m, 1H), 2.20-2.03 
(m, 4H) 1.73 (s, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 0.92 (d, J = 7.0 Hz, 3H), 0.88 (d, J = 6.9 Hz, 
3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 172.3, 154.1, 139.5, 131.9, 125.5, 124.0, 65.2, 63.8, 58.6, 
43.0, 39.6, 28.6, 26.5, 25.8, 18.1, 17.8, 16.8, 14.9 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 346.1995, found 346.1980. 
 
FT-IR (ATR): ν =3495 (w), 2964 (w), 2925 (w), 2976 (w), 1778 (s), 1699 (m), 1447 (w), 
1386 (s), 1373 (s), 1302 (m), 1204 (s), 1179 (m), 1143 (w), 1120 (w), 1102 (w), 1058 (m), 
1020 (m), 972 (w), 845 (w), 775 (w), 754 (w), 713 (w), 640 (w), 587 (w), 527 (w), 454 (w) 
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(4S)-3-((E)-3-hydroxy-2,5,9-trimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.16a) 
 
 
 
Prepared according to the general procedure from 4.4c,d and 4.13a after flash 
chromatography (46 mg, 14 %) as colourless oil. [α]20D = +42.7 (c 1.0, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.19 (d, J = 8.3 Hz), 5.12-5.01 (m, 1H), 4.51-4.40 (m, 1H), 
4.32-4.16 (m, 1H), 4.32-4.19 (m, 2H), 3.91 (dq, J = 13.8, 6.9 Hz), 2.50-2.34 (m, 1H), 2.16-
1.95 (m, 4H) 1.70 (s, 3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.08 (d, J = 6.9 Hz, 3H), 0.96 (d, J = 7.0 
Hz, 3H), 0.89 (d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 176.7, 154.5, 140.9, 132.0, 125.7, 124.0, 71.9, 63.4, 59.1, 
44.2, 39.8, 28.6, 26.5, 25.8, 18.1, 17.8, 17.0, 14.7, 14.2 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 337.2253, found 360.2145. 
 
FT-IR (ATR): ν = 3501 (w), 2966 (m), 2924 (m), 2878 (w), 1775 (vs), 1698 (s), 1487 (w), 
1454 (m), 1383 (vs), 1301 (m), 1251 (m), 1202 (vs), 1142 (m), 1121 (m), 1107 (m), 1081 (m), 
1054 (m), 990 (s), 954 (m), 901 (w), 817 (w), 775 (w), 760 (w), 709 (w), 636 (w), 530 (w), 
462 (w).  
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(S)-3-((2R,3S,E)-3-hydroxy-2,5,9-trimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.16b) 
 
 
Prepared according to the general procedure from 4.4c,d and 4.13a after flash 
chromatography (184 mg, 55 %) as a colourless oil. [α]20D = +43.6 (c 1.0, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.22 (dd, J = 8.7, 1.1 Hz, 1H), 5.11-5.01 (m, 1H), 4.49-4.42 
(m, 1H), 4.32-4.16 (m, 1H), 4.31-4.17 (m, 2H), 4.04-3.94 (m, 1H), 2.42-2.26 (m, 1H), 2.14-
1.96 (m, 4H) 1.70 (s, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 1.19 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 7.0 
Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 175.9, 154.3, 140.4, 131.9, 125.7, 124.0, 69.8, 63.4, 58.8, 
43.1, 39.9, 28.7, 26.5, 25.8, 18.1, 17.8, 17.0, 14.8, 11.9 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 360.2151, found 360.2145. 
 
FT-IR (ATR): ν = 3496 (w), 2965 (m), 2926 (m), 2878 (w), 1775 (vs), 1697 (s), 1487 (w), 
1453 (w), 1375 (s), 1300 (m), 1203 (vs), 1143 (w), 1120 (m), 1101 (m), 1054 (w), 1015 (w), 
989 (m), 954 (m), 904 (w), 818 (w), 776 (w), 709 (w), 640 (w), 537 (w), 441 (w).  
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(4S)-3-((E)-3-hydroxy-2,5,9-trimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.16c) 
 
 
 
Prepared according to the general procedure from 4.4c,d and 4.13a after flash 
chromatography (61 mg, 18 %) as a colourless oil. [α]20D = +38.3 (c 1.2, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.16 (d, J = 9.1 Hz, 1H), 5.09-4.99 (m, 1H), 4.58-4.44 (m, 
2H), 4.30-4.13 (m, 2H), 3.82 (dq, J = 14.1, 7.0 Hz, 1H), 2.38-2.29 (m, 1H), 2.15-1.97 (m, 4H) 
1.68 (s, 3H), 1.65 (s, 3H), 1.58 (s, 3H), 1.10 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.87 
(d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 176.6, 154.0, 140.9, 131.9, 125.2, 123.9, 76.1.8, 63.6, 58.6, 
44.5, 39.7, 28.7, 26.4, 25.5, 18.0, 17.8, 16.9, 14.9, 14.7 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 360.2151, found 360.2145. 
 
FT-IR (ATR): ν = 3445 (w), 2645 (m), 2928 (m), 2878 (w), 1778 (vs), 1696 (s), 1485 (w), 
1455 (m), 1382 (vs), 1300 (m), 1256 (s), 1225 (s), 1202 (vs), 1142 (m), 1120 (m), 1104 (m), 
1076 (m), 1055 (m), 988 (s), 954 (m), 901 (w), 846 (w), 818 (w), 775 (w), 760 (w), 733,6 (w), 
707 (m), 638 (w), 527 (w), 461 (w). 
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(4S)-3-((Z)-3-hydroxy-2,5,9-trimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.17a) 
 
 
 
Prepared according to the general procedure from 4.4c,d and 4.13b after flash 
chromatography (25 mg, 7 %) as a colourless oil. [α]20D = +30.2 (c 1.2, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.18 (d, J = 9.2 Hz, 1H), 5.14-5.00 (m, 1H), 4.51-4.36 (m, 
2H), 4.34-4.15 (m, 3H), 3.95-3.82 (m, 1H), 2.46-2.30 (m, 1H), 2.19-2.03 (m, 4H) 1.73 (s, 
3H), 1.66 (s, 3H), 1.58 (s, 3H), 1.06 (d, J = 6.9 Hz, 3H), 0.90 (d, J = 7.1 Hz, 3H), 0.88 (d, J = 
7.0 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 176.7, 154.3, 141.2, 132.3, 126.6, 123.9, 71.3, 63.3, 59.9, 
44.9, 38.6, 28.0, 26.6, 25.7, 23.4, 18.2, 17.9, 14.6, 14.4 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 360.2151, found 360.2168. 
 
FT-IR (ATR): ν = 3517 (w), 2965 (m), 2931 (m), 2877 (w), 1776 (vs), 1700 (s), 1487 (w), 
1450 (w), 1386 (s), 1373 (s), 1301 (w), 1248 (m), 1205 (s), 1143 (w), 1121 (m), 1056 (m), 
1015 (m), 990 (m), 953 (w), 900 (w), 816 (w), 773 (w), 757 (w), 698 (w), 634 (w), 533 (w). 
  
95 
 
(S)-3-((2R,3S,Z)-3-hydroxy-2,5,9-trimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.17b) 
 
 
 
Prepared according to the general procedure from 4.4c,d and 4.13b after flash 
chromatography (201 mg, 59 %) as a colourless oil. [α]20D = +26.7 (c 1.2, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.18 (d, J = 9.3 Hz, 1H), 5.15-5.05 (m, 1H), 4.56-4.44 (m, 
2H), 4.31-4.15 (m, 2H), 3.88-3.77 (m, 1H), 2.42-2.26 (m, 1H), 2.22-1.98 (m, 4H) 1.74 (s, 
3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.12 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 
6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 176.6 (C-1), 154.0 (C-3), 141.4 (C-5'), 132.4 (C-9'), 126.1 
(C-4'), 123.9 (C-8'), 70.3 (C-4), 63.6 (C-5), 58.6 (C-3'), 44.3 (C-2'), 32.5 (C-6'), 28.7 
(CH(CH3)2), 26.7 (C-7'), 25.7 (C-10'), 23,.5 (CH3), 18.0 (CH3), 17.8 (CH3), 15.0 (2 CH3) 
ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 360.2151, found 360.2164. 
 
FT-IR (ATR): ν = 3497 (w), 2965 (m), 2926 (m), 2877 (m), 1774 (vs), 1696 (s), 1487 (w), 
1454 (m), 1374 (vs), 1300 (m), 1201 (vs), 1142 (m), 1119 (m), 1100 (m), 1054 (m), 1014 (m), 
989 (s), 965 (m), 954 (m), 904 (w), 845 (w), 819 (w), 775 (w), 761 (w), 709 (m), 640 (w), 555 
(w), 533 (w), 451 (w). 
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(4S)-3-((Z)-3-hydroxy-2,5,9-trimethyldeca-4,8-dienoyl)-4-isopropyloxazolidin-2-one 
(4.17c) 
 
 
 
Prepared according to the general procedure from 4.4c,d and 4.13b after flash 
chromatography (56 mg, 17 %) as a colourless oil. [α]20D = +24.6 (c 1.1, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.18 (d, J = 9.3 Hz, 1H), 5.15-5.05 (m, 1H), 4.56-4.44 (m, 
2H), 4.31-4.15 (m, 2H), 3.88-3.77 (m, 1H), 2.42-2.26 (m, 1H), 2.22-1.98 (m, 4H) 1.74 (s, 
3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.12 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 
6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 176.6, 154.0, 141.4, 132.4, 126.1, 123.9, 70.3, 63.6, 58.6, 
44.3, 32.5, 28.7, 26.7, 25.7, 23,.5, 18.0, 17.8, 15.0 ppm. 
 
MS (ESI): m/z = calcd for[C18H29NO4
+
]: 360.2151, found 360.2158. 
 
FT-IR (ATR): ν = 3469 (w), 2964 (m), 2931 (m), 2977 (w), 1777 (s), 1696 (s), 1455 (m), 
1382 (s), 1300 (m), 1255 (m), 1225 (s), 1202 (s), 1143 (w), 1120 (m), 1101 (m), 1055 (m), 
988 (s), 954 (m), 901 (w), 848 (w), 819 (w), 775 (w), 707 (m), 638 (w), 595 (w), 528 (w), 449 
(w). 
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(R,E)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-5,9-dimethyl-1-oxodeca-4,8-dien-3-yl (2S)-
3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((S)-4.20) 
 
 
 
To a solution of 4.14b (19.9 mg) in anhydrous CH2Cl2 (2 ml), anhydrous pyridine (10.5 µL), 
(R)-MTPACl (20.0 mg) dissolved in anhydrous CH2Cl2 (1 ml) and DMAP (3.70 mg) were 
added in this order at 0 °C. The reaction mixture was slowly warmed to room temperature and 
stirred overnight. The solvent was removed under vacuum and the residue was purified by 
flash chromatography (SiO2, 6:1 petroleum ether/ethyl acetate) to give (S)-4.20 (28 mg, 85 %) 
as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.49-7.46 (m, 2H), 7.41-7.34 (m, 4H), 6.21 (td, J = 9.5, 3.7 
Hz, 1H), 5.09-5.03 (m, 2H), 4.39-4.33 (m, 1H), 4.26-4.16 (m, 2H), 3.52 (s, 3H), 3.44 (dd, J = 
17.1, 9.4 Hz, 1H), 3.16 (dd, J = 17.1, 3.7 Hz, 1H), 2.41-2.30 (m, 1H), 2.11-1.96 (m, 4H), 1.86 
(s, 3H), 1.66 (s, 3H), 1.59 (s, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 169.3, 165.6, 154.1, 143.5, 132.6, 132.1, 128.3, 127.7, 
124.2, 123.6, 122.6, 120.5, 70.5, 63.6, 58.7, 55.7, 40.4, 39.6, 29.8, 26.4, 25.8, 18.1, 17.8, 17.1, 
14.7 ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 562.2393, found 562.2387. 
 
FT-IR (ATR): ν = 2960 (m), 2924 (m), 2854 (w), 1782 (vs), 1746 (s), 1703 (s), 1488 (w), 
1452 (w), 1452 (m), 1387 (s), 1301 (m), 1269 (s), 1238 (s), 1169 (vs), 1121 (s), 1080 (m), 
1018 (m), 991 (m), 920 (w), 831 (w), 766 (w), 719 (m), 641 (w).  
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(R,E)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-5,9-dimethyl-1-oxodeca-4,8-dien-3-yl 
(2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((S)-4.20) 
 
 
 
Prepared as described for (S)-4.20 from 4.14b (19.9 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (S)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg) to give (R)-4.20 (27 mg, 84 %) after flash chromatography (SiO2, 6:1 
petroleum ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.54-7.49 (m, 2H), 7.39-7.33 (m, 4H), 6.26 (td, J = 9.5, 3.8 
Hz, 1H), 5.23 (d, J = 9.6 Hz, 1H), 5.09-5.03 (m, 1H), 4.22-4.07 (m, 3H), 3.54 (s, 3H), 3.54-
3.49 (m, 1H), 3.03 (dd, J = 16.9, 3.8 Hz, 1H), 2.36-2.27 (m, 1H), 2.12-1.99 (m, 4H), 1.87 (s, 
3H), 1.66 (s, 3H), 1.60 (s, 3H), 0.88 (t, J = 7.9 Hz, 3H), 0.84 (d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 169.0, 165.4, 154.1, 143.9, 132.8, 132.2, 129.5, 128.3, 
127.6, 124.3, 123.5, 122.6, 120.6, 70.4, 63.6, 58.6, 55.6, 40.1, 39.6, 28.5, 26.4, 25.8, 18.1, 
17.8, 17.2, 14.7 ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 562.2393, found 562.2387. 
 
FT-IR (ATR): ν = 2964 (w), 2925 (w), 2854 (w), 1780 (s), 1747 (s), 1703 (s), 1488 (w), 1451 
(w), 1386 (s), 1258 (s), 1237 (s), 1204 (s), 1167 (vs), 1120 (s), 1106 (s), 1080 (m), 1017 (s), 
989 (s), 971 (s), 914 (m), 824 (w), 765 (m), 731 (s), 717 (s), 697 (s), 642 (m), 579 (w), 553 
(w), 510 (w), 442 (w). 
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(R,Z)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-5,9-dimethyl-1-oxodeca-4,8-dien-3-yl (2S)-
3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((S)-4.21) 
 
 
 
Prepared as described for (S)-4.20 from 4.15b (19.9 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (R)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg) to give (S)-4.21 (23 mg, 70 %) after flash chromatography (SiO2, 5:1 
petroleum ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.50-7.45 (m, 2H), 7.41-7.34 (m, 4H), 6.24-6.16 (m, 1H), 
5.16-5.11 (m, 1H), 5.11-5.04 (m, 1H), 4.38-4.32 (m, 1H), 4.24-4.18 (m, 2H), 3.51 (s, 3H), 
3.47 (dd, J = 17.4, 9.7 Hz, 1H), 3.07 (dd, J = 17.4, 3.3 Hz, 1H), 2.42-2.32 (m, 1H), 2.21-2.12 
(m, 2H), 2.12-2.04 (m, 1H), 1.73 (s, 3H), 1.66 (s, 3H), 1.61 (s, 3H), 0.92 (d, J = 7.0 Hz, 3H), 
0.86 (d, J = 7.0 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 169.3, 165.5, 154.1, 143.3, 132.8, 132.6, 129.6, 128.3, 
127.7, 124.0, 121.4, 70.0, 63.6, 58.7, 55.7, 40.5, 32.6, 28.8, 26.6, 25.8, 18.1, 17.8, 14.7, 14.3 
ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 562.2393, found 562.2401. 
 
FT-IR (ATR): ν = 2962 (m), 2924 (m), 2854 (w), 1782 (vs), 1747 8s), 1702 (s), 1591 (w), 
1487 (w), 1451 (w), 1387 (s), 1270 (s), 1238 (s), 1206 (s), 1183 8vs), 1169 (vs), 1121 (s), 
1107 (m), 1080 (m), 1019 (m), 991 (m), 972 (m), 919 (w), 823 (w), 765 (w), 719 (m), 641 
(w), 600 (w), 559 (w), 502 (w), 450 (w). 
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(R,Z)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-5,9-dimethyl-1-oxodeca-4,8-dien-3-yl 
(2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((R)-4.21) 
 
 
 
Prepared as described for (S)-4.20 from 4.15b (19.9 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (S)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg,) to give (R)-4.21 (26 mg 80 %) after flash chromatography (SiO2, 6:1 
petroleum ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.53-7.49 (m, 2H), 7.38-7.35 (m, 4H), 6.27 (td, J = 9.8, 3.4 
Hz), 5.24 (d, J = 9.8 Hz, 1H), 5.16-5.10 (m, 1H), 4.20-4.05 (m, 3H), 3.59-3.50(m, 1H), 3.54 
(s, 3H), 2.94 (dd, J = 17.2, 3.4 Hz, 1H), 2.38-2.27 (m, 1H), 2.22-2.02 (m, 4H), 1.76 (s, 3H), 
1.65 (s, 3H), 1.61 (s, 3H), 0.89 (d, J = 7.0 Hz, 3H), 0.83 (d, J = 7.0 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 168.9, 165.3, 154.1, 143.6, 132.9, 132.4, 129.4, 128.3, 
127.7, 123.9, 121.4, 70.0, 63.6, 58.6, 55.6, 40.2, 32.6, 28.5, 26.6, 25.8, 23.5, 18.1, 17.8, 14.7 
ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 562.2393, found 562.2387. 
 
FT-IR (ATR): ν = 2965 (w), 2925 (w), 2854 (w)1780 (vs), 1748 (s), 1703 (s), 1487 (w), 1451 
(w), 1386 (s), 1237 (s), 1168 (vs), 1120 (s), 1106 (s), 1080 (m), 1018 (s), 989 (s), 971 8s), 917 
(w), 825 (w), 765 (m), 718 (s), 697 (m), 642 (w), 581 (w), 553 8w), 507 (w), 452 (w).  
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(2R,2S,E)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-2,5,9-trimethyl-1-oxodeca-4,8-dien-3-
yl (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((S)-4.22) 
 
 
 
Prepared as described for (S)-4.20 from 4.16b (20.7 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (R)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg) to give (S)-4.22 (29 mg, 88 %) after flash chromatography (SiO2, 6:1 
petroleum ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.51-7.45 (m, 2H), 7.40-7.34 (m, 4H), 5.99 (dd, J = 9.6, 7.1 
Hz, 1H), 5.09 (dd, J = 9.6, 0.8 Hz, 1H), 5.06-5.02 (m, 1H), 4.44-4.38 (m, 1H), 4.28-4.14 (m, 
3H), 3.55 (s, 3H), 2.23-2.15 (m, 1H), 2.23-2.15 (m, 1H), 2.09-1.94 (m, 5H), 1.84 (s, 3H), 1.65 
(s, 3H), 1.59 (s, 3H), 1.23 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 7.1 Hz, 3H), 0.79 (d, J = 6.9 Hz, 
3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 173.1, 165.9, 153.8, 144.5, 132.4, 132.1, 129.6, 128.4, 
127.6, 124.2, 123.7, 122.6, 119.4, 75.3, 63.2, 58.6, 55.7, 41.9, 39.8, 28.4, 26.4, 25.8, 18.0, 
17.8, 17.2, 14.5, 14.3, 13.2 ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 576.2549, found 576.2558. 
 
FT-IR (ATR): ν = 2965 (w), 2925 (w), 2855 (w), 1778 (s), 1744 (s), 1700 (s), 1488 (w), 1452 
(m), 1385 (s), 1299 (m), 1260 (s), 1229 (s), 1184 (vs), 1120 (s), 1104 (s), 1081 (m), 1056 (m), 
1014 (vs), 990 (s), 965 (m), 910 (s), 803 (m), 765 (m), 731 (vs), 719 (vs), 697 (s), 648 (m), 
550 (w), 521 (w), 445 (w), 411 (w).  
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(2R,3S,E)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-2,5,9-trimethyl-1-oxodeca-4,8-dien-3-
yl (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((R)-4.22) 
 
 
 
Prepared as described for (S)-4.20 from 4.16b (20.7 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (S)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg) to give (R)-4.22 (29 mg, 87 %) after chromatography (SiO2, 6:1 petroleum 
ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.55-7.49 (m, 2H), 7.41-7.33 (m, 4H), 5.96 (dd, J = 9.5, 8.3 
Hz, 1H), 5.24 (d, J = 9.7 Hz, 1H), 5.07-4.98 (m, 1H), 4.45-4.34 (m, 1H), 4.26-4.15 (m, 3H), 
3.54 (s, 3H), 2.25-2.15 (m, 1H,), 2.11-1.96 (m, 5H), 1.83 (s, 3H), 1.64 (s, 3H), 1.58 (s, 3H), 
1.08 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 7.1 Hz, 3H), 0.81 (d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 173.5, 165.8, 153.8, 144.9, 132.7, 132.2, 129.6, 128.4, 
127.4, 124.3, 123.6, 119.7, 75.2, 63.2, 58.6, 55.6, 41.9, 39.8, 28.4, 26.4, 25.8, 18.0, 17.8, 17.2, 
14.5, 14.3, 13.4 ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 576.2549, found 562.2560. 
 
FT-IR (ATR): ν = 2964 (w), 2924 (w), 2853 (w), 1778 (s), 1746 (s), 1699 (s), 1488 (w), 1452 
(m), 1384 (s), 1299 (m), 1268 (s), 1229 (s), 1168 (vs), 1120 (s), 1104 (s), 1081 (m), 1055 (m), 
1014 (vs), 989 (s), 964 (m), 932 (m), 910 (s), 805 (m), 765 (m), 731 (vs), 719 (vs), 697 (s), 
648 (m), 577 (w), 553 (w), 520 (w), 444 (w), 414 (w). 
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(2R,3S,Z)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-2,5,9-trimethyl-1-oxodeca-4,8-dien-3-
yl (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((S)-4.23) 
 
 
 
Prepared as described for (S)-4.20 from 4.17b (20.7 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (R)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg) to give (S)-4.23 (28 mg, 85 %) after chromatography (SiO2,5:1 petroleum 
ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.50-7.46 (m, 2H), 7.41-7.34 (m, 4H), 6.03 (dd, J = 9.7, 7.4 
Hz, 1H), 5.22-5.13 (m, 1H), 5.10 (dd, J = 23.9, 7.9 Hz, 1H), 4.45-4.37 (m, 1H), 4.29-4.13 (m, 
3H), 3.55 (s, 3H), 2.33-2.02 (m, 5H), 1.69 (s, 6H), 1.64 (s, 3H), 1.23 (d, J = 6.8 Hz, 3H), 0.87 
(d, J = 7.4 Hz, 3H), 0.80 (d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 173.6, 165.8, 153.8, 144.6, 132.4, 132.0, 129.6, 128.3, 
127.7, 124.2, 120.2, 74.7, 63.1, 58.6, 55.7, 41.9, 29.7, 28.3, 26.5, 25.8, 18.1, 17.7, 14.3, 13.5 
ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 576.2549, found 562.2563. 
 
FT-IR (ATR): ν = 2965 (m), 2925 (m), 2876 (w), 2854 (w), 1779 (vs), 1745 (s), 1700 (s), 
1488 (w), 1452 (m), 1384 (s), 1300 (m), 1261 (s), 1232 (s), 1184 (vs), 1121 (s), 1105 (s), 
1081 (m), 1056 (m), 1014 (s), 990 (s), 965 (m), 909 (m), 803 (m), 765 (m), 731 (s), 718 (s), 
697 (m), 648 (w), 517 (w), 449 (w), 412 (w).  
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(2R,3S,Z)-1-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-2,5,9-trimethyl-1-oxodeca-4,8-dien-3-
yl (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate ((R)-4.23) 
 
 
 
Prepared as described for (S)-4.20 from 4.17b (20.7 mg) in anhydrous CH2Cl2 (2 ml), 
anhydrous pyridine (10.5 µL), (S)-MTPACl (20.0 mg) in anhydrous CH2Cl2 (1 ml), and 
DMAP (3.70 mg) to give (R)-4.23 (29 mg, 88 %) after chromatography (SiO2, 5:1 petroleum 
ether/ethyl acetate) as a colourless oil. 
 
1
H NMR (400 MHz, CDCl3): δ = 7.56-7.49 (m, 2H), 7.41-7.32 (m, 4H), 6.02 (dd, J = 9.8, 8.4 
Hz, 1H), 5.27 (d, J = 9.9 Hz), 5.18-5.12 (m, 1H), 4.42-4.37 (m, 1H), 4.26-4.15 (m, 3H), 3.54 
(s, 3H), 2.33-2.19 (m, 3H), 2.11-2.03 (m, 2H), 1.72 (s, 3H), 1.66 (s, 3H), 1.62 (s, 3H), 1.07 (d, 
J = 6.8 Hz, 3H), 0.88 (d, J = 7.1 Hz, 3H), 0.81 (t, J = 6.8 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 173.6, 165.7, 153.8, 145.0, 132.8, 132.1, 129.6, 128.4, 
127.5, 124.1, 120.5, 74.6, 63.1, 58.6, 55.6, 42.0, 32.7, 28.2, 26.5, 25.8, 23.6, 18.1, 17.7, 14.4, 
13.6 ppm. 
 
MS (ESI): m/z = calcd for[C28H36F3NO6
+
]: 576.2549, found 562.2562. 
 
FT-IR (ATR): ν = 2965 (m), 2923 (m), 2877 (w), 2854 (w), 1778 (vs), 1746 (s), 1699 (s), 
1488 (w), 1452 (m), 1383 (s), 1299 (m), 1232 (vs), 1167 (vs), 1120 (s), 1103 (s), 1080 (s), 
1055 (s), 1014 (vs), 989 (vs), 964 (s), 931 (s), 909 (s), 803 (s), 765 (m), 730 (s), 718 (vs), 697 
(s), 648 (m), 595 (w), 554 (w), 509 (w), 450 (w), 408 (w).  
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(2S,3S,4E)-2,5,9-trimethyldeca-4,8-diene-1,3-diol (4.24) 
 
 
 
To a solution of 4.16b (100 mg) in abs. THF/abs. MeOH (5:0.05 mL), LiBH4 (4 M in THF, 
222 μL) was added dropwise at 0 °C and the reaction mixture was stirred for 3 h. Then, a 
saturated solution of NaHCO3 (10 mL) was added, the layers were separated, and the aqueous 
layer was extracted with ethyl acetate (3×15 mL). The combined organic layers were dried 
with MgSO4 and the solvent was removed under vacuo. The residue was purified by flash 
chromatography (SiO2, 2:1 petroleum ether/ethyl acetate) to give the product 4.24 (40 mg, 64 
%) as a colourless oil. [α]20D = +65.2 (c 1.0, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.29 (dd, J = 9.0, 1.1 Hz, 1H), 5.11-4.99 (m, 1H), 4.50 (dd, 
J = 9.0, 4.1 Hz, 1H), 3.68 (dd, J = 10.7, 7.6 Hz, 1H), 3.57 (dd, J = 10.8, 4.6 Hz, 1H), 2.52 (s, 
2H), 2.16-1.98 (m, 4H), 1.99-1.85 (m, 1H), 1.66 (s, 6H), 1.59 (s, 3H), 0.86 (d, J = 7.0 Hz, 3H) 
ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 139.4, 131.9, 124.9, 124.0, 71.9, 66.3, 40.6, 39.9, 26.5, 
25.8, 17.8, 16.8, 11.9 ppm. 
 
MS (EI): m/z = calcd for[C13H24O2
+
]: 212.1776, found 212.1776. 
 
FT-IR (ATR): ν = 3338 (m), 2965 (m), 2921 (m), 2064 (w), 1731 (w), 1669 (w), 1669 (w), 
1449 (m), 1376 (m), 1261 (w), 1106 (m), 1082 (m), 1030 (s), 970 (s), 816 (w), 562 (w), 447 
(w), 419 (w). 
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(2S,3S,4Z)-2,5,9-trimethyldeca-4,8-diene-1,3-diol (4.25) 
 
 
 
Prepared as described for 4.24, from 4.17b (100 mg) in abs. THF/abs. MeOH (5:0.05 mL), 
LiBH4 (4 M in THF, 222 μL), saturated solution of NaHCO3 (10 mL), extraction with ethyl 
acetate (3×15 mL) and flash chromatography (SiO2, 2:1 petroleum ether/ethyl acetate) gave 
4.25 (38 mg, 60 %) as a colourless oil. [α]20D = +68.6 (c 1.2, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.34 (d, J = 9.2 Hz, 1H), 5.15-5.02 (m, 1H), 4.47 (dd, J = 
9.3, 4.3 Hz, 1H), 3.68 (dd, J = 10.8, 7.2 Hz, 1H), 3.64-3.52 (m, 1H), 2.39 (s, 2H), 2.20-1.98 
(m, 4H), 1.96-1.81 (m, 1H), 1.75 (s, 3H), 1.67 (s, 3H) 1.59 (s, 3H), 0.88 (d, J = 7.0 Hz, 3H) 
ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 139.9, 132.4, 125.5, 123.9, 71.2, 66.3, 40.2, 32.2, 26.5, 
25.6, 23.5, 17.6, 11.7 ppm. 
 
MS (EI): m/z = calcd for[C13H24O2
+
]: 212.1776, found 212.1768. 
 
FT-IR (ATR): ν = 3346 (m), 2965 (m), 2916 (m), 2876 (m), 1994 (w), 1972 (w), 1726 (w), 
1665 (w), 1449 (m), 1376 (m), 1262 (w), 1104 (m), 1080 (m), 1031 (s), 968 (s), 857 (w), 820 
(w), 731 (w), 596 (m), 453 (w). 
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(4S,5S)-4-[(1E)-2,6-dimethylhepta-1,5-dien-1-yl]-2,2,5-trimethyl-1,3-dioxane (4.26) 
 
 
 
To a solution of 4.24 (20 mg) in anhydrous acetone (1 mL) dimethoxypropane (98.4 μL) and 
PPTS (1 mg) were added at room temperature. The reaction mixture was stirred for 3 h and 
then the solvent was removed under vacuum. The residue was purified by flash 
chromatography (SiO2, 10:1 petroleum ether/ethyl acetate and 1 vol.-% Et3N) to give the 
product 4.26 (21 mg, 90 %) as a colourless oil. [α]20D = +52.8 (c 1.1, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.21 (dd, J = 7.7, 1.2 Hz, 1H), 5.13-5.02 (m, 1H), 4.75 (dd, 
J = 7.7, 2.8 Hz, 1H), 4.15 (dd, J = 11.5, 2.9 Hz, 1H), 3.59 (dd, J = 11.5, 1.7 Hz, 1H), 2.18-
1.96 (m, 4H), 1.67 (s, 3H) 1.66 (s, 3H), 1.50 (s, 3H), 1.49-1.44 (m, 1H), 1.42 (s, 3H), 1.11 (d, 
J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 138.3, 131.8, 124.2, 124.0, 98.8, 69.3, 66.7, 39.8, 32.9, 
29.9, 26.5, 25.8, 19.3, 17.8, 17.0, 11.3 ppm. 
 
MS (EI): m/z = calcd for[C16H28O2
+
]: 252.2089, found 252.2097. 
 
FT-IR (ATR): ν = 3411 (w), 2965 (m), 2925 (m), 2858 (m), 2125 (w), 1671 (w), 1450 (m), 
1378 (m), 1270 (m), 1239 (m), 1195 (m), 1166 (m), 1137 (m), 1102 (m), 1087 (m), 1008 (s), 
983 (m), 963 (m), 914 (m), 862 (m), 843 (m), 817 (m), 753 (w), 540 (w), 517 (m), 433 (w). 
  
108 
 
(4S,5S)-4-[(1Z)-2,6-dimethylhepta-1,5-dien-1-yl]-2,2,5-trimethyl-1,3-dioxane (4.27) 
 
 
 
Prepared as described for 4.26, from 4.25 (20 mg) in anhydrous acetone (1 mL), 
dimethoxypropane (98.4 μL), PPTS (1 mg), after flash chromatography (SiO2, 10:1 petroleum 
ether/ethyl acetate and 1 vol.-% Et3N) gave the product 4.27 (20 mg, 88 %) as a colourless oil. 
[α]20D = +57.7 (c 1.1, CH2Cl2). 
 
1
H NMR (400 MHz, CDCl3): δ = 5.24 (dd, J = 8.2, 1.1 Hz, 1H), 5.17-5.04 (m, 1H), 4.74 (dd, 
J = 8.2, 2.7 Hz, 1H), 4.13 (dd, J = 11.5, 2.9 Hz, 1H), 3.59 (dd, J = 11.5, 1.7 Hz, 1H), 2.22-
1.95 (m, 4H), 1.75 (s, 3H) 1.68 (s, 3H), 1.61 (s, 3H), 1.49 (s, 3H), 1.47-1.42 (m, 1H), 1.41 (s, 
3H), 1.13 (d, J = 6.9 Hz, 3H) ppm. 
 
13
C NMR (100 MHz, CDCl3): δ = 138.3, 131.8, 124.2, 124.0, 98.8, 69.3, 66.7, 39.8, 32.9, 
29.9, 26.5, 25.8, 19.3, 17.8, 17.0, 11.3 ppm. 
 
MS (EI): m/z = calcd for[C16H28O2
+
]: 252.2089, found 252.2080. 
 
FT-IR (ATR): ν = 3359 (w), 2962 (m), 2925 (m), 2856 (m), 2168 (w), 2071 (w), 2037 (w), 
2026 (w), 1734 (w), 1455 (m), 1377 (m), 1261 (w), 1104 (w), 1034 (m), 967 (m), 512 (w), 
451 (w), 422 (w), 407 (w). 
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5 APPROACH TO THE SYNTHESIS OF NATURAL HERBICIDE 
AUSCALITOXIN AGLYCONE
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5.1 Introduction 
The globally widespread diffusion of resistance in weed populations has led to the loss of 
effectiveness of entire classes of commercial herbicides. Furthermore, no herbicides with a 
novel mode of action have been launched on the market in the last twenty years.
1,2
 Thus, the 
discovery of herbicides with novel mechanism of actions is crucial to avoid the loss of crops 
productivity caused by weeds competition, and the related increase of the costs of weeds 
management. 
As discussed in Chapter 1, natural compounds represent an important source of lead 
compounds for the discovery and development of new agrochemicals. Despite of this, natural 
and natural-derived herbicides are underrepresented if compared to synthetic agents.
3
  
It is often challenging to achieve natural compounds in adequate amounts , thus the 
development of efficient synthetic strategies able to overcome the chemical complexity of 
these compounds is pivotal to perform the required research and development studies. 
The development of a strategy for the total synthesis of molecules with such a chemical 
complexity requires a sequence of reactions with high degree of selectivity. The development 
of new reagents, methodologies, and the application of existing reagents underpins the 
advance of new synthetic strategies as it enriches the arsenal of chemical tools available to 
chemists to face the chemical complexity of natural compounds. 
In this Chapter the results of our efforts towards the total synthesis of the fungal toxin with 
herbicidal activity auscalitoxin aglycone 5.1 are discussed. 
 
5.1.1 Auscalitoxin and auscalitoxin aglycone 
Ascochyta caulina (P. Karst.) v.d. Aa & v Kest. is a plant pathogenic fungus, that has been 
proposed as biocontrol agent for the globally widespread weed Chenopodium album. This 
fungus causes the formation of necrotic areas on leaves and stem and can lead to retard in the 
growth or death of the weed.
4
 
As several species of the genus Ascochyta are known to produce toxic metabolites,
5
 the 
filtrate of in vitro culture of A. caulina were tested to assess the production of phytotoxic 
compounds. From the filtrate, three compounds with herbicidal activity were isolated and 
characterized. The three phytotoxins were trans-4-amino-D-proline
6
 5.3, auscalitoxin
4
 5.2, 
and its aglycone
7
 5.1. The chemical structures are highlighted in Figure 5.1. 
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Figure 5.1 Structure of toxins isolated from A. caulina 
 
The main compound auscalitoxin 5.2, is a N
2
-glucoside of the non-proteinogenic bis-
aminoacid 2,4,7-triamino-5-hydroxyoctandioic acid. The absolute configuration of the four 
stereogenic centres of the naturally occurring compound is still undetermined, but the relative 
configuration was determined by Bassarello et al. in 2001 through a J-based NMR 
configurational analysis. The authors suggest that the configuration at carbons C-4 and C-5 is 
opposite to that at carbons C-2 and C-7.
8
 
In preliminary studies, the aglycone of auscalitoxin 5.1 has proven to show a more potent 
phytotoxic activity than auscalitoxin. The mechanism of action was investigated by Duke et 
al. in 2011. It was demonstrated that the aglycone 5.1 shows a strong herbicidal activity 
against Lemna paucicostata with IC50 below 1 μM, and most of proteinogenic aminoacids, 
non-proteinogenic aminoacids (ornithine and citrulline), D-aminoacids and oxaloacetate were 
able to reverse the phytotoxicity. Furthermore, the aglycone of auscalitoxin 5.1 has proven to 
induce alterations on metabolites levels with changes in aminoacids, enhanced levels of 
intermediates of citrate cycle and reduction in concentration of antioxidants. The authors 
suggest that the aglycone 5.1 could act as a protoxin or its phytotoxic activity could be 
mediated by inhibition of one or more aminoacid transporters.
9
 
Because of the high herbicidal activity and the possible novel mechanism of action, the 
aglycone of auscalitoxin 5.1 represents a valuable lead compound for the development of new 
natural compound-based herbicides. 
Besides of the herbicidal activity, our interest in the aglycone of the auscalitoxin 5.1 is related 
to its chemical structure that represents a challenging task to the development of a strategy for 
its total synthesis. The presence of different stereogenic centres requires the development of a 
series of reactions characterized by high degrees of stereoselectivity. Furthermore, the 
presence of multiple amino groups and one hydroxy entail reactions with high degree of 
chemoselectivity and an efficient strategy of protection. In our approach to the total synthesis 
of 5.1 we decided to apply the chemistry of samarium and in particular a samarium(II) iodide-
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mediated pinacol coupling as the key reaction for the synthesis of the central amino alcohol 
moiety. 
5.1.2 Samarium(II) iodide-mediated pinacol coupling 
As discussed in Chapter 4 Samarium(II) iodide has become a valuable tool in organic 
synthesis with hundreds of different applications because of the unique combination of 
chemical reactivity and versatility combined with selectivity and a great functional-group 
tolerance. The possibility to mediate the formation of new carbon-carbon bonds combined 
with selectivity and its mild nature, has made samarium(II) iodide a powerful tool in total 
synthesis of natural compounds.
10
 
A valuable application of samarium(II) iodide’s ability in the formation of new carbon-carbon 
bond is represented by SmI2-pinacol coupling. Samarium(II) iodide-mediated pinacol 
coupling was first described by Kagan et al. in 1983,
11
 while the application of the 
intramolecular version of this reaction for the formation of rings was first reported by 
Molander and Kenny in 1988.
12
 
Pinacol coupling is the formation of a diol by reductive coupling of two carbonyl groups. The 
general accepted mechanism for the SmI2-mediated coupling is highlighted in Figure 5.2. The 
SmI2-mediated reduction of the carbonyl compound 5.4 leads to the formation of the ketyl 
radical 5.5, which can attack a second carbonyl group generating the oxygen radical 5.6. 
Then, a second rapid SmI2-mediated reduction and the subsequent quench of the alkoxide 
provides the product of pinacol coupling 5.7. 
 
 
Figure 5.2 Mechanism SmI2-mediated pinacol coupling 
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Intermolecular SmI2-mediated pinacol coupling is generally characterized by poor 
stereoselectivity. Conversely, the intramolecular version of the reaction exhibits a high degree 
of stereoselectivity in favour of cis-diol, because of the chelation of the ketyl radical. The 
presence of an alkoxy group close to one of the carbonyls leads to the formation of the anti- 
rather than the cis-diol.
13
 
SmI2‐mediated pinacol‐type reactions can also be performed to couple a ketone or an 
aldehyde with oximes,
14
 nitriles,
15
 or hydrazones.
16
 
A samarium diiodide-mediated asymmetric pinacol-type cross-coupling between an aldehyde 
and a chiral N-sulfinyl imine was described by Zhong et al. in 2005. In this procedure, 
different chiral N-tert-butanesulfinyl imines were coupled with aldehydes affording the 
corresponding amino alcohol with anti-stereochemistry with high yield and high degree of 
diastereo- and enantioselectivity.
17
 The results of that research are reported in Table 5.1. 
 
Table 5.1 SmI2-mediated cross-coupling of aldehydes with N-tert-butanesulfinyl imine
17
 
 
Entry R1 R2 Yield (%) dr ee 
1 4-CH3C6H4 iPr 92 >99:1 98 
2 4-CH3C6H4 C6H11 90 99:1 >99 
3 4-CH3C6H4 (Et)2CH 73 >99:1 99 
4 4-CH3C6H4 n-C5H11 90 91:9 95 
5 4-CH3C6H4 PhC2H4 95 88:12 95 
6 Ph iPr 86 99:1 97 
7 4-FC6H4 iPr 89 98:2 >99 
8 4-ClC6H4 iPr 71 99:1 98 
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9 4-BrC6H4 iPr 70 >99:1 >99 
10 4-AcOC6H4 iPr 82 >99:1 >99 
11 4-CH3OC6H4 iPr 84 >99:1 >99 
12 3,4-(MeO)2C6H3 iPr 90 >99:1 >99 
13 2,4-(MeO)2C6H3 iPr 73 >99:1 >99 
14 iPr iPr 88 >99:1 98 
15 PhC2H4 iPr 87 96:4 >99 
16 n-C5H11 iPr 95 98:2 97 
17 BnOCH2 iPr 82 >99:1 97 
Diasteromeric ration was determined by HPLC-MS and 
1
H NMR of the crude materials. Enantiomeric 
excess was determined for the free β-amino alcohols after acidic hydrolysis. 
 
The authors do not discuss the possible mechanism of this reaction. It can be speculated that 
the reaction occurs following the accepted mechanism of the SmI2-mediated pinacol coupling 
discussed above. The observed high diastereo- and enantioselectivity arise from the chiral 
sulfinyl imine that could be involved in the chelated transition state. 
 
5.2 Results and discussion 
5.2.1 Retrosynthetic analysis 
Our retro-synthetic approach for the synthesis of aglycone of auscalitoxin 5.1 started with the 
disconnection between the carbons C-4 and C-5, to obtain the two key fragments 5.10 and 
5.11, as highlighted in Figure 5.3. The assembly of the aldehyde 5.10 and the chiral N-
sulfinyl imine 5.11 could be performed using the samarium diiodide-mediated asymmetric 
pinacol-type cross-coupling developed by Zhong et al. in 2005 discussed above.
17
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Figure 5.3 Retrosynthetic analysis 
 
The main advantage of this strategy is the possibility to build the carbon backbone and to 
insert all the functional group at the same time. The choice of the chiral sulfinyl imine allows 
to introduce the amino group at the carbon C-5 with the desired configuration. Since the main 
product of the reaction is the anti-1,2-amino alcohol, the configuration at the carbon C-4 must 
be inverted, after the condensation at the level of intermediate 5.9, to obtain the desired 
compound.  
The inversion of the stereochemistry at the carbon C-4 could be performed in a multistep 
process involving the deprotection and the subsequent protection with tert-butyloxycarbonyl 
group (Boc) of the amino group at the carbon C-5, conversion of the hydroxy group at the 
carbon C-4 in a suitable leaving group, and, finally, inversion via SN2 cyclization to 
oxazolidinone. The strategy is highlighted in Figure 5.4. 
Selective cleavage of the N- tert-butylsulfinyl group could be obtained in presence of iodine 
in neutral condition following the procedure reported by Chen et al. in 2014.
18
 The inversion 
via SN2 cyclization to oxazolidinone could be performed by treatment with methanesulfonyl 
chloride as described by Benedetti and Norbedo in 2000 or mediated by a Ph3P-CCl4-Et3N 
system as reported by Madhusudhan et al. in 2003.
 19,20
 Finally, the formed oxazolidinone ring 
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could be opened in mild condition by hydrolysis with Cs2CO3 after Boc protection of the 
nitrogen, following the procedure described by Ishizuka and Kunieda in 1987.
21
 
 
 
Figure 5.4 Strategy for the inversion of the alcohol group at C-4 
 
Both the fragment 5.10 and 5.11 can be prepared starting from a commercially available 
protected aspartic acid 5.12. 
Considering the obvious high polarity of the target molecule, the protecting group strategy 
was designed to reduce the number of deprotection steps in the end of the synthesis and to 
simplify the handling and the purification of the last intermediates. Thus, tert-
butyloxycarbonyl was selected for the protection of the amino groups at the carbon C-2 and 
C-7 because it can be removed in mild acid condition. To protect the carboxylic acid moieties, 
the conversion in benzyl esters was selected, considering that the benzyl esters can be 
removed in mild condition by catalytic hydrogenation, orthogonally to the nitrogen protecting 
groups. 
As the absolute configuration of the natural occurring aglycone of auscalitoxin 5.1 in still 
undetermined, and due to the necessity of testing the viability of this synthetic approach, we 
decided to start from a less expensive protected Boc-L-aspartic acid 1-benzyl ester 5.12. In the 
case this approach was successful, the synthetic could be repeated with the D-isomer. 
 
5.2.2 Synthesis of precursors 5.10 and 5.11 
The aspartic acid derivative 5.12 was converted with high yields in the Weireb’s amide 5.17 
by activation of the free carboxylic group with 1,1'-carbonyldiimidazole, followed by reaction 
of the in situ generated mixed anhydrides with N,O-dimethylhydroxylamine hydrochloride.
22
 
Aldehyde 5.10, was obtained in quantitative yield by reduction of the Weireb’s amide 5.17 by 
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diisobutylaluminium hydride at -78 °C.
23
 Finally, compound 5.11 was obtained from the 
aldehyde 5.10 by reaction with the commercially available Ellman’s chiral sulfinamide in 
presence of anhydrous CuSO4 as dehydrating agent.
24
 
 
 
Figure 5.5 Synthesis of precursors 5.10 and 5.11. (a) 1,1'-carbonyldiimidazole, HNMeOMe·HCl, 
CH2Cl2, rt 80 %; (b) DIBAL, THF, -78 °C, quantitative yield; (c) Ellman’s sulfinamide, CuSO4, CH2Cl2, 
rt, 87 % 
 
5.2.3 SmI2-mediated asymmetric pinacol-type cross-coupling 
To build the carbon backbone of the target molecule inclusive of the amino alcoholic function 
at carbons C-4 and C-5, fragments 5.10 and 5.11 were coupled in a samarium(II) iodide-
mediated pinacol-type cross-coupling.
17
 The coupling of the compound 5.11 with an excess 
(1.5 eq.) of 5.10 was performed at -78 °C, with two equivalents of samarium(II) iodide in 
solution of absolute tetrahydrofuran, in presence of tert-butanol as proton donor. The reaction 
led to the formation of two diastereomers in ratio 84:16. The ratio was determined by 
1
H-
NMR. The major diastereomer was obtained in 54 % yield after flash chromatography. The 
minor diastereomer was recovered in 1:1 mixture with the major one.  
The major diastereomer was identified as the coupling products 5.9 by 
1
H-and 
13
C-NMR. The 
structure of compound 5.9 is highlighted in Figure 5.5; the reported configuration at C-4 and 
C-5 is the expected one according to the results reported by Zhong et al. in 2005.
17
 The 
reaction did not go to completion, but total consumption of samarium(II) iodide was observed 
by colour change from dark blue to yellow. In the end of the reaction, 25% of 5.11 could still 
be recovered.  
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Figure 5.6 SmI2-mediated cross-coupling. (a) SmI2 0.1 M in abs. THF, -78 °C, 54 % 
 
With this promising result, a screening of different conditions was started to optimize the 
reaction. Firstly, the amount samarium(II) iodide added at the beginning of the reaction was 
progressively increased up to six equivalents. No effects on the consumption of the starting 
material and improvements in the yield were observed. Furthermore, samarium(III) 
hydroxides formed during the work up of the reaction are poorly soluble in organic solvents 
and in neutral or slightly acid aqueous solution. This favoured the formation of emulsions 
during liquid-liquid extraction and made the work up of the reaction particularly tedious. 
Similarly, addition of samarium(II) iodide during the progression of the reaction had no effect 
on the outcome of the coupling.  
The reaction was repeated with freshly prepared samarium(II) iodide solutions in order to 
exclude problems related to the title of the solutions of the commercially available reagent. 
The solution of samarium(II) iodide in anhydrous THF was prepared from commercially 
available samarium metallic powder and iodide, following the procedure described by 
Concellón et al.
25
 The obtained dark blue solution was used immediately after the preparation, 
unfortunately, in this case too, no improvement in the reaction was observed. 
With these results in hands, we concluded that the problems of the reactions were not due to 
samarium(II) iodide. Thus, we decided to change the order of addition of the reactants to the 
reaction, however the addition of the chiral N-sulfinyl imine 5.11 to the samarium(II) iodide 
solution, followed by the aldehyde 5.10 and tert-butanol had no effect on the outcome of the 
reaction. Conversely, addition first of the aldehyde 5.10 led to a formation of small amounts 
of unidentified by-products, probably derived by aldehyde pinacol coupling, with a reduction 
in the yield. Also, tert-butanol was found to be essential for the reaction, as variation in the 
order of addition led to reduction of the yields and formation of many by-products. 
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5.2.4 Absolute configuration at C-4 and C-5 
Once the coupling product 5.9 was obtained, the attention was focused to the investigation of 
the absolute configuration at the carbons C-4 and C-5. Despite the stereochemistry of the 
amino alcohol derived from the samarium(II) iodide-mediated pinacol cross-coupling is 
known
17
, the presence of other groups able to coordinate samarium(III) ions in the two 
products 5.10 and 5.11 could interfere with the mechanism of the reaction, leading to a 
different stereochemistry. 
Since the carbon at C-4 of 5.9 bears a free hydroxyl group, we decided to apply the Mosher’s 
method.
26
 Compound 5.9 was treated with both the enantiomers of the Mosher’s acid under 
Steglich’s esterification condition,27 but formation of the desired chiral esters was not 
observed. Thus, the same reaction was performed with the more reactive Mosher’s acyl 
chlorides in presence of a catalytic amount of DMAP and triethylamine as base.
28
 The 
formation of the same product was observed from the reactions with both the enantiomers of 
the Mosher’s acyl chloride and it was identified as a lactonization product by 1H-NMR 
analysis.  
As highlighted in Figure 5.7, involvement of the carboxylic group at C-1 or at C-8 can lead to 
the formation of two different cyclic compound, one with six atoms and the other with five 
atoms. Because only one compound was observed, we were interested to determine the 
structure of the lactone. Furthermore, since the formation of the cycle involves the stereogenic 
centres at the carbons C-4 and C-5, the determination of the structure of the lactone could be 
useful to assign the stereochemistry. Thus, compound 5.9 was treated with a catalytic amount 
of DMAP and triethylamine, in the same condition used for the acylation with the Mosher’s 
acyl chloride, in order to prepare an amount of lactone suitable to the NMR studies. We found 
that this lactonization reaction occurs very easily under these conditions and in general in 
presence of a base. The reaction occurs in neutral and slightly acid solution as well. 
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Figure 5.7 Possible pathways for lactonization reaction. (a) Et3N, DMAP, CH2Cl2, 0 °C to rt, 63 % 
 
To determine which of the two possible proposed structures was obtained from the cyclization 
a series of NMR experiments were performed. Correlation spectroscopy (COSY), 
heteronuclear single-quantum correlation spectroscopy (HSQC), and Long-Range HETCOR 
experiments were used to obtain the complete assignment. 
The starting point of our investigation was the identification of the signal belonging to the 
proton and relative carbon at the position C-4. Proton directly linked to the heteroatom were 
identified in a Heteronuclear Single-Quantum Correlation (HSQC) experiment as the signal 
which does not correlate with any carbon signal. In the same experiment each proton 
correlates with the directly bound carbon. Thus, the signals belonging to C-2, C-4, C-5, and 
C-7 were identified. Out of these selected signals one resulted to be very different from the 
others in term of chemical shift and was identified as the C-4. 
The structure of the molecule was determined by a Long-Range HETCOR experiment 
performed at low temperature (7 °C). Long range correlations were observed between the 
proton at the position C-4 and the carbons C-3, C-2, and C-1. These correlations, and in 
particular the one with C-2, suggest the involvement of a five atoms cycle. The involvement 
of the six atoms cycle was excluded. In fact, C-2 in the structure 5.18 is equivalent to C-7 in 
structure 5.19, but in the case of this second structure no correlation between proton on C-4 
should be observed with C-7. 
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Long-Range HETCOR experiments permitted to assign all the other signals. The most 
relevant signal in the assignment of the structure are listed in Table 5.2. 
 
Table 5.2 Assignment of the most relevant protons and carbons  
Position 
1H δ (ppm) 13C δ (ppm) 
1 — 174.00 
2 4.39 50.97 
3 2.70/1.90 32.01 
4 4.28 78.92 
5 3.72 55.03 
6 2.16/1.94 32.69 
7 4.59 49.52 
8 — 172.57 
9-NH 5.87 — 
10-NH 4.77 — 
11-NH 5.02 — 
PhCH2 5.26/5.11 67.64 
CO (Boc) — 155.73/155.38 
C-ipso — 135.12 
CH arom. 7.45-7.26 128.63/128.43/128.16 
Correlations were observed between the benzylic proton C-12 and the carbonyl carbon C-8 
and the carbon ipso of the aromatic ring. Proton at C-2 and C-7 showed a coupling with the 
carbonyl carbons of the Boc groups. For proton at C-7 a correlation was observed with 
carbons C-5 and C-6. Proton at C-2 coupled with C-3, but no correlation with C-4 was 
observed. Interestingly, only one proton at C-3 exhibited a correlation with C-4. Protons at C-
6 correlated with C-5, C-7 and C-8. 
For NH-9 and NH-11 correlations with C-2 and C-7 respectively were observed. The 
quaternary carbon of the tert-butyl of the sulfinyl amide group was identified by a correlation 
with NH-10. 
A nuclear Overhauser effect spectroscopy (NOESY) experiment was performed to assign the 
absolute configuration at the carbon C-4 and C-5. Observed NOE effects are listed in Table 
5.3. 
 
Table 5.3 Observed NOE 
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Proton 
1H δ (ppm) Observed NOE 
2 4.39 H-3a; H-3b (vw); NH-11 
3a 2.70 H-2; H-4 
3b 1.90 H-2 (vw); H-4 (w); H-5; NH-10; NH-11 
4 4.28 H-3a; H-3b (w); H-5; H-6a; H-6b 
5 3.72 H-3b; H-4; H-6a; H-6b; H-7; NH-9; NH-10 
6a 2.16 H-4; H-5; H-7; NH-9 
6b 1.94 H-4; H-5; H-7; NH-9 
7 4.59 H-4 (w); H-5; H-6a; H-6b; NH-9; NH-10 
9-NH 5.87 H-5; H-6a (w); H-6b (w); H-7 
10-NH 4.77 H-3b (w); H-4 (w); H-5; H-6b; H-7 
11-NH 5.02 H-2; H-3b 
Weak (w); very weak (vw) 
 
A strong NOE was observed for the proton C-2 with one of the protons at C-3 (proton 3a), 
while a very weak NOE was observed with the other (proton 3b) at the same position. This 
suggests that protons 2 and 3a are oriented on the same plane of the ring, while 3b is oriented 
on the opposite side. Proton 3b showed a weak NOE with proton at C-4 and two strong NOE 
with NH-10 and NH-11. Conversely, for proton 3a a very strong NOE was observed with 
proton at C-4. This suggests that protons 4, 3a and 2 are oriented on the same side of the ring. 
(Figure 5.8) 
The absolute configuration at C-2 is known since it is derived by the protected aspartic acid 
5.12 used as starting material. This permits to assign the absolute configuration at C-4. Since 
protons C-2 and C-4 are oriented on the upper side of the ring, the absolute configuration at 
the C-4 is S. This is in agreement with the expected absolute configuration deriving by the 
Sm(II) iodide-mediated cross-coupling. 
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Figure 5.8 Observed NOE for 5.18 
 
The absolute configuration at the position C-5 can not be determined by NOESY experiment. 
Since rotation around the bond connecting C-4 and C-5 is allowed it was not possible to 
identify NOE correlations appropriate to determine the orientation in the space of the proton 
at C-5. Further investigations are required assign the absolute configuration at C-5 and 
confirm the stereoselectivity of the samarium(II) iodide-mediated pinacol coupling. 
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5.3 Summary 
In this chapter the results of our efforts in developing a strategy for the synthesis of 
auscalitoxin aglycone 5.1 are described. 
The retrosynthetic analysis of the molecule was performed in order to define the most 
appropriate synthetic pathway. Considering the structure of the target molecule, in our 
approach we decided to disconnect the molecule at the level of the central amino alcoholic 
group. This approach has the advantage that all the stereogenic centres are present in the two 
moieties used in the condensation step. Indeed, the terminal aminoacidic functions can be 
obtained by the use the appropriate commercially available aminoacids as starting materials. 
To synthetize the key C-4-C-5 α-amino alcoholic group a samarium(II) iodide mediated 
pinacol coupling was selected. This procedure provides an evidence of the power of 
samarium(II) iodide as reagent in the synthesis of natural compounds since it permits to build 
the carbon backbone of the molecule and to install the functional group with high degree of 
stereoselectivity. 
The synthesis of the precursors 5.10 and 5.11 was successfully performed starting from the 
Weireb’s amide 5.17 that was easily prepared starting from commercially available protected 
aspartic acid 5.12. 
Samarium(II) iodide-mediated pinacol coupling of compounds 5.10 and 5.11 led to the 
formation of compound 5.9 in 55 % together with a minor diastereomer. Diastereomeric ratio 
was determined by 
1
H-NMR and resulted to be 84:16. Complete consumption of the starting 
materials was not observed, indeed 25 % of unreacted compound 5.11 was recovered at the 
end of the reaction. 
Any attempts to optimize the reaction failed. Changing in the amount of SmI2, the use of 
freshly prepared SmI2 solution, and modification of the order of addition of the reagents led to 
no improvements and in some cases revealed to be detrimental for the reaction. 
Product 5.9 turned out to be prone to lactonization. The first evidence of this behaviour was 
observed during the esterification reaction to prepare the Mosher’s derivatives. 
The product of lactonization was exploited to confirm the stereochemistry of the coupling 
product 5.9. A series of NMR experiments was used to determine the structure of the lactone 
that was identified to be the compound 5.18. 
The absolute configuration at the C-4 was determined by a NOESY experiment. It was 
assigned the absolute configuration at the C-4 as S , in agreement with the SmI2-pinacol 
coupling mechanism. It was not possible to determine the absolute configuration at the C-5 
because of the conformational mobility of the chain. Further investigations are needed to 
127 
 
assign the absolute configuration at the C-5. Selective cleavage of the sulfinyl chiral auxiliary 
could be performed in order to induce different cyclization pattern. Thus, the obtained 
compounds could be exploited for further NMR studies. 
Overall, the samarium(II) iodide-mediated pinacol coupling demonstrated to be a reliable 
approach for the construction of the amino alcohol moiety of the aglycone of auscalitoxin 5.1. 
Further investigation must be performed to identify the detrimental factors and to improve the 
outcome of the reaction. In particular, modification of the samarium(II) iodide reactivity by 
use of additives and cosolvent is a strategy that must be evaluate. 
The observed lactonization of compound 5.9 is a limiting factor in the progress of the total 
synthesis. Variation of the protecting group of the terminal carboxyl groups could be useful to 
limit this problem.  
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5.4 Experimental part 
Benzyl (S)-2-(tert-butoxycarbonylamino)-4-(methoxy(methyl)amino)-4-oxobutanoate 
(5.17) 
 
 
 
To a solution of Boc-aspartic acid-O-benzyl ester 5.12 (1.0 g 1.0 eq.) in abs. CH2Cl2 (10 mL) 
was added at room temperature 1,1'-carbonyldiimidazole (551.5 mg, 1.1 eq.) and the resulting 
solution was stirred for 1 h at the same temperature. After that, solid N,O-
dimethylhydroxylamine hydrochloride (331.5 mg, 1.1 eq.) was added, and the solution was 
stirred at room temperature for 12 h. The reaction mixture was diluted with ethyl acetate (15 
mL) and washed with aqueous 1 M HCl (1×15 mL), saturated aqueous solution of NaHCO3 
(1×15 mL), and a saturated solution of NaCl (1×15 mL). The organic layer was dried with 
Na2SO4 and the solvent was removed at reduced pressure. The crude was purified by flash 
chromatography (SiO2, 3:1 → 2:1 petroleum ether/ethyl acetate) to afford 5.17 (906 mg, 80 
%) as colourless oil. [α]D
20
 +19.8 (c 1.0 in CHCl3). 
 
1
H NMR (300 MHz, CDCl3): δ =7.40-7.27 (m, 5H,), 5.76 (d, 1H, J = 8.9 Hz), 5.25-5.08 (m, 
2H), 4.68-4.57 (m, 1H), 3.63 (s, 3H), 3.28-2.64 (m, 1H), 3.13 (s, 3H), 1.42 (s, 9H) ppm. 
 
Spectroscopic data were in accordance with the literature.
29
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Benzyl (S)-2-tert-butoxycarbonylamino-4-oxobutanoate (5.10) 
 
 
To a solution of 5.17 (900 mg, 1.0 eq.) in abs THF (19 mL) solution of DIBAL 1 M in 
CH2Cl2 (3.7 mL, 1.5 eq.) was added dropwise at -78 °C a. The resulting solution was stirred 
for 2 h at the same temperature. After that, 0.35 M aqueous solution of NaHSO4 (33 mL) was 
carefully added dropwise at -78 °C. The reaction mixture was slowly warmed to room 
temperature and layers were separated. The aqueous layer was extracted with Et2O (3×25 
mL). The combined organic extracts were washed with 1 M aqueous HCl (3×20 mL), 
saturated aqueous solution of NaHCO3 (3×20 mL), and a saturated solution of NaCl (3×20 
mL). The organic layer was dried with Na2SO4 and the solvent was removed at reduced 
pressure obtaining 5.10 (756 mg, quantitative yield) as colourless oil. [α]D
20
 +16.5 (c 1.0 in 
CHCl3). The crude product was used for the next steps without further purification. 
 
1
H NMR (300 MHz, CDCl3): δ = 9.71 (s, 1H), 7.41-7.28 (m, 5H), 5.40 (d, J = 7.1 Hz, 1H), 
5.17 (s, 2H), 3.11 (dd, J = 18.3, 5.2 Hz, 1H), 3.01 (dd, J = 18.3, 4.6 Hz), 1.42 (s, 9H) ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 199.3, 171.0, 155.2, 135.4, 128.6, 128.4, 128.3, 128.2, 80.3, 
67.8, 49.1, 45.4, 27.6 ppm. 
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Benzyl [2S, N(E), S(S)]-2-tert-butyloxycarbonyl-4-(2-methyl-propane-2-sulfynilimino)-
butanoate (5.11) 
 
 
 
In a round bottom flask a solution of 5.10 (375 mg, 1.0 eq.) in abs. CH2Cl2 (7 mL) and solid 
(S)-2-methyl-2-propanesulfinamide were added to anhydrous CuSO4 (778.8 mg, 4.0 eq.) and 
the resulting suspension was stirred for 10 h at room temperature. The solid was removed by 
filtration over a pad of celite and the solvent was removed at reduced pressure. The crude was 
purified by flash chromatography (SiO2, 4:1 → 2:1 hexane/ethyl acetate) to afford 5.11 (436 
mg, 87 %) as white solid: mp 106-108 °C. [α]D
20
 +24.1 (c 1.0 in CHCl3). 
 
1
H NMR (300 MHz, CDCl3): δ = 8.02 (dd, J = 3.5, 3.5 Hz, 1H), 7.41-7.27 (m, 5H,), 5.33 (d, J 
= 7.6 Hz, 1H), 5.16 (s, 2H), 4.71-4.57 (m, 1H), 3.22-2.97 (m, 2H), 1.41 (s, 9H), 1.16 (s, 9H) 
ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 171.0, 165.4, 155.1, 135.2, 129.0, 128.6, 128.0, 80.2, 67.6, 
50.7, 38.1, 28.4, 22.4 ppm. 
  
131 
 
1,8-Dibenzyl [2S, 4R, 7S, S(S)]-2,7-bis-(tert-butyloxycarbonylamino)-4-hydroxy-5-(2-
methyl-propane-2-sulfinylamino)-octadioate (5.9) 
 
 
 
To a solution of SmI2 0.1 M in abs. THF (13 mL, 2.0 eq.) at -78 °C was added dropwise a 
solution of 5.11 (267 mg, 1.0 eq.), 5.10 (300 mg 1.5 eq.), and tert-butanol (96.5 mg, 2.0 eq.) 
in abs. THF (7 mL). The resulting solution was stirred for 5 h at the same temperature. The 
reaction was quenched by dropwise addition of a saturated solution of Na2S2O3 (20 mL) at -
78 °C. The solution was slowly warmed to room temperature and then the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3×15 mL). The unite organic 
layers were dried with Na2SO4 and the solvent was removed at reduced pressure. The residue 
was purified by flash chromatography (SiO2, 3:1:1 hexane/ethyl acetate/acetone) to afford 5.5 
(260 mg, 55 %) as white waxy solid. [α]D
20
 +28.7 (c 1.0 in CHCl3). 
 
1
H NMR (300 MHz, CDCl3): δ = 7.44-7.28 (m, 10H,), 5.78 (d, J = 5.2 Hz, 1H), 5.51 (d, J = 
8.0 Hz, 1H), 5.28-5.05 (m, 4H), 4.57-4.43 (m, 2H), 4.37 (d, J = 4.9 Hz, 1H), 3.94 (bs, 1H), 
3.59-3.46 (m, 1H), 3.36-3.22 (m, 1H), 2.22-2.09 (m, 1H), 2.08-1.93 (m, 1H), 1.88-1.71 (m, 
1H), 1.70-1.53 (m, 1H), 1.42 8 (s, 9H), 1.41 (s, 9H), 1.18 (s, 9H) ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 173.5, 172.8, 157.7, 157.0, 142.0, 141.8, 130.0, 129.7, 
129.6, 129.4, 129.3, 129.2, 73.4, 72.8, 71.0, 70.6, 68.0, 64.1, 54.9, 54.2, 53.9, 34.8, 32.0, 26.5, 
26.1, 24.3 ppm. 
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Benzyl [2S, S(S), 2ʹS, 4ʹS]-2-tert-butoxycarbonylamino-4-(4ʹ-tert-butoxycarbonylamino-
5ʹ-oxo-tetrahydro-furan-2ʹ-yl)-4-(2-methyl-propane-2-sulfinylamino)-butanoate (5.18) 
 
 
 
To a solution of 5.9 (200 mg, 1.0 eq.) in anhydrous CH2Cl2 (2 mL) at 0 °C were added DMAP 
(3.4 mg, 0.1 eq.) and dropwise triethylamine (116 μL, 3.0 eq.). The resulting solution was 
stirred for 8 h at room temperature. The solution was diluted with ethyl acetate (10 mL) and 
washed with saturated aqueous solution of NH4Cl (3×10 mL). The organic layer was dried 
with Na2SO4 and the solvent was removed at reduced pressure. The crude was purified by 
flash chromatography (SiO2, 3:1:1 hexane/ethyl acetate/acetone) to afford 5.18 (107 mg, 63 
%) as white waxy solid. [α]D
20
 +21.3 (c 1.0 in CHCl3). 
 
1
H NMR (300 MHz, CDCl3): δ = 7.46-7.23 (m, 5H), 5.88 (bs, 1H), 5.23-5.10 (m, 2H), 5.05 
(bs, 1H), 4.76 (bs, 1H), 4.60-4.52 (m, 1H), 4.44-4.37 (m, 1H), 4.33-4.24 (m, 1H), 3.36-3.24 
(m, 1H), 2.70-2.64 (m, 1H), 2.25-2.17 (m, 1H), 1.98-1.94 (m, 1H), 1.92-1.82 (m, 1H), 1.47 (s, 
9H), 1.42 (s, 9H), 1.20 (s, 9H) ppm. 
 
13
C NMR (75 MHz, CDCl3): δ = 174.0, 172.6, 155.7, 155.4, 135.12, 128.6, 128.3, 128.2, 
80.7, 80.3, 65.8, 29.7, 28.3, 28. ppm. 
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5.5 NMR spectra 
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6 CONCLUSIONS 
In conclusion, through this Ph.D. thesis it was possible to develop novel approaches for the 
discovery and development of new agrochemicals. This is particularly important considering 
the crucial role of this agents in maximizing crop production and the continuous need of new 
products to face the changes of the agronomic systems. 
 
In the first part of the thesis we demonstrated the value of the design of dual-target active 
compounds as a novel approach to the discovery and development of agrochemicals. In 
particular, we first confirmed that is possible to combine strobilurin fungicides with succinate 
dehydrogenase inhibitors obtaining compounds able to act on both target enzymes. Three 
compounds 3.23a-c expressing both strobilurin that SDH inhibitory activity have been 
identified. Out of these three compounds, 3.23a exhibits a remarkable antifungal activity 
against the fungus Pyricularia oryzae, which is the causal agent of one of the most serious 
diseases of cultivated rice, and responsible for 10-30 % yield loss of rice at harvest every 
year. Compound 3.23a was selected as a candidate for in vivo studies. Because of the 
promising antifungal activity, compounds 3.23a-c represent a valuable starting point for 
further optimization focused on the improvement of the activity and the spectrum of action. 
 
In the second part of the work, two different applications of the chemistry of samarium(II) 
iodide were investigated as versatile approaches in the synthesis of different bioactive 
compounds. Overall, we confirmed the synthetic utility of this reagent in developing 
alternative synthetic strategy. 
A SmI2-mediated Reformatsky reaction of Evans’ N-acyl-oxazolidinones with terpene 
aldehydes was studied as key step for the synthesis of cembranoids. The reaction was 
successfully performed and the role of a series of different factors (e.g. halide, double bond 
configuration, temperature etc.) on the outcome of the reaction was determined. The absolute 
configuration of the products of the reaction was successfully determined. Overall, we 
demonstrated that this reaction represents a complementary approach to Evans aldol reaction 
for the synthesis of cembranoids precursors, providing mainly products with syn-
configuration 
A SmI2-mediated pinacol coupling was studied as key step for the total synthesis of the 
natural herbicide auscalitoxin aglycone 5.1. We demonstrated the reliability of this approach, 
but further studies are needed to improve the reaction and to identify the factors that can 
influence the outcome of the reaction. We found that the coupling product 5.9 is unstable 
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since it easily undergoes to a cyclization reaction with the formation of a lactone. The 
instability is a limiting factor for further development of the synthesis. Variation of the 
protecting groups could be a strategy to overcome this problem. 
We determined the absolute configuration at C-4 of compounds 5.9 exploiting the 
lactonization product in a series of NMR experiments. Lactonization compound was 
successfully identified as compound 5.18. It was demonstrated a S configuration at the C-4. It 
was not possible to determine the absolute configuration at the C-5 because of the 
conformational mobility of the molecule. Further investigations are needed to confirm the 
configuration at this position. A possible approach could be the selective removal of the chiral 
auxiliary on the nitrogen at C-5. In this way, alternative cyclization pathways will be available 
leading to conformationally blocked compounds that could be used in further NMR studies. 
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7 MATERIALS AND METHODS 
7.1 Solvents and general experimental procedures 
All the chemicals were provided by supplier and used without further purification unless 
otherwise stated. The solvents were purified by distillation and dried using various desiccants 
as show in Table 7.1. 
 
Table 7.1 Absolute solvents and their respective dessicants 
Solvent Dessicant 
Tetrahydrofuran 
Sodium/Benzophenone (Ch. 3,5) 
or 
Potassium/Benzophenone (Ch. 4) 
 
Dichlorometane 
Phosphorous pentoxide (Ch. 3,5) 
or 
Calcium hydride (Ch. 4) 
 
Acetone 4 Åmolecular sieves 
Methanol 3 Å molecular sieves 
 
Samarium (II) iodide solution was prepared as described by Concellón et al. in 2003 by 
sonication of metallic samarium powder and iodine in dry degassed THF.
1
 
When necessary solvents were degassed by bubbling nitrogen through the solvent for 30 
minutes. All reactions requiring anhydrous conditions were performed under a positive 
nitrogen flow with with Schlenk-type oven-dried and/or flame-dried glassware. 
Low temperature reactions were carried out using Kryostat TC100E (Huber). 
 
7.2 Analytics and Apparatus 
The following equipment was used for the characterization of compounds 
 
7.2.1 NMR Spectroscopy 
NMR spectra were recorded on Varian Mercury 300 (
1
H, 300 MHz; 
13
C 75 MHz) and Bruker 
AV600 (
1
H, 600 MHz; 
13
C 150 MHz) spectrometers (Chapter 3,5), or on Bruker Avance 700 
(
1
H, 700 MHz; 
13
C 175 MHz), Bruker Avance 500 (
1
H, 500 MHz; 
13
C 126 MHz), Bruker 
Avance 400 (
1
H, 400 MHz; 
13
C 100 MHz), Bruker Avance 300 (
1
H, 300 MHz; 
13
C 75 MHz). 
(Chapter 4) 
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TMS was used as an internal standard. CDCl3 was used as solvent for the spectroscopy. All 
the spectra were recorded at room temperature.  
1
H signals were referred to by the following abbreviations: s (singlet), d (doublet), t (triplet), 
dd (doublet of doublets), m (multiplet). 
 
7.2.2 IR Spectroscopy 
FT-IR were recorded on Bruker FT-IR-Spectrometer Vector 22 with MKII Golden Gate 
Single Reflection Diamant ATR system. The absorption bands have been rounded to the 
nearest wavenumber and the intensity of each band was abbreviated to: vs (very strong), s 
(strong), m (medium), w (weak). (Chapter 4) 
 
7.2.3 Mass spectrometry 
Mass spectra (MS) and high-resolution mass spectra (HRMS) were recorded with a Bruker 
Daltonics MicroOTOF-Q spectrometer for measurements with electrospray ionisation (ESI) 
or a Finnigan MAT MAT 95 spectrometers for electron impact ionisation (EI). (Chapter 4) 
 
7.2.4 Polarimetry 
Optical rotations were measured with P-2000 polarimeter (Jasco) (Chapter 3,5) or with 
Perkin-Elmer 241 polarimeter (Chapter 4) at 20 °C 
 
7.2.5 Thin layer chromatography 
Analytical TLC was conducted on TLC plates (silica gel 60 F254, aluminum foil). Substances 
were detected with a UV-light source (λ = 254 or 365 nm) or stained with by spraying with 
10% phosphomolybdic acid solution [10.0 g phosphomolybdic acid in 100 mL of abs. 
ethanol] or with ninhydrin solution [1.5 g ninhydrin, 3.0 mL acetic acid in 100 mL of abs. 
ethanol]. (Chapter 3,5) 
ALUGRAM
®
 Xtra SIL G/UV254 Aluminium sheets pre-coated with 0.2 mm of silica gel 60 F
254
 
(Macherey-Nagel) were used for thin layer chromatography (TLC). Substances were detected 
with a UV-light source (λ = 254 nm) or stained by spraying with anisaldehyde solution [6.0 g 
anisaldehyde, 1.5 mL conc. H2SO4 in 250 mL ethanol]. (Chapter 4) 
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7.2.6 Column chromatography 
Isolation and purification of the compounds were performed by flash column chromatography 
on silica gel 60 with grain size within 40-63 μm (Sigma), (Chapter 3,5), or on silica gel with 
grain size within 40-63 μm (Fluka). (Chapter 4) 
 
7.3 Antifungal activity evaluation 
7.3.1 Fungal strains 
The following fungal and oomycete strains, belonging to a collection maintained in the 
laboratory of Plant Pathology at DeFENS, University of Milan, Italy, were used in the study: 
Botrytis cinerea BC4A and BC-2F-2016, Curvularia sp. CURV3, Fusarium fujikuroi FFM2 
and FFM4, Pyricularia oryzae A2.5.2, TA102, A.4.31.1-0 and A4.31.1-1, Pythium ultimum 
FW407 and Sclerotinia sclerotiorum SW361. Rhizoctonia solani FW408 was obtained from 
Dr. Andrea Minuto (Centro di Sperimentazione e Assistenza Agricola, Albenga, Italy). The 
strains were maintained as single-spore isolates in malt-agar medium slants (MA: 20 g/L malt 
extract, Difco Laboratories, USA; 15 g/L agar, Applichem, Germany) at 4 °C. 
 
7.3.2 Fungicides 
The following commercially available fungicides were used in the study: azoxystrobin (AZX, 
Amistar SC – suspension concentrate, 22.9 % active ingredient., Syngenta Crop Protection), 
kresoxim-methyl (KM, Sovran WG – wettable granules, 50 % active ingredient., BASF Italia, 
S.p.A.), fluopyram (FLP, Luna Privilege SC, 50 % active ingredient., Bayer CropScience, 
S.r.l) and fluxapyroxad (FXP, Sercadis EC – emulsifiable concentrate, 30 % active 
ingredient., BASF Italia, S.p.A.). 
 
7.3.3 Inhibition of mycelium growth on media supplemented with fungicides 
A mycelium plug (0.5 cm in diameter) obtained from actively growing fungal colonies of B. 
cinerea BC4A and BC-2F-2016, Curvularia sp. CURV3, F. fujikuroi FFM2 and FFM4, P. 
oryzae A2.5.2 and TA102, P. ultimum FW407, R. solani FW408 and S. sclerotiorum SW361 
was transferred to MA medium plates supplemented with fungicides at the concentration 25 
mg/L ai. Because the tested molecules had low solubility in water, they were dissolved in 
acetone. Therefore, two controls were included: MA medium not supplemented with 
fungicides (NTC), and MA medium supplemented with acetone at the final concentration 1% 
v/v (ACT). The plates were incubated at 24 °C in the dark. The mycelium growth was 
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measured 2-7 days after inoculation (dai) and the inhibition of mycelium growth (%) was 
calculated by comparing the mycelium growth on control and fungicide-supplemented plates. 
The mycelium growth of four strains of P. oryzae (A2.5.2, TA102, A.4.31.1-0 and A4.31.1-1) 
was evaluated on MA plates supplemented with increasing concentrations of selected 
compounds and. commercial fungicides. Again, NTC and ACT were included as controls. 
The mycelium growth was measured after 3-12 dai and the inhibition (%) was calculated as 
described above.  
 
7.4 Cell-free enzymatic assay 
7.4.1 Preparation of P. oryzae submitochondrial fraction 
The submitochondrial fraction was prepared according to Ye et al. with some modifications.
2
 
Mycelium liquid culture (200 mL, 20 g/L malt extract medium, ML, in 1 L flask) was 
inoculated with 10 MA plugs of actively-grow P. oryzae (A2.5.2) and incubated at 25 °C in 
an orbital shaker (124 rpm) in the dark for 5 days. Mycelium was cooled on ice and harvested 
by vacuum filtration through Miracloth (Calbiochem
®
, La Jolla, CA, U.S.A.). During vacuum 
filtration residual culture medium was removed by washing 3-times with 30 mL of ice pre-
cooled water. The collected well-drained mycelium was chopped in small pieces by scalpel 
and thoroughly powdered in mortar and pestle in the presence of liquid nitrogen. The 
mycelium powder (~ 6 g) was suspended in 10 volumes of ice-cooled mitochondrial buffer 
(0.5 M sucrose, 10 mM KH2PO4, 10 mM KCl, 10 mM MgCl2, 0.2 mM EDTA, pH 7.2), and 
mildly mixed 60 min by magnetic stirrer at 4 °C. The suspension was centrifuged two-times 
10 min at 4 °C, 5500 rpm (rotor JA20, Beckman). The cleared supernatant was furtherly 
centrifuged 20 min at 4 °C, 11250 rpm (rotor JA20, Beckman). The collected pellet (~ 33 mg) 
was suspended in mitochondrial buffer (1 mL / centrifuge tube), fractionated in 2 Eppendorf 
tubes and centrifuged again 20 min at 4 °C, 10000 rpm (rotor F45-24-11, Eppendorf). Each 
pellet was suspended in 0.2 mL of the same buffer and stored at - 80 °C till use. 
 
7.4.2 Cell-free NADH-consumption assay 
The mitochondrial NADH-driven respiration was evaluated monitoring the oxidation rate of 
NADH in the presence of the submitochondrial fraction according to Steinfeld et al. with 
some modifications.
3
 The assay was carried out using a spectrophotometer (Lambda2S; 
Perkin Elmer, UK) equipped with a thermostated (30°C) cell holder (Peltier Temperature 
Programmer, PTP6; Perkin Elmer, UK) in a cuvette containing the assay buffer (82 mM 
HEPES, 8 mM MgSO4, pH 8), 0.2 mM NADH (added from a 4 mM stock in 0.05 M 
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Tris/HCl, 1 mM EDTA, pH 7.7) in the presence of azoxystrobin (Pestanal
®
) and selected 
compounds (20-200 µM; from stock in DMSO), or DMSO (negative inhibition control). The 
reaction was started with the addition of the submitochondrial fraction suspension (10 µL). 
The time-drive absorbance ( = 340 nm) decrease in the first 60 sec time-window was used 
for the measurement of the initial NADH-oxidation rate. Each rate was subtracted from the 
NADH autoxidation rate (recorded soon before the addition of submitochondrial fraction). 
The rate of the negative inhibition control was used to calculate the percent inhibition value. 
 
7.4.3 Cell-free DBH2-Cyt c oxidoreductase activity assay 
The inhibition of DBH2-Cyt c oxidoreductase activity was evaluated monitoring the reduction 
rate of Cyt c in the presence of the submitochondrial fraction according to Zhu et al. with 
some modifications.
4
 The assay was carried out using a spectrophotometer (Lambda2S; 
Perkin Elmer, UK) equipped with a thermostated (30°C) cell holder (Peltier Temperature 
Programmer, PTP6; Perkin Elmer, UK) in a quartz cuvette containing the assay buffer 
(KH2PO4 50 mM previous degassed by stirring under vacuo, 3 mM NaN3, 0,01 % lauryl 
maltoside, pH 7.4), Cyt c (added from a stock 2 mg/mL in stock in 0.05 M Tris/HCl, 1 mM 
EDTA, pH 7.7), and after 30 seconds, reduced decilubichinone (added from a stock reduced 
decylubichinone in 245 µL HCl 1 M in ethanol degassed with a stream of nitrogen), in the 
presence of azoxystrobin (Pestanal
®
), fluxapyroxad (Pestanal
®
) and selected compounds (20-
200 µM; from stock in DMSO), or DMSO (negative inhibition control). The reaction was 
started with the addition of the submitochondrial fraction suspension (10 µL). The time-drive 
absorbance ( = 550 nm) decrease in the first 6 sec. Each rate was subtracted from the Cyt c 
autoreduction rate (recorded soon before the addition of submitochondrial fraction). The rate 
of the negative inhibition control was used to calculate the percent inhibition value. 
Reduced decylubiquinone was prepared from 2,3-dimethoxy-5-methyl n-decyl-1,4-
benzoquinone (Sigma) following the procedure described by Gudz et al.
5
 After the reaction 
the solvent was removed by flushing with a stream of nitrogen and the product was liofilized 
(Savant Speedvad Concentrator). The product was dissolved in degassed ethanol acidified 
with 10mM HCl and stored at -80 °C. 
 
7.4.4 Cell-free SDH activity assay 
The inhibition of SDH activity was evaluated monitoring by comolorimetric assay in the 
presence of the submitochondrial fraction according to Ye et al. with some modifications.
2
 
The assay was carried out using a spectrophotometer (Lambda2S; Perkin Elmer, UK) 
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equipped with a thermostated (30°C) cell holder (Peltier Temperature Programmer, PTP6; 
Perkin Elmer, UK) in a microtitration plate containing assay buffer (sodium succinate 50 mM, 
saccharose 250 mM , 3 mM NaN3, pH 7.2), the submitochondrial fraction suspension 
(preactivated with sodium succinate 10 mM at 30 °C for 30 min.; 5-20 L according to 
activity). 0.2mM 2,3-dimethoxy-5-methyl-1,4-benzoquinone, 140 M DCPIP, in the presence 
of fluxapyroxad (Pestanal
®
), azoxystrobin (Pestanal
®
) and selected compounds (20-200 µM; 
from stock in DMSO), or DMSO (negative inhibition control). The reaction was started with 
the addition of 10 mM sodium succinate. The time-drive absorbance ( = 595 nm) was 
measured after 2, 5, 10, 20, 30, 40, 50, and 60 min. The rate of the negative inhibition control 
was used to calculate the percent inhibition value. 
 
7.5 Molecular modelling 
The CytB homology model was based on the primary sequence of the CytB protein from P. 
grisea (Uniprot code: Q85KP9). The structure of CytB from P. grisea was modelled by using 
the resolved CytB structure from S. cerevisiae in complex with the inhibitor Stigmatellin A 
(PDB Id: 3CX5) as the template.  
The SDH structure is composed of four subunits which have to be modelled together since the 
binding site is located at the interface between them. In detail, the homology model was based 
on three primary sequences from P. oryzae (i.e. Subunit A: G4NE44; Subunit B: L7JQS7; 
Subunit C: G4N2P5) while the sequence from P. grisea was used for subunit D (Q5G5B2) 
since the corresponding sequence from P. oryzae is unavailable. Then the SDH structure was 
generated based on the resolved structure of the porcine enzyme in complex with N-[(4-tert-
butylphenyl)methyl]-2-(trifluoromethyl)benzamide (E23). 
In both cases, the sequence alignment was performed by NIH Cobalt
6
 while the homology 
models were generated by Modeller9.16.
7
 Among the proposed models, the best ones were 
selected based on DOPE and GA341 scores and optimized by keeping fixed the backbone 
atoms to preserve the predicted folding. The Stigmatellin A and E23 ligands were then 
accommodated within the binding sites of the selected models by superimposing the key 
residues with those of the utilized templates. The so obtained complexes were finally 
minimized by keeping fixed all atoms outside a 10 Å radius sphere around the bound ligands. 
The so optimized complexes revealed a set of stabilizing interactions very similar to those 
seen in the resolved structures, a finding which emphasizes the reliability of the generated 
homology models. 
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The conformational profile of the considered ligands was explored by Monte Carlo 
procedures as described elsewhere.
8
 
The docking simulations were performed by PLANTS focusing the search on a 8.0 radius 
sphere around the bound ligands.
9
 For each ligand, 10 poses were generated and scored by the 
ChemPLP score with a speed equal to 1. Along with the computed primary score, the best 
complexes were also selected based on the interaction similarity with the complexes with 
Stigmatellin A and E23. The so obtained complexes were finally minimized by keeping fixed 
all atoms outside a 10 Å radius sphere around the bound ligand.  
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ABSTRACT 
BACKGROUND: Superficial fungal infections are the most common fungal diseases in 
humans, affecting more than 25% of the population worldwide. Methods: In the present study, 
we have investigated the activity of kakuol, a natural compound isolated from the rhizomes of 
Asarum sieboldii, and some analogues, against various dermatophytes and pharmacologically 
relevant yeasts.  
RESULTS: One of the tested compounds, 2-acryloyl-4,5-methylenedioxyphenol, showed a 
broadspectrum activity against most of the fungal species assayed, resulting particularly 
effective against dermatophyte strains (MIC values in the range of 0.25-0.5 μg/mL, two/four-
fold lower than the positive control miconazole).  
CONCLUSION: The results suggest that this molecule can be considered a promising 
starting point for the development of new antifungal compounds. 
 
Keywords: kakuol, Asarum sieboldii, antifungal agents, Candida albicans, dermatophytes, 
3,4-methylenedioxyphenol. 
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ABSTRACT 
BACKGROUND: Crop disease management often implies repeated application of 
fungicides. However, hazardous effects of fungicides to human health and environment and 
the increasing emergence of fungicide-resistant pathogens are the major drawbacks to their 
uses. Tank-mix combination treatments using fungicides with different modes of action is in 
general hard to manage either by farmers or chemical companies. An alternative and 
unexploited strategy is based on the use of bifunctional fungicides, i.e. compounds resulting 
from conjugation of the pharmacophores of fungicides with different mechanisms of action. 
RESULTS: In this paper we report our efforts to develop a new approach to antifungal 
treatment based on the synthesis of dual agents. The hybrids were obtained by merging into a 
new entity the pharmacophores of strobilurins and SDH inhibitors. The selected compound 
inhibits the growth of P. oryzae with activity comparable with kresoxim-methyl, and even 
better than that of fluopyram. Inhibition of the NADH-driven respiration in cell-free 
submitochondrial preparations of P. oryzae confirmed the hypothesis that the mitochondrial 
respiratory electron-flow is targeted by this molecule.  
Molecular modelling studies showed that the selected compound is capable of forming stable 
complexes with both CytB subunit and succinate dehydrogenase enzyme, providing a 
computational validation to the design of strobilurin-SDHI-dual molecules.  
CONCLUSION: Due to the call for additional molecules active against P. oryzae, one of the 
most detrimental pathogens worldwide, this work can be considered an important first step 
towards the development of novel dual-action agents with optimized structure and improved 
interaction with the targets.  
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Keywords: dual-action inhibitors, antifungal compounds, succinate dehydrogenase inhibitors 
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Plant pathogenic fungi are among the major causes of crop losses worldwide. Although these 
losses may be reduced using suitable agronomical practices, fungicides remain a critical 
element to increase crop production. Fungicides play also an important role in the control of 
mycotoxin-producing fungi ensuring the quality of food. 
Due to a substantial reduction of available fungicides after the EU revision of agrochemicals 
and because of the risk of fungicide resistance emergence in pathogen populations, new 
fungicides must be continuously developed. Resistance to fungicides is one of the most 
serious problems in disease management and generally the use of a single molecule is not able 
to provide a durable control of fungi. 
The efficacy of fungicides could be improved using hybrid bifunctional molecules, i.e. 
compounds containing the pharmocophores of different fungicides designed to inhibit 
simultaneously multiple targets relevant to pathogen growth/survival. 
Here we report the results of our efforts to develop new hybrid fungicides. In particular, we 
combined the pharmacophoric features of two classes of commercially validated antifungal 
compounds: strobilurines and succinate dehydrogenase inhibitors. 
The dual inhibitors were designed based on reported SAR studies on both classes of 
fungicides, which allowed to define the key moieties of the new hybrid molecules. A simple 
divergent synthetic strategy was developed for the preparation of the hybrids and the 
antifungal activity was assessed in vitro against different pathogenic fungi of agronomical 
interest. Moreover, the inhibitory activity on the enzymatic target was assessed in vitro on 
mitochondrial fraction to elucidate the mechanism of action of the new synthesized 
molecules. 
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This Ph.D. thesis dealt with the exploration of a new approach for antifungal agents discovery 
based on the synthesis of hybrid bifunctional compounds. The molecules were obtained by 
merging the pharmacophoric features of existing fungicides belonging to the class of 
succinate dehydrogenase inhibitors (SDHI) and of strobilurins. 
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Nanomaterials possess physico-chemical properties that are different from the same material 
on macroscale. For this reason, they are very interesting for applications in many disciplines 
such as medicine, food and environment sciences. Several studies show that nanomaterials 
could be successfully applied also to agricultural production and crop protection. In fact, there 
are evidences that some nanomaterials could be used to enhance seeds germination and plants 
growth, as nanosensors for detection of pesticide residue and pathogens and for improvement 
of existing arochemicals. 
As regards agrochemicals, the use of nanomaterials and more generally of the 
nanotechnologies is emerging in recent years and it is expected to be in rapid development in 
the near future. In particular, the efforts are oriented to the development of nanoformulations, 
i. e., formulations that consist in or contain elements with dimensions on nanoscale. The aims 
of nanoformulations are basically the improvement of the solubility and therefore of the 
bioavailabilty of the active ingredients and the realization of controlled/targeted release. 
More interestingly, nanomaterials could be used as nanocarriers for pesticides. Indeed, they 
could provide a better penetration and distribution of the active ingredients in the plants, 
resulting in an increased efficacy and a possible reduction of the required doses. Despite the 
potential advantages of the use of pesticide nanocarriers this topic is still underexplored and 
very little is reported in the scientific literature. For these reasons we planned to explore the 
possibility of using gold nanoparticles as nanocarriers for fungicides and to evaluate their 
activity against well known pathogens of agronomical interest. Here we describe the synthesis 
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and the functionalization of gold nanoparticles with a triazole fungicide. The active moiety of 
tetraconazole was derivatized with a spacer chain in order to provide an uncleavable linker, 
and then it was linked to gold nanoparticle by a PEG chain. The functionalized nanoparticles 
were fully caracterized and then both their preventive and curative antifungal activity was 
assessed against experimental infection with powdery mildew (Podosphaera fusca) of 
cucumber plants (Cucumis sativus) under greenhouse conditions. 
